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STELLINGEN 
1. Ook met betrekking tot de Iichaamsvetverdeling van dikke vrouwen kan men 
appels (abdominale vetverdeling) niet met peren (gluteaal-femorale vetverdeling) 
vergelijken. 
Dit proefschrift 
2. De aanzienlijke bijdrage van bet gewichtsverlies aan de verbetering van het serum-
lipidenprofiel van dikke mensen bij een energiebeperkt dieet benadrukt het belang 
van afslanken. 
Dit proefschrift 
3. Dikke mensen met een overmaat aan visceraal vet (abdominale vetverdeling) 
vallen niet makkelijker af dan dikke mensen met weinig visceraal vet (gluteaal-
femorale vetverdeling). 
-Dit proefschrift 
4. De vetverdeling over het lichaam verandert door gewichtsverlies. 
O.a. dit proefschrift 
5. Peervormige vrouwen zijn vruchtbaarder dan appelvormige vrouwen. 
Zaadstra BM, et at Fat and female fecundity: prospective study of effect of body fat 
distribution on conception rates. Br Med J 1993;306:484-487 
6. Het meeste baat bij het gebruik van 'afslank'-produkten heeft niet de consument 
maar de producent 
7. Eenvoud siert niet alleen de mens, maar ook het wetenschappelijk onderzoek. 
8. Het in Pakistan bestaande 'purdah'-systeem, dat ervoor zorgt dat vrouwen letterlijk 
en figuurlijk slecht te bereiken zijn, bemoeilijkt het geven van voedings-
voorlichting. 
9. "Studies with a statistically significant result for the main outcome of interest are 
more likely to be submitted for publication and more likely to be published than 
studies with null results. Therefore, conclusions based only on a review of published 
data should be interpreted cautiously." 
Easterbrook PJ, et aL Publication bias in clinical research. Lancet 1991;337:867-872 
10. "Het is niet belangrijk wat men van ons maakt, maar wat wij zelf maken van wat 
men van ons gemaakt heeft." ("L'important n'est pas ce qu'on fait de nous, mais ce 
que nous faisons nous-meme de ce qu'on a fait de nous.") 
Sartre J-P. Saint Genet, comidien et martyr, 1952 
11. Het feit dat geld voor ontwikkelingssamenwerking niet altijd op de juiste plaats 
terecht komt, impliceert niet dat de kraan voor ontwikkelingssamenwerking dicht 
gedraaid moet worden. 
12. Links rijden en rechts voorrang verlenen is veiliger dan rechts rijden en rechts 
voorrang verlenen. 
13. "Over 100 jaar zijn jullie allemaal dood en wij ook!" 
Klein Orkest (Jekkers H & Smit L) 
Stellingen behorend bij het proefschrift Visceral fat and weight loss in obese subjects -
relationship to serum lipids, energy expenditure and sex hormones-' van Rianne Leenen. 
Wageningen, 28 april 1993. 
CONTENTS 
Abstract 
Chapter 1 
Chapter 2 
Chapter 3 
Chapter 4 
Chapter 5 
Chapter 6 
Introduction 
Visceral fat accumulation measured by magnetic resonance 
imaging in relation to serum lipids in obese men and women 
(Atherosclerosis 1992;94:171-181) 
Visceral fat accumulation in obese subjects: relation to energy 
expenditure and response to weight loss (American Journal of 
Physiology: Endocrinology & Metabolism 1992;263(26):E913-E919) 
Visceral fat loss measured by magnetic resonance imaging in 
relation to changes in serum lipid levels of obese men and 
women (Arteriosclerosis and Thrombosis 1993;13:487-494) 
Relative effects of weight loss and dietary fat modification on 
serum lipid levels in the dietary treatment of obesity (Submitted 
for publication) 
Visceral fat accumulation in relation to sex hormones in obese 
men and women undergoing weight loss therapy (Submitted for 
publication) 
Chapter 7 General discussion 
Appendix Nutrient composition of the diets given in the study 
list of abbreviations 
Summary 
Samenvatting 
Dankwoord/ Acknowledgements 
Curriculum vitae 
9 
11 
21 
35 
51 
67 
81 
97 
109 
111 
113 
115 
119 
123 
VISCERAL FAT AND WEIGHT LOSS IN OBESE SUBJECTS 
-relationship to serum lipids, energy expenditure and sex hormones-
PhD Thesis, Department of Human Nutrition, Wageningen Agricultural University, 
The Netherlands, 28 April 1993. 
Rianne Leenen 
ABSTRACT 
This thesis describes the relationships between visceral fat accumulation and serum 
lipids, energy expenditure, and sex hormone levels in healthy obese men and 
premenopausal women undergoing weight loss therapy. The subjects, aged 27-51 years, 
with an initial body mass index of 28-38 kg/m2, received a controlled diet for 13 weeks 
providing a 4.2 MJ/day energy deficit. Magnetic resonance imaging was used to quantify 
fat depots. 
In women but not in men, visceral fat accumulation was associated with a less 
favourable serum lipid profile independent of age and body fat percentage. In addition, 
in women only, visceral fat predominance was positively related to resting metabolic rate 
(RMR) and diet-induced thermogenesis (DIT) as well as to a relatively increased 
androgenicity. In obese men, no relationship could be found between visceral fat 
accumulation and any of the sex hormone levels. 
The mean weight reduction of 12.2 ± 3.5 (SD) kg due to the energy-deficit diet, 
resulted in larger reductions in serum levels of total cholesterol, LDL cholesterol, and 
triglycerides and a larger increase in the HDL cholesterol/LDL cholesterol ratio in men 
compared with women. Men with an initially larger visceral fat depot than women did 
not lose more body weight, but they lost more visceral fat than women. Comparison of 
these average changes between both sexes suggests a potential role of visceral fat loss 
in improving the serum lipid profile. While in women, a loss of visceral fat was related 
to an increased HDL cholesterol, a more general beneficial effect of visceral fat loss was 
not seen using correlation analyses within each sex. In women but not in men, visceral 
fat accumulation before weight loss was associated with improvement of HDL cholesterol 
and triglyceride levels after weight loss. In women only, a reduction in the visceral fat 
depot also seems to be accompanied by a relative reduction in androgenicity regardless 
of total body fat loss. 
In this study, the effect of weight loss alone on serum lipids could be separated from 
the effect of dietary fat modification usually accompanying a dietary weight loss 
treatment. The favourable effect of weight loss per se seems to be considerable in 
optimizing the serum lipid profile of obese subjects and even greater than that of dietary 
fat modification. 
It is concluded that there may be gender differences in the associations between 
visceral fat accumulation and serum lipids, energy expenditure (RMR and DIT), and sex 
hormone levels in healthy moderately obese subjects. In addition, particularly healthy 
moderately obese women with a visceral fat predominance benefit from a dietary weight 
loss treatment with respect to their serum lipid profile and sex hormone levels. In healthy 
moderately obese men, the critical role of the visceral fat depot could not be confirmed. 
CHAPTER 1 
INTRODUCTION 
Human obesity, which is generally defined as an excessive storage of body fat, is a major 
public health problem in affluent societies. Estimates of its prevalence range from 10-
50% or more in the adult population, depending entirely upon the criteria used to define 
obesity (1-3). It is well known that obesity is associated with a large number of metabolic 
complications, including coronary heart disease (CHD), cerebrovascular disease, non-
insulin-dependent diabetes mellitus (NIDDM), gallbladder disease, hormone-dependent 
neoplasms such as carcinoma of endometrium, as well as other diseases such as gout and 
diseases of joints (4,5). Obese subjects are usually advised to lose body weight by means 
of energy intake restriction in order to reduce the increased health risks associated with 
obesity. 
However, several studies have suggested that not just the amount of excessive fat 
deposited in the body, but its localisation may be responsible for some of the known 
health hazards of obesity (6). In particular, the adipose tissue stored in the abdominal 
cavity i.e. the visceral fat depot, seems to play a crucial role (7-9). Enlargement of the 
main peripheral fat depots, the subcutaneous femoral and gluteal fat depots, typically 
observed in women, has been found to increase the risk for varicose veins (10) and may 
be a source of concern because of aesthetic reasons (11), and might, therefore, constitute 
a relatively minor medical risk. There is now increasing support to recommend weight 
loss treatment primarily for those obese individuals with abdominal fat predominance 
(12,13). However, clear and consistent evidence for this recommendation is still scarce. 
The purpose of the research described in this thesis was, therefore, to study the 
relationships between visceral fat accumulation and serum lipids, energy expenditure, and 
sex hormones in healthy obese men and premenopausal women undergoing weight loss 
therapy. In contrast to most other studies, both men and women were involved. 
This introduction briefly describes the associations between body fat distribution and 
the three mentioned aspects. An outline of this thesis and a short description of the study 
design are given at the end of this chapter. 
Body fat distribution 
Jean Vague (14) was the first to postulate that the pattern of body fat distribution in 
humans, classified by the brachio-femoral adipo-muscular ratio, had metabolic 
significance. An increased localisation of body fat in the upper body is seen more 
frequently in men than in women and has been denoted android, centralised, abdominal 
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or visceral obesity in the literature, depending on the different indices used for 
classification. Lower body obesity is regarded as characteristic in women and the 
following nomenclature has been used for this type of obesity: gynoid, peripheral or 
gluteal-femoral obesity. Both types of fat distribution do, however, occur in men as well 
as in women. 
Various anthropometric indexes like skinfold thicknesses and body circumference 
measurements, have been used to assess body fat distribution (4). The most commonly 
anthropometric measurement used to describe body fat distribution has been the ratio 
of waist/hip circumference, which is a relatively simple indicator of fat distribution, and 
therefore, particularly useful for epidemiological studies. Although by using 
anthropometry for the classification of body fat topography, one can distinguish between 
upper and lower body fat predominance, one can not differentiate between the various 
fat depots (15,16). 
Currently, the deposition of visceral fat seems to be the most hazardous fat depot for 
metabolic disorders (7-9). The recent utilization of imaging techniques such as computed 
tomography (CT) and magnetic resonance imaging (MRI), does allow the quantification 
of adipose tissue at the various sites of the body accurately (17-19). MRI is a non-
invasive technique without X-ray exposure for the subjects, and thus, an useful alternative 
to CT in longitudinal studies with repeated measurements of total body scanning, in 
which the total exposure to ionizing radiation could be considerable. The technical and 
practical aspects of these two scanning techniques have been discussed in detail 
Figure 1. Transversal MRI-images at abdominal level of an obese subject with visceral fat 
accumulation (left) and an obese subject with a large amount of subcutaneous fat 
(right). Adipose tissue is represented by white areas. 
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elsewhere (20). In the study described in this thesis, MRI was used to determine the size 
of the visceral fat depot. Figure 1 shows transversal MRI-images at abdominal level of 
two obese subjects, one with a visceral fat predominance and one with an abundance of 
subcutaneous fat. 
Body fat distribution and serum lipids 
Epidemiological studies have demonstrated that an abdominal fat distribution is a risk 
factor for coronary heart disease independent of the degree of obesity (21-23). This 
suggests an important role of body fat topography in determining serum lipid levels. It 
is known that adipose tissue differs physiologically and morphologically depending on its 
anatomical location, and that the visceral adipose tissues in particular have specific 
unfavourable characteristics (24-26). 
Accumulation of visceral adipose tissue may lead to a considerable free fatty acid 
(FFA) flux into the portal vein, exposing the liver to high concentrations of FFA. High 
portal FFA concentrations are known to cause increased hepatic secretion of very-low-
density-lipoproteins (VLDL), leading to increased triglyceride levels and decreased levels 
of high-density-lipoproteins (HDL) (8). VLDL is secreted from the liver in proportion 
to elevated portal FFA levels, thus increasing the risk of increased concentrations of 
circulating low-density-lipoproteins (LDL) as well. Another important effect of exposure 
of the liver to high concentrations of FFA is an increased hepatic gluconeogenesis (8), 
probably via stimulation of regulatory key enzymes (27). Previous studies have shown 
that FFAs also effectively inhibit hepatic insulin uptake and catabolism (28,29), which 
may lead to pronounced hyperinsulinaemia and peripheral insulin resistance. Kissebah 
and Peiris (30) have demonstrated that upper body fat localisation is characterized by 
a greater decrease in hepatic and peripheral insulin sensitivity, as well as a marked 
reduction in maximal stimulation of peripheral glucose utilization. Hyperinsulinaemia 
seems also to be associated, perhaps causally, with hypertension (31) as well as with 
increased VLDL (32). Overall, FFAs in the portal circulation increase circulating 
concentrations of VLDL, LDL, glucose, and insulin, as well as indirectly blood pressure, 
and decrease HDL concentrations. These end-results represent most of the well-
established risk factors for CHD and NIDDM. They are often found together as a 
cluster, which has been termed 'syndrome X' (32). Abdominal obesity may be an 
important element in the causation of this 'syndrome'. 
However, recent studies in which the associations between body fat distribution and 
serum lipid levels were investigated in obese and non-obese subjects, yielded several 
contradictory results (Chapter 2). Therefore, in the present study, the relationships 
between visceral fat accumulation and serum lipids were examined cross-sectionally as 
well as prospectively in men and women. 
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Body fat distribution and energy expenditure 
The common therapeutic approach to reduce the obesity-related risks is to reduce body 
weight. Several studies have previously evaluated the ability to lose body weight in 
relation to regional fat distribution, but the results of these studies were conflicting (33-
39). Some studies have suggested that obese women with an abdominal type of fat 
distribution may lose body weight and fat easier than those with a gluteal-femoral fat 
distribution (33-35). Other investigators did not observe associations between the type 
of body fat distribution and the extent of weight reduction (36-39). 
It has previously been proposed that an excessive accumulation of visceral fat 
increases energy expenditure due to its greater metabolic activity and above all, of its 
especially high lipolytic activity. However, several studies could not confirm the existence 
of a link between body fat distribution and energy expenditure (39-42). This thesis 
focused, in particular, on two components of total energy expenditure: resting metabolic 
rate (RMR) and diet-induced thermogenesis (DIT). These elements together account for 
70-85 percent of total energy expenditure in the average sedentary adult individual. 
Detailed description of both components as well as the methodological aspects of these 
measurements are reported elsewhere (43). 
Body fat distribution and sex hormones 
In view of the clear different patterns of fat deposition in men and women (14,44), it 
seems reasonable to postulate that upper body obesity is associated with 'masculinity' 
(male sex hormones) and lower body obesity with 'femininity' (female sex hormones). 
Thus, obese women having an upper body fat distribution may have hyperandrogenism, 
or higher production rates and/or blood levels of androgens, whereas lower body obesity 
in men may be associated with relatively increased oestrogen levels. Indeed, obese 
women exhibiting overt signs of hyperandrogenism such as hirsutism and poly cystic ovary 
syndrome, are found to have a typical male upper body fat distribution (45,46). In men 
with decreased androgen and elevated oestrogen production, i.e. Klinefelter's syndrome, 
other forms of male hypogonadism, and advanced cirrhosis, a tendency towards a lower 
body fat distribution has been reported (47,48). These studies, however, referred mostly 
to pathological situations. 
It has previously been suggested that sex hormones may play an important role in the 
regulation of body fat distribution (49,50), due to their specific effects on adipocyte 
metabolism in the different regions of the body. However, comparison of the various 
studies in which the relationship between the distribution of adipose tissue and sex 
hormones were investigated, revealed many discrepancies (Chapter 6). Nevertheless, the 
most consistent finding was an inverse association between abdominal fat distribution 
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and sex-hormone-binding globulin (SHBG) levels, although not all studies could confirm 
this finding. SHBG acts as a transport protein by reducing the metabolic clearance rate 
of most sex hormones and thereby prolonging their effective half-life time in peripheral 
blood (51). SHBG levels are determined largely by the ratio of androgens to oestrogens 
(52). Since the affinity of SHBG for testosterone is considerably higher than that for 
oestradiol (52), SHBG seems to be a sensitive indirect indicator for androgenicity. 
Furthermore, SHBG plays a role in the availability for biological activity of these 
hormones, since it has been demonstrated that the fraction not bound to SHBG is 
biologically available (53). Thus, changes in SHBG concentrations regulate the 
availability of free sex hormones in blood plasma and vice versa. 
Differences in study populations, and in methods used for the assessment of sex 
hormone levels and body fat distribution may be explanations for the inconsistent 
findings, in particular with respect to androgen and oestrogen levels. All previous studies 
used the waist/hip ratio as a measure of body fat distribution, except for the study of 
Seidell and colleagues (54) in which CT was performed for measurement of the visceral 
fat depot in male subjects. Pasquali et al. (55) proposed that there seems to exist a 
gender difference in the relationship between fat distribution and androgen levels. 
However, up to now, there have been no studies which included both men and women. 
In addition, data on the effect of reductions of the visceral fat depot on sex hormones 
in obese subjects were also lacking. In the present study, the associations between initial 
body fat distribution and sex hormone levels were studied as well as between changes 
that occurred in response to an energy-deficit diet in men as well as in women. 
Outline of the thesis 
The cross-sectional associations between visceral fat accumulation and the serum lipid 
profile of healthy obese men and women are described in Chapter 2. In Chapter 3, the 
relationships between visceral fat accumulation and components of energy expenditure 
(RMR and DIT) are reported. In this chapter, also the ability to lose body weight and 
body fat from the abdominal fat depots in relation to the initial type of body fat 
distribution was investigated. In Chapter 4, the effects of visceral fat loss due to a 
controlled energy-deficit diet for 13 weeks on serum lipid levels are presented. The study 
design enabled us to investigate the effect of weight loss alone on the serum lipid profile 
of obese subjects. The findings are described in Chapter 5. In Chapter 6, the 
relationships between visceral fat accumulation and sex hormone levels in obese subjects 
undergoing weight loss therapy are shown. Finally, the overall conclusions and the 
implications for future research are discussed in Chapter 7. 
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Study design 
The study was part of an extensive project in which the effects of weight loss, weight 
regain and several weight maintenance diets varying in nutrient composition, were 
investigated on body fat distribution, body composition, risk factors for coronary heart 
disease, energy expenditure, and several hormones. In Figure 2, the study design of the 
whole project is given. 
DIETARY INTERVENTION FOLLOW-UP 
1989 
1990 
h 3 H - -13-
K 3 - H 7 •+• 
K3-H—5—H-
r-3-r— 5-
- t -3Hwk 
-13-
-13-
•13-
H-3Hwk 
H-3-I wk 
-3-I wk 
- 1 8 — - Q - -W -Q wk 
High-fat, high-saturated-fat, normal-protein 
| I Low-fat, low-saturated-fat, high-protein: 
low level indicates energy restriction 
• Time point of measurement 
W!M\ Low-fat, low-saturated-fat, normal-protein 
HHU Low-fat, high-saturated-fat, normal-protein 
wk Weeks 
Figure 2. Study design 
In summary, 96 healthy moderately obese subjects, 48 men and 48 premenopausal 
women, were selected for participation. The subjects were divided into 4 groups. Two 
groups started in 1989 and the other 2 groups in 1990. In each group, subjects with an 
abdominal and gluteal-femoral fat distribution, based on the waist/hip ratio (cut-off 
points: 0.85 in women; 1.00 in men), were matched for age and body mass index within 
each sex. The project consisted of a dietary intervention period and a follow-up period. 
The dietary intervention was well controlled. The diets were provided and factors known 
to affect the variables measured such as drug treatment, cigarette smoking, and alcohol 
consumption were absent or minimal and did not change during the intervention period, 
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while physical activity was also kept as constant as possible. No diets or weight-
maintenance counselling were provided in the follow-up period. During the controlled 
dietary intervention, all subjects received an affluent-type diet for 3 weeks, during which 
their body weight was kept stable. Some of the subjects stayed on a weight-stable diet 
for another 5-7 weeks. The weight loss intervention was identical for each subject, which 
consisted of a 4.2 MJ/day energy-deficit diet for 13 weeks. Afterwards, all subjects were 
given a weight-stabilising diet for another 3 weeks. The nutrient composition of the 
different diets given in this study are presented in the Appendix. The participants were 
subsequently studied, on average, 18 and 67 weeks after the dietary intervention period. 
The part of the project described in this thesis focused on the relationships between 
visceral fat accumulation and serum lipids, energy expenditure, and sex hormones in 
healthy obese men and premenopausal women undergoing weight loss therapy. Other 
aspects of the project dealing with the effects of weight loss and subsequent weight 
regain on body composition, fat distribution and resting energy expenditure, are 
described and discussed in detail elsewhere (56). 
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VISCERAL FAT ACCUMULATION MEASURED BY MAGNETIC RESONANCE 
IMAGING IN RELATION TO SERUM LIPIDS IN OBESE MEN AND WOMEN* 
Rianne Leenen, Karin van der Kooy, Jaap C. Seidell and Paul Deurenberg 
ABSTRACT 
In 91 apparently healthy obese subjects (45 premenopausal women and 46 men), 
the associations between specific fat depots and serum lipids were studied. 
Magnetic resonance imaging was used to quantify fat depots at abdominal and 
hip level. In women, an accumulation of visceral fat was associated with a less 
favourable serum lipid profile, even after adjustment for age and body fat 
percentage: higher triglyceride levels (p < 0.001), lower levels of HDL cholesterol 
(p<0.01) and a diminished HDL cholesterol/LDL cholesterol ratio (p<0.01). 
In men, however, the significant inverse relationship between an abundance of 
visceral fat and the HDL cholesterol/LDL cholesterol ratio and the significant 
positive correlations with total-, LDL cholesterol and triglycerides disappeared 
after adjustment for age and fat percentage. Within each sex, subcutaneous fat 
neither at abdominal level nor at hip level was significantly related to serum 
lipids. It is concluded that there are gender differences in the associations 
between visceral fat accumulation and serum lipids. 
INTRODUCTION 
Obesity is known to be associated with the risk of coronary heart disease, non-insulin-
dependent diabetes mellitus and mortality (1). Epidemiological studies have shown that 
the distribution of fat rather than obesity itself may be an independent predictor for 
coronary heart disease and diabetes mellitus (2-4). However, the results of several 
investigations in which the relations between fat distribution and serum lipids were 
examined are inconsistent (5-20). This might be due to differences in age and degree of 
obesity between study populations as well as to differences in the existence of possible 
confounders such as smoking (21), recent weight reduction (22,23), the use of oral 
' Atherosclerosis 1992;94:171-181. 
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contraceptives (24), consumption of alcohol (21), and composition of the diet (25). 
In the majority of studies, adipose tissue distribution was measured by 
anthropometrical methods such as skinfolds (5) and the ratio of the waist-to-hip 
circumference (6-18). Current hypotheses concerning the associations between fat 
distribution and serum lipids emphasise the importance of using direct methods such as 
computed tomography (CT) or magnetic resonance imaging (MRI) to quantify 'portal' 
intra-abdominal adipose tissue (26). Only in a few studies was CT used to measure the 
absolute and relative intra-abdominal fat distribution directly (6,8,19). Most studies have 
been carried out in non-obese subjects (5,7-9,11,13-17) or in obese women 
(6,10,12,16,19,20). There have been few reports on the relationship between adipose 
tissue distribution and serum lipids in healthy obese men (12,18-20). Only in the study 
of Fujioka et al. (19) was CT used to assess the amount of intra-abdominal adipose tissue 
in men. In this study, however, patients with glucose intolerance and diabetics were 
included. 
Therefore, in the present study the relationships between serum lipids and fat 
distribution were measured in apparently healthy obese men and obese premenopausal 
women, controlling for possible confounders and including indirect and direct methods 
for the assessment of body fat distribution. 
MATERIAL AND METHODS 
Subjects 
Ninety-six obese subjects (48 women and 48 men) were selected for this study. All 
subjects were apparently healthy, as evaluated by a medical history and physical 
examination. Only subjects with a body mass index (BMI=weight/height2) between 28 
kg/m2 and 38 kg/m2 were allowed to participate. Subjects with glycosuria and proteinuria 
were excluded. Their levels of serum lipids before the experiment ranged from 3.67 to 
8.35 mmol/L (mean, 6.01 mmol/L) for total cholesterol and from 0.38 to 3.32 mmol/L 
(mean, 1.43 mmol/L) for triglycerides. Their serum glucose ranged from 4.24 to 7.10 
mmol/L (mean, 5.59 mmol/L) and their systolic blood pressure from 110 to 180 mm Hg 
(mean, 139 mm Hg). Seventy-nine subjects did not smoke and the remaining 17 (8 
women and 9 men) smoked less than 5 cigarettes per day. In addition, 17 subjects (10 
women and 7 men) did not drink alcohol and the remaining group drank less than 2 
alcoholic consumptions per day. None of the volunteers received medication known to 
affect serum lipids. All women were premenopausal and did not use oral contraceptives. 
Subjects with an abdominal and gluteal-femoral fat distribution, based on the waist/hip 
ratio (cut-off points: 0.85 in women; 1.00 in men), were matched for age and body mass 
index in each sex. Data of 5 subjects were excluded before the analysis of the results 
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because 2 were diagnosed as having subclinical hypothyroidism and 2 were found to have 
severe fasting hyperinsulinemia (>100 jiU/mL). One subject withdrew from the study 
before measurements were taken. 
The aim and protocol of the study, approved by the Medical Ethical Committee of the 
Department of Human Nutrition, were fully explained to the volunteers. All subjects 
gave their written informed consent. 
Diets 
The subjects consumed a standardized Western-type diet for 3 weeks. All food was 
supplied and individually tailored to meet each person's energy requirement, which was 
estimated from resting metabolic rate and physical activity pattern as described by 
Weststrate et al. (27). However, the participants were allowed to choose a limited 
number of food items, free of fat and cholesterol, which provided a fixed amount of 5% 
of the total daily energy intake. The experimental diet consisted of conventional foods 
and menus were changed daily. 
The nutrient composition of the individual diets was calculated using the 1985 edition 
of the Dutch computerized food table (28). The diet consisted of 12% of energy (en%) 
as protein, 40 en% as total fat (20 en% as saturated fatty acids, 15 en% as 
monounsaturated fatty acids, 5 en% as polyunsaturated fatty acids) and 48 en% as 
carbohydrates. Body weights were recorded twice a week and energy intakes were 
adjusted to counteract weight changes. 
Blood sampling and analyses 
Venous blood was sampled in the morning after an overnight fast of 11-13 h twice in the 
last week of the study period with an interval of 2 days. The mean value of the 2 samples 
was used for statistical analyses. Serum was prepared by centrifugation at 1200 xg within 
1 h after venipuncture and stored at -80 °C until analysis. Total serum cholesterol was 
determined by an enzymatic colorimetric method (29). Serum HDL cholesterol was 
measured after precipitation (30) using the same enzymatic method (29). Serum 
triglyceride was determined as described by Sullivan et al. (31). All samples of one 
subject were analyzed within one run. The within-run coefficient of variation of control 
sera was 1.4% for total cholesterol, 1.6% for HDL cholesterol and 1.7% for triglycerides. 
Accuracy for total cholesterol and triglycerides was checked by analysis of serum pools 
of known value provided by the U.S. Centers for Disease Control (Atlanta,GA). 
Accuracy for HDL cholesterol was checked by serum pools of known value produced by 
Solomon Park Research Laboratories (Kirkland,WA). The mean bias with regard to 
target values of the Centers for Disease Control was + 0.13 mmol/L for total cholesterol 
and -0.02 mmol/L for triglycerides. The mean bias with regard to the Solomon Park 
target value for HDL cholesterol was + 0.08 mmol/L. The LDL cholesterol concentration 
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was calculated using the Friedewald equation (32). The ratio of HDL cholesterol to LDL 
cholesterol was calculated to estimate the atherogenic index. 
Body composition 
All anthropometric measurements were made with the subjects wearing only swimming 
gear or underwear. Body weight was determined to the nearest 0.05 kg on a digital scale 
(Berkel ED-60-T, Rotterdam, The Netherlands) and body height was measured by a 
wall-mounted stadiometer to the nearest 0.001 m. Body mass index was calculated as 
weight/height2 (kg/m2). Total body density was measured by the underwater weighing 
method with simultaneous measurement of residual lung volume by a helium dilution 
technique (33). Body fat percentage was calculated from total body density using the 
equation of Siri (34). The fat percentage of 2 subjects, who did not undergo underwater 
weighing, was determined from weight and total body water (deuterium oxide dilution) 
assuming a hydration coefficient of the fat free mass of 0.73 (35). These women were 
afraid of complete immersion under water. In this study population, the deuterium 
dilution technique gave comparable results with the underwater weighing method 
(r=0.86, standard error of estimate (SEE)=2.4% in women; r=0.84, SEE=2.3% in men). 
Fat distribution 
Circumference measurements to the nearest 0.001 m were made with the subject 
standing upright. Waist circumference was measured in each subject midway between the 
lower rib margin and the iliac crest at the end of a gentle expiration. The hip 
circumference was measured at the level of the widest circumference over the great 
trochanters. 
Magnetic resonance imaging (MRI)-scans were made on a whole-body scanner 
(GYROSCAN S15, Philips Medical Systems, Best, The Netherlands) using a 1.5-T 
magnetic field (64 MHz) and a slice thickness of 10 mm. Transverse MRI-scans were 
taken midway between the lower rib margin and the iliac crest and for a subsample of 
the study population (32 women, 37 men) at trochanter level, while subjects were lying 
supine. The scans were performed and interpreted as described previously by Seidell et 
al. (36). In this obese population, the reproducibility of calculating fat areas from the 
same scan was 1.8%, 5.0% and 2.2% for the estimation of total-, visceral- and 
subcutaneous abdominal fat areas, respectively. The ratio of visceral fat to subcutaneous 
abdominal fat (V/S ratio) was calculated. 
Statistical methods 
Deviations from normality of the distributions of the variables were checked within each 
sex. Only triglycerides and intra-abdominal fat area and the V/S ratio had a skewed 
distribution and natural logarithmic transformed values were used in statistical analyses. 
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Differences between men and women were tested with the Student's Mest. Pearson's 
product-moment correlations and partial correlation coefficients were computed within 
each sex using univariate and multiple linear regression techniques with serum lipids as 
dependent variables and covariates as independent variables. Differences between 
equations of men and women were tested for differences in slopes and coincidence by 
the method described by Kleinbaum et al. (37). Two-sided p-values were considered 
statistically significant at p< 0.05. Results are expressed as means ± standard deviation 
(SD). 
RESULTS 
Table 1. Descriptive characteristics of the subjects 
WOMEN MEN 
N 
Age(yr) 
Anthropometric variables 
Weight (kg) 
Height (m) 
Body mass index (kg/nr) 
Body fat (%) 
Waist/hip ratio 
Fat areas (cm 1 
Abdominal: Subcutaneous 
Visceral 
Total 
V/S ratio 
Hip: Subcutaneous* 
Serum lipids (mmol/L) + 
Total cholesterol 
LDL cholesterol 
HDL cholesterol 
HDL/LDL ratio 
Triglycerides 
45 
39 
86.2 
1.66 
31.2 
43.6 
0.87 
390 
105 
495 
0.29 
415 
539 
3.78 
1.23 
0.33 
1.27 
* 
+ 
+ 
± 
+ 
+ 
+ 
± 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
6 
8.3 
0.06 
2.4 
4.3 
0.07 
102 
43 
109 
0.13 
66 
0.88 
0.73 
0.25 
0.07 
030 
46 
40 
98.6 
1.79 
30.8 
33.3 
0.98 
318 
156 
474 
031 
267 
5.81 
4.01 
0.96 
0.25 
1.86 
+ 
+ 
± 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
± 
6 
8.7** 
0.06" 
2.4 
4.6" 
0.05" 
78* 
4 4 " 
93 
0.17" 
4 8 " 
0.97 
0.84 
0.19" 
0.07" 
0.71" 
Values are means ± SD; 
V/S ratio=visceral/subcutaneous abdominal fat ratio, LDL=low density lipoprotein, HDL=high density lipoprotein, HDL/LDL 
ratio=hdl cholesterol/ldl cholesterol ratio; 
t 32 women, 37 men; 
+ To convert values for total-, LDL- and HDL cholesterol to mg/dL, multiply by 38.67. To convert values for triglycerides to mg/dL, 
multiply by 8834; 
* p<0.001, ** p<0.0001: statistical comparison for differences between men and women. 
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Table 1 shows some characteristics of the study population, separately for men and 
women. All the anthropometric variables were significantly different between men and 
women, except for the body mass index. In addition, there were no sex differences in 
total abdominal adipose tissue and age. However, men had a larger average area of 
visceral fat and smaller subcutaneous fat areas at abdominal and hip level than women. 
Consequently, the mean V/S ratio was also higher in men than in women. Men had, on 
average, higher concentrations of triglycerides and lower levels of HDL cholesterol than 
women. The concentrations of total cholesterol and LDL cholesterol did not differ 
between both sexes. Within each sex, no statistically significant differences were found 
in characteristics between smokers and non-smokers and between drinkers and non-
drinkers (data not shown). 
Table 2. Pearson correlation coefficients between body fat distribution variables and serum 
lipids in obese women and men 
WOMEN 
Waist/hip ratio 
Abdominal fat area: 
Visceral fat 
Subcutaneous fat 
V/S ratio 
Total fat 
Hip fat area: 
Subcutaneous fat' 
MEN 
Waist/hip ratio 
Abdominal fat area: 
Visceral fat 
Subcutaneous fat 
V/S ratio 
Total fat 
Hip fat area: 
Subcutaneous fat* 
Total 
cholesterol 
-0.04 
0.06 
0.04 
0.02 
0.07 
0.06 
0.32* 
0.42" 
0.03 
0.30* 
0.22 
0.10 
LDL 
cholesterol 
-0.01 
0.02 
0.03 
-0.01 
0.03 
-0.03 
0.31* 
0.41** 
0.04 
0.30* 
0.22 
0.12 
HDL 
cholesterol 
-0.48*** 
-0.33* 
-0.09 
-0.21 
-0.19 
-0.01 
-0.16 
-0.21 
0.04 
-0.20 
-0.07 
0.07 
HDL/LDL 
ratio 
-0.48*** 
-0.40** 
-0.13 
-0.24 
-0.24 
-0.01 
-0.38** 
-0.49*** 
-0.02 
-0.38** 
-0.24 
-0.05 
Triglycerides 
0.40** 
0.49*** 
0.12 
0.31* 
0.30* 
0.34 
0.32* 
0.35* 
-0.03 
0.27 
0.14 
-0.01 
V/S ratio=visceral/subcutaneous abdominal fat ratio, LDL=low density lipoprotein, HDL=high density lipoprotein, HDL/LDL 
ratio=hdl cholesterol/Idl cholesterol ratio; 
t 32 women, 37 men; 
* p<0.05, ** p<0.01, *** p<0.001. 
Correlation coefficients of serum lipids with body fat distribution variables are shown 
in Table 2. In women as well as in men, an abundance of visceral fat was associated with 
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higher serum triglyceride levels and with a diminished HDL cholesterol/LDL cholesterol 
ratio. In women, visceral fat was inversely related to HDL cholesterol, but did not 
correlate with total cholesterol and LDL cholesterol. In men, however, total cholesterol 
and LDL cholesterol were positively correlated with visceral fat area, but no correlation 
with HDL cholesterol was found. Within each sex, intra-abdominal fat deposition and 
waist/hip ratio showed similar tendencies with serum lipids. For both sexes, the amount 
of total abdominal fat as well as of subcutaneous fat at abdominal and hip level were not 
significantly associated with serum lipids, except for a positive correlation between 
serum triglycerides and total abdominal fat in women. In men, the V/S ratio showed the 
same significant tendencies as the amount of visceral adipose tissue, although the 
correlation with triglycerides did not reach statistical significance. In women, only a 
positive significant correlation was found between the V/S ratio and serum triglycerides. 
hdl/ldl ratio 
0.55 r 
0.45 
0.35 
0.25 
0.15 
Y=-0.08 X + 0.70 
r=-0.40, p< 0.01 
0
 . "*****0^  
o • • 
Y=-0.11 Xt0.78 
r = -0.49, p< 0.001 
I I 
4.5 5.5 6.5 
log [visceral fat] (cm ) 
Figure 1. Relation between HDL/LDL ratio and visceral fat in women (o, — ) and men 
(•"-) 
Figure 1 shows the linear relationship for visceral fat and the HDL cholesterol/LDL 
cholesterol ratio for both sexes. The 2 regression lines were parallel, although the lines 
were not significantly coincident (p< 0.025). In Figure 2, the association between visceral 
fat and serum triglycerides is presented. The regression lines of men and women did not 
differ significantly in slope and were coincident. 
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Figure 2. Relation between serum triglycerides and visceral fat in women (o, — ) and men 
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Table 3 shows the correlations of age and body fat percentage with parameters of 
abdominal fat distribution and serum lipids. In women, no significant associations were 
found, with the exception of age with visceral fat and the V/S ratio. In men, however, 
age was associated with a less favourable lipid profile and fat percentage was significantly 
negatively correlated with the HDL cholesterol/LDL cholesterol ratio. In addition, in 
men, age and fat percentage were positively correlated with variables of abdominal fat 
distribution, except for the association between body fat percentage and V/S ratio, due 
to the high relationship between fat percentage and the amount of subcutaneous 
abdominal adipose tissue (r=0.65,/><0.0001). Adjustment for the potential confounding 
effects of age and body fat percentage was necessary to evaluate the independent role 
of abdominal fat distribution on lipid profiles. 
The age and body fat percentage adjusted correlations are presented in Table 4, 
separately for men and women. In women, the correlation coefficients of serum lipids 
with regional fat distribution, visceral fat area and the V/S ratio were not appreciably 
affected after adjustment for age and body fat percentage. In men, however, the 
statistically significant relationships observed in univariate regression analysis (Table 3) 
disappeared when the effects of age and body fat percentage on serum lipids were 
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Table 3. Pearson correlation coefficients for age and body fat percentage with serum lipids 
and the explanatory variables in obese women and men 
Age 
Women Men 
Fat percentage 
Women Men 
Serum lipids 
Total cholesterol 
LDL cholesterol 
HDL cholesterol 
HDL/LDL ratio 
Triglycerides 
Fat distribution 
Waist/hip ratio 
Visceral fat area 
V/S ratio 
0.20 
0.17 
0.13 
-0.08 
0.07 
0.25 
0.33* 
0.33* 
0.34* 
0.32* 
-0.26 
-0.45** 
0.35* 
0.40** 
039**** 
033*** 
-0.05 
-0.09 
0.01 
0.04 
0.04 
0.03 
0.17 
-0.19 
0.23 
0.23 
-0.18 
-0.34* 
0.28 
0.48*** 
0.61*** 
0.04 
V/S ratio=visceral/subcutaneous abdominal fat ratio, LDL=low density lipoprotein, HDL=high density lipoprotein, HDL/LDL 
ratio=hdl cholesterol/ldl cholesterol ratio; 
* p<0.05, ** p<0.01, *** p<0.001, ***• p<0.0001. 
controlled for. In men as well as in women still no significant correlations were found 
between serum lipids and subcutaneous fat at abdominal and hip level after adjustment 
for these variables (data not shown). The waist/hip ratio and visceral adipose tissue 
showed the same tendencies with serum lipids within each sex. 
Table 4. Partial correlations (adjustment for age and body fat percentage) of body fat 
distribution variables with serum lipids 
WOMEN 
Waist/hip ratio 
Visceral fat area 
V/S ratio 
MEN 
Waist/hip ratio 
Visceral fat area 
V/S ratio 
Total 
cholesterol 
-0.09 
0.01 
-0.08 
0.17 
0.25 
0.18 
LDL 
cholesterol 
-0.06 
-0.02 
-0.10 
0.17 
0.25 
0.19 
HDL 
cholesterol 
-033*** 
-0.40" 
-0.28 
-0.02 
-0.01 
-0.10 
HDL/LDL 
ratio 
-0.47** 
-0.41** 
-0.22 
-0.16 
-0.21 
-0.23 
Triglycerides 
0.40** 
030*** 
0.33* 
0.14 
0.09 
0.14 
V/S ratio=visceral/subcutaneous abdominal fat ratio, LDL=low density lipoprotein, HDL=high density lipoprotein, HDL/LDL 
ratio=hdl cholesterol/ldl cholesterol ratio; 
* p<0.05, ** p<0.01, *** p<0.001. 
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DISCUSSION 
The findings of the present study indicate that an accumulation of visceral fat in healthy 
obese women is associated with an unfavourable lipid profile, even after adjustment for 
possible confounding effects of age and body fat percentage. In obese men, however, 
neither visceral fat accumulation nor age or body fat percentage are correlated to serum 
lipids independently of each other. 
Obesity per se is associated with a less favourable lipid profile (38). In the present 
study, however, no significant associations were found between serum lipids and total 
fatness indices, such as body fat percentage or body mass index (data not shown), except 
for a negative correlation between fat percentage and HDL/LDL cholesterol ratio in 
men. The lack of these relationships could be due to the selection of the study 
population, since all subjects were moderately obese. Despite the fact that men had a 
lower body fat percentage than women, the obese men had a lipid profile that indicates 
a higher risk for coronary heart disease than premenopausal women with comparable age 
and body mass index. The men had significantly higher triglyceride levels and lower HDL 
cholesterol levels compared with the women. This finding is consistent with previous 
studies (5,12,39). High triglyceride levels are associated with diminished lipoprotein-
lipase activity, resulting in a reduced VLDL catabolism, which finally results in a 
diminished HDL cholesterol formation (39). The levels of total- and LDL cholesterol did 
not differ between men and women. Krotkiewski et al. reported similar results (20). 
Comparison of several studies in which the relationships between abdominal fat 
predisposition and serum lipids were investigated in obese subjects reveals discrepancies 
(see Table 5). In accordance with the majority of the reported studies, the present study 
revealed positive correlations between an abdominal fat predominance and serum 
triglycerides. This finding is in agreement with the proposed high lipolytic activity of 
intra-abdominal adipose tissue that could stimulate triglyceride synthesis by exposing the 
liver to high free fatty acid concentrations (40). There is still conflicting evidence about 
the observed correlations between HDL cholesterol and abdominal fat predominance. 
The results from this study in obese women are in agreement with those of Despres et 
al. (6) and Terry et al. (18), who also observed a significant inverse association. The role 
of intra-abdominal adipose tissue on HDL cholesterol concentrations is probably 
mediated by the enzyme hepatic-triglyceride-lipase (40). It has been proposed that in 
women, increased concentrations of testosterone could produce an increase in the 
accumulation of visceral fat and an increase in activity of hepatic-triglyceride-lipase, both 
leading to reduced HDL-levels (40,41). Increased male sex steroids have been found to 
be associated with increased visceral fat accumulation in women (42), but not in men 
(43). This might explain the lack of association between the amount of visceral fat and 
HDL cholesterol in men in this study. 
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The lack of a significant relationship between abdominal fat distribution and total- and 
LDL cholesterol concentrations in the female subjects of this study is consistent with the 
findings of several previous reported studies (6,10,16,18). The particle size and 
composition of LDL cholesterol may play an important role (38). Terry et al. (18) found 
no association between abdominal fat distribution and LDL cholesterol, whereas a 
significant positive association was found with the small LDL-particles. In men, however, 
we observed a positive correlation for total- and LDL cholesterol with the amount of 
abdominal adipose tissue. This observation supports previous findings in obese men 
(12,19). It has been suggested that a high triglyceride level is associated with increased 
cellular cholesterol synthesis and less cholesterol is cleared from the plasma through the 
LDL-receptor pathway (40). However, in men, the associations between total- and LDL 
cholesterol and abdominal fat predominance did not reach statistical significance after 
adjustment for age and body fat percentage. 
Discrepancies between the present study and others may be explained by differences 
in populations studied (e.g., inclusion of postmenopausal women (10) and patients with 
glucose intolerance (19)), the lack of controlling for smoking habits, age, alcohol 
consumption, oral contraceptives, diet and the methods used for assessment of body fat 
distribution. 
This study shows that intra-abdominal adipose tissue seems to be the fat depot that 
plays a critical role in the associations with serum lipid concentrations, particularly in 
women. This is in agreement with previous findings (6). In contrast, Terry et al. suggested 
that femoral adipose tissue, measured by dual-photon absorptiometry, may contribute to 
favourable lipoprotein profiles that predict lower risk of coronary heart disease (18). In 
the present study, no favourable effects of subcutaneous fat at hip level on serum lipids 
were found in both sexes, even after adjustment for age and body fat percentage. In the 
study of Terry et al. (18), no distinction was made between subcutaneous and visceral 
abdominal fat, so the effect of visceral adipose tissue alone could not be demonstrated. 
Only a few studies reported the associations between intra-abdominal adipose tissue 
measured by CT and serum lipids (6,8,19). CT involves X-ray exposure of the subjects 
and is, therefore, not an attractive tool for studies in healthy people. This study 
demonstrated that the risk profile associated with intra-abdominal fat accumulation can 
also be confirmed by using magnetic resonance imaging. 
From this study with apparently healthy premenopausal obese women and obese men 
and the use of MRI to measure intra-abdominal adipose tissue, it can be concluded that 
there are gender differences in the associations between visceral fat accumulation and 
serum lipids. Although the reason for these gender differences are still unknown, sex-
steroid hormone concentrations may be partly responsible for these differences. Further 
research is required to reveal the complex associations between hormonal status, serum 
lipids and abdominal fat distribution. 
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VISCERAL FAT ACCUMULATION IN OBESE SUBJECTS: RELATION TO ENERGY 
EXPENDITURE AND RESPONSE TO WEIGHT LOSS* 
Rianne Leenen, Karin van der Kooy, Paul Deurenberg, Jaap C. Seidell, Jan A Weststrate, 
Frans J.M. Schouten and Joseph G-A.J. Hautvast 
ABSTRACT 
Seventy-eight healthy obese subjects, 40 premenopausal women and 38 men 
aged 27-51 yr received a 4.2 MJ/day energy-deficit diet for 13 wk. Resting 
metabolic rate (RMR) and diet-induced thermogenesis (DIT) were measured 
by indirect calorimetry. Abdominal subcutaneous and visceral fat areas were 
calculated from magnetic resonance imaging scans before and after weight loss. 
Before weight loss, visceral fat accumulation was positively correlated with 
higher levels of RMR (p<0.05) and DIT (p<0.01) in women but not in men. 
The mean weight reduction was 12.2 ± 3.5 kg (mean ± SD). In men but not in 
women, an initially large visceral fat depot was associated with a reduced loss 
of weight and total fat mass (p<0.05). Within each sex, an initial abundance of 
visceral fat was significantly related to a larger loss of visceral fat (p< 0.001) and 
in men to a smaller loss of subcutaneous fat (p < 0.05). These results suggest that 
there may be gender differences in the associations between visceral fat 
accumulation and components of energy expenditure (RMR and DIT) in obese 
subjects. Obese subjects with an initial abundance of visceral fat do not lose 
more body weight but more visceral fat than subjects with less visceral fat. 
INTRODUCTION 
Obesity is one of the most prevalent nutritional problems in affluent societies and is 
often treated by energy intake restriction. Obese subjects can be classified according to 
types of body fat distribution (1). The distribution of fat independently of the degree of 
obesity is related to several metabolic disorders (2). Several investigators reported that 
* American Journal of Physiology: Endocrinology & Metabolism 1992;263(26):E913-
E919. 
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it is easier for people with abdominal obesity to lose weight when energy intake is 
restricted than it is for obese subjects with a gluteal-femoral type of fat distribution (3-5). 
These findings could have important consequences for weight reduction therapy of 
obesity. Other investigators did, however, not confirm this (6-9). Contradictions between 
the results of these studies may be explained by differences in study population or by 
differences in methodology and experimental design. 
In addition, the results of the studies in which the relations between body fat 
distribution and components of energy expenditure such as resting metabolic rate (RMR) 
and diet-induced thermogenesis (DIT) were examined also yielded contradictory results 
(9-14). Adipose tissue distribution was, in most studies, measured by the waist/hip ratio, 
which does not allow one to distinguish between the various abdominal fat depots, 
something which is possible with imaging techniques (15). To our knowledge, only one 
cross-sectional study has been carried out in obese men (12). Currently, only in the study 
of den Besten et al. (9) has the relation between waist/hip ratio and energy expenditure 
been prospectively investigated before and after weight loss in a limited number of obese 
women (« = 15). 
In the present study, the influence of body fat distribution on the degree of weight 
reduction and the components of energy expenditure (RMR and DIT) were determined 
before and after a standardized energy-deficit diet in 78 healthy obese men and 
premenopausal women. Magnetic resonance imaging was used to assess body fat 
distribution. 
MATERIAL AND METHODS 
Subjects 
Participants were recruited by means of advertisements in local newspapers. Ninety-six 
obese subjects (48 women and 48 men) were selected on the basis of their body mass 
index (between 28 and 38 kg/m2), age (between 25 and 51 yr), premenopausal state, 
smoking behavior (<5 cigarettes/day), and drinking behavior (<2 alcoholic 
consumptions/day). All subjects were apparently healthy, as evaluated by a medical 
history and physical examination. None of the volunteers received any medication known 
to affect the variables measured, and the women did not use oral contraceptives. None 
of the subjects had been on a slimming diet for several months before the study. Within 
each sex, abdominal and gluteal-femoral obese subjects, based on the waist/hip ratio, 
were matched for age and body mass index. 
Fourteen subjects did not complete the dietary treatment successfully (4 due to 
intercurrent illness, 6 for personal reasons, and 4 were excluded because of suspicion of 
bad compliance). In addition, data of 4 subjects were also excluded because 2 subjects 
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were later diagnosed as having subclinical hypothyroidism, and 2 were later found to 
have severe fasting hyperinsulinemia (> 100 jiU/mL). Results of 78 subjects (40 women 
and 38 men) remained for statistical analysis. 
The study was carried out with the approval of the Medical Ethical Committee of the 
Department of Human Nutrition of the Wageningen Agricultural University. The 
procedures had been fully explained to the volunteers. All subjects gave their written 
informed consent. 
Experimental design and diet 
After 3 wk on a weight-stable diet, baseline measurements were performed to determine 
body composition, body fat distribution, blood parameters, and energy expenditure. The 
diets were individually tailored to meet each person's energy requirement, which was 
estimated from RMR and physical activity pattern, as described by Weststrate and 
Hautvast (16). Body weights were recorded two times a week by the subjects, and energy 
intakes were adjusted individually, if necessary, to prevent weight changes. Some of the 
subjects remained on a weight-stable diet up until 7 wk before the weight loss treatment 
started. In these subjects, the assessment of body composition, waist/hip ratio, and 
energy expenditure was repeated at the end of this weight-stable period. The weight-
stable period was followed by a weight reduction period of 13 wk during which the 
subjects received a 4.2 MJ/day energy-deficit diet. The energy-deficit diet consisted of 
25 energy percent (en%) protein, 33 en% fat (11 en% saturated fatty acids, 11 en% 
monounsaturated fatty acids, 11 en% polyunsaturated fatty acids), and 42 en% 
carbohydrates. Individual energy deficits were based on estimated daily energy 
requirements at the end of the weight-stable period. After the energy-deficit period the 
subjects were given a diet for 3 wk to maintain the new achieved body weight. At the end 
of this period, measurements of body composition, fat distribution, and energy 
expenditure were repeated. Ninety-five energy percent of the food in each dietary period 
was supplied to the volunteers. The participants were allowed to choose a limited 
number of food items, free of fat and cholesterol, which provided a fixed amount of 5% 
of the total daily energy intake. The weight-stable diets consisted of conventional foods, 
whereas the energy-deficit diet was a combination of slimming products and conventional 
foods. The nutrient composition of the individual diets was calculated using the 1985 
edition of the Dutch computerized food table (17). 
The subjects were instructed to maintain their habitual physical activity pattern and 
smoking habits during the study period. They were asked to record any sign of illness, 
deviations of diet, medication used, free item choice, and changes in both smoking and 
activity patterns in a diary. Compliance of the diet was checked by weight control and 
meetings with trained dieticians every fortnight. 
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Body composition 
All anthropometric measurements were made with the subjects wearing only swimming 
gear or underwear. Body weight was determined to the nearest 0.05 kg on a digital scale 
(Berkel ED-60-T, Rotterdam, The Netherlands), and body height was measured to the 
nearest 0.001 m using a wall-mounted stadiometer. Body mass index was calculated as 
weight (kg) divided by height squared (m2). Whole body density was determined by 
underwater weighing (18). Residual lung volume was measured simultaneously by a 
helium dilution technique (19). Percent body fat was calculated from total body density 
using the equation of Siri (18). Percent body fat of 2 subjects was determined from 
weight and total body water, assessed by deuterium oxide dilution, assuming a hydration 
coefficient of the fat free mass of 0.73 (20). These women were afraid of complete 
immersion under water. The total amount of body energy loss (MJ) was calculated as 
described by Grande (21), assuming that 'lean body weight' has 19.4% protein and using 
values of 16.8 and 37.8 kj/g protein and fat, respectively. 
Fat distribution 
Circumference measurements to the nearest 0.001 m were made with the subjects 
standing. Waist circumference was measured midway between the lower rib margin and 
the iliac crest at the end of gentle expiration. The hip circumference was measured at 
the level of the widest circumference over the great trochanters. Magnetic resonance 
imaging (MRI) scans were made on a whole body scanner (GYROSCAN S15, Philips 
Medical Systems, Best, The Netherlands) using a 1.5-T magnetic field (64 MHz) and a 
slice thickness of 10 mm before and after weight loss. Transverse MRI scans were taken 
midway between the lower rib margin and the iliac crest, while subjects were lying 
supine. The scans were performed and interpreted as described previously (22). In this 
obese population, the reproducibility of calculating fat areas from the same scan before 
weight loss was 1.8%, 5.0%, and 2.2% for the estimation of total, visceral, and 
subcutaneous abdominal fat areas, respectively. The ratio of visceral fat to subcutaneous 
fat (V/S ratio) was calculated. In 6 subjects (3 women, 3 men) only the measurements 
before weight loss were used for statistical analysis due to practical problems with the 
measurements after weight loss. 
Energy metabolism 
Energy metabolism (RMR and DIT) was measured two times in each measurement 
period with an interval of 1 day. For each subject, all the measurements were performed 
either in the morning or in the afternoon. When RMR was measured during the 
morning, the subjects were in a 12- to 14-h postabsorptive state. Afternoon RMR values 
were measured with subjects in a 5- to 6-h postabsorptive state after a light standardized 
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breakfast of <2 MJ. The subjects were instructed to refrain from sleeping, drinking 
coffee, and strenuous physical activity in the morning before the afternoon tests. Previous 
research from our laboratory showed that there are no differences in RMR and DIT 
when the same subjects are measured in the morning and afternoon (23). Furthermore, 
in the present study there were no differences between the subjects who were measured 
in the morning and in the afternoon with respect to fat distribution (neither waist/hip 
ratio nor visceral and subcutaneous fat). On the day of each measurement the 
participants were taken to the laboratory by car. After voiding, they lay supine but awake 
and practically motionless on a hospital bed. After a rest period of 15 min, RMR was 
measured continuously during 45 min. After the RMR measurement the subjects ingested 
a standardized liquid test meal through a straw within 5 min. According to duplicate 
chemical analysis the test meal had an energy content of 1,520 kJ and consisted of 12.4 
en% protein, 31.5 en% total fat, and 56.1 en% carbohydrates. Postprandial energy 
expenditure (PEE) was measured continuously for 3 hours after consuming the test meal. 
During the energy measurements the subjects watched video films and were asked to 
relax. The cumulative postprandial increase above the RMR over 3 hours was defined 
as the DIT (DIT=PEE-RMR). The DIT (kJ/min) is expressed in absolute terms, as a 
percentage of the increase over RMR, and as a percentage of the metabolizable energy 
content of the test meal. In this study, the within-person day-to-day coefficient of 
variation for the RMR measurements before weight loss was on average 4.3% for women 
and 4.0% for men. For the DIT measurements the within-person day-to-day variation 
coefficients before weight loss were 25.4% and 26.4%, respectively. 
Gas exchange measurements 
RMR and PEE measurements were performed by use of an open-circuit ventilated hood 
system as previously described (24). During each measurement, a pump (Ocean SCL210, 
Dieren, The Netherlands) drew fresh outside air through the transparent hood. The flow 
rate through the hood was measured by a thermal mass flowmeter (Brooks 5812N, 
Veenendaal, The Netherlands) and was maintained at 40 L/min by an electrically 
operated control valve (Brooks 5837, Veenendaal, The Netherlands). Oxygen (02) and 
carbon dioxide (C02) content of the expired air were continuously analyzed by, 
respectively, a paramagnetic 0 2 analyzer (Servomex 1100A, Zoetermeer, The 
Netherlands) and an infrared COz analyzer (Servomex 1410, Zoetermeer, The 
Netherlands). Before each measurement, calibration was performed with calibrated dried 
standard gasses. Every hour during the energy measurements, 0 2 and C02 concentrations 
in dried filtered outside air were measured. The outputs from the gas analyzers were 
continuously recorded with a multipen recorder (Kipp and Zonen BD101, Delft, The 
Netherlands). C02 production and 0 2 consumption were subsequently calculated as mean 
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values for each 2-min interval period with the Haldane correction (24). The metabolic 
rate was calculated according to the equation described by Weir (25). Movements of the 
participant during the measurement were recorded by a load cell (Tokyo Sokki Kenkyujo 
TKA-200A, Tokyo, Japan) under the hospital bed and were also registrated by the 
multipen recorder as an index value. If high 0 2 consumption and C02 production values 
appeared in combination with a high body movement index (corresponding to shifting 
the body on the bed), these values were excluded. Values were also excluded when the 
subjects needed to visit the lavatory. The invalid values during the DIT measurement 
were replaced by the mean of the 2 preceding and the 2 following values. Less than 4% 
of the recorded values had to be corrected per measurement session, so the impact on 
the RMR and DIT levels was negligible. 
Blood parameters 
Two blood samples were taken with an interval of 2 days after an overnight fast. The 
mean value of the 2 samples was used for statistical analyses. Serum total cholesterol, 
high-density-lipoprotein (HDL) cholesterol, and triglyceride levels were measured as 
previously described (26). Glucose levels were determined enzymatically (Abbott b.v., 
Amstelveen, The Netherlands), and insulin was analyzed in one blood sample in 
duplicate using the enzyme-linked immunoabsorbent assay method (Boehringer 
Mannheim GmbH, Almere, The Netherlands). The insulin/glucose ratio was calculated 
as an index of insulin sensitivity. 
Statistical methods 
The distributions of triglycerides, insulin, the insulin/glucose ratio, visceral fat, the V/S 
ratio and the change in visceral fat were slightly skewed. Therefore, natural logarithmic 
transformed values for these variables were used in statistical analyses. However, no 
transformation for change in visceral fat was used, because this resulted in findings 
principally identical to analyses based on normally distributed variables. Differences in 
variables before and after the dietary treatment were tested using the Student's paired 
r-test. Pearson's product-moment correlations and partial correlation coefficients were 
computed within each sex using univariate and multiple linear regression techniques. 
Differences between equations of men and women were tested for differences in slopes 
and intercepts by the method described by Kleinbaum et al. (27). Correlations were 
tested for equality using the Fisher's z transformation (27). Two-sided p-values were 
considered statistically significant at p< 0.05. Results are expressed as means ± standard 
deviation (SD). 
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RESULTS 
The baseline characteristics are presented in Table 1. There were significant sex 
differences for all variables, except for age, body mass index, total abdominal fat area, 
total cholesterol, insulin, the insulin/glucose ratio, and the DIT expressed as percentage 
increase over RMR. 
Table 1. Descriptive charateristics of subjects 
WOMEN MEN 
N 
Age(yr) 
Weight (kg) 
Body mass index (kg/m2) 
Body fat (%) 
FFM(kg) 
Fat mass (kg) 
Waist/hip ratio 
Abdominal fat areas 
Visceral (cm ) 
Subcutaneous (cm2) 
Total (cm2) 
V/S ratio 
Blood parameters 
Total cholesterol (mmol/L) 
HDL cholesterol (mmol/L) 
Triglycerides (mmol/L) 
Glucose (mmol/L) 
Insulin (uU/ml)t 
Insulin/glucose (uU/umol)' 
Energy expenditure 
RMR (kJ/min) 
RMR/FFM (kJ/min'kg) 
DIT (kJ/min) 
DIT/RMR (%) 
DIT/En-test (%) 
40 
39 
85.8 
31.2 
43.9 
48.0 
37.9 
0.87 
106 
390 
496 
0.29 
5.57 
1.24 
1.27 
5.19 
13.3 
2.6 
4.25 
0.089 
0.54 
12.7 
6.3 
± 
± 
+ 
+ 
+ 
± 
+ 
+ 
+ 
+ 
-
+ 
± 
+ 
± 
+ 
± 
+ 
± 
± 
± 
+ 
6 
8.2 
2.1 
4.4 
45 
6.2 
0.07 
44 
103 
109 
0.14 
0.83 
0.26 
0.52 
0.33 
9.6 
2.0 
0.39 
0.008 
0.14 
3.4 
1.8 
38 
41 
97.4 
30.7 
33.5 
64.7 
32.7 
0.99 
156 
314 
470 
0.52 
5.77 
0.95 
1.89 
5.36 
12.2 
2.3 
5.23 
0.081 
0.70 
13.5 
8.3 
+ 
+ 
± 
± 
+ 
+ 
+ 
+ 
+ 
+ 
± 
+ 
± 
+ 
+ 
+ 
± 
^ 
± 
± 
± 
+ 
6 
7.8»«* 
2.1 
3.9*** 
5.8*** 
5.0" 
0.05*" 
39*** 
67** 
77 
0.17*** 
0.87 
0.17*** 
0.65*** 
0.37* 
6.2 
1.1 
0.41*** 
0.006** 
0.17*** 
3.6 
2.0*** 
Values are means ± SD; 
FFM=fat free mass, V/S ratio=visceral/subcutaneous fat ratio, HDL=high density lipoprotein, RMR=resting metabolic rate, 
DIT=diet induced thermogenesis, En-test=energy content of test meal; 
t 37 men; 
* p<0.05, ** p<0.001, *** p<0.0001: women versus men. 
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Table 2 shows the bivariate correlations of age and initial fat mass with initial 
parameters of energy expenditure and body fat distribution. In women, age was positively 
correlated with the variables of body fat distribution, and fat mass was positively related 
with RMR in absolute terms as well as with RMR expressed per kilogram fat-free mass 
(FFM). In men, age and fat mass were significantly correlated with the body fat 
distribution variables (except for the association between fat mass and the V/S ratio) but 
not to energy expenditure variables. FFM was not significantly correlated with the body 
fat distribution variables in men nor in women. The correlation between FFM and 
visceral fat was r=0.01,p=0.99 in women and r=-0.15,/>=0.38 in men. Adjustment for 
the potential confounding effects of age and body fat mass was performed to evaluate 
the independent contribution of abdominal fat distribution on energy expenditure. 
The age and fat mass adjusted baseline correlation coefficients between body fat 
distribution and energy expenditure variables are shown in Table 3. Additional 
adjustment for FFM or daytime period of energy expenditure measurement (morning or 
afternoon) did not affect the observed correlations (data not shown). In women, an 
Table 2. Pearson correlation coefficients for age and fat mass with baseline variables of 
energy expenditure and body fat distribution 
Age(yr) 
Enerev expenditure 
RMR (kJ/min) 
RMR/FFM (IcJ/min'kg) 
D1T (kJ/min) 
Fat distribution 
Waist/hip ratio 
Visceral fat (cm ) 
V/S ratio 
Women 
-0.15 
0.12 
0.13 
0.33* 
0.41" 
0.37* 
Men 
-0.06 
-0.01 
-0.13 
0.31 
0.49' 
0.44* 
Fat mass 
Women 
05V 
0.37* 
-0.26 
-0.03 
0.11 
-0.27 
(kg) 
Men 
0.15 
0.10 
0.20 
0.45* 
0.46* 
-0.08 
RMR=resting metabolic rate, FFM=fat free mass, DIT=diet induced thermogenesis, V/S ratio=visceral/subcutaneous fat ratio; 
* p<0.05, ** p<0.01, •** p<0.001. 
abundance of visceral fat was significantly associated with higher levels of RMR and 
DIT. Subcutaneous abdominal adipose tissue in women was significantly inversely related 
to RMR but not to DIT (p=0.17). No significant correlations were found between the 
waist/hip ratio and RMR (p = 0.64) or DIT (p=0.17) in women. In men, neither the 
amount of visceral fat nor the waist/hip ratio were significantly correlated with the 
components of energy expenditure. The correlations for visceral fat accumulation with 
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Table 3. Partial correlations (adjusted for age and fat mass) between baseline variables of 
energy expenditure and fat distribution 
RMR (kJ/min) 
Women 
-0.08 
0.33* 
-0.37* 
0.42** 
Men 
-0.14 
-0.15 
-0.08 
-0.07 
DIT (kJ/min) 
Women 
0.23 
0.42" 
-0.23 
0.43" 
Men 
-0.01 
0.06 
-0.04 
0.05 
Waist/hip ratio 
Visceral fat (cm ) 
Subcutaneous fat (cm2) 
V/S ratio 
RMR=resting metabolic rate, DIT=diet-induced thermogenesis, V/S ratio=visceral/subcutaneous fat ratio; 
* p<0.05, " p<0.01. 
Table 4. Changes in variables after weight reduction^ 
WOMEN MEN 
N 
Weight (kg) 
Body fat (%) 
FFM(kg) 
Fat mass (kg) 
Waist/hip ratio 
Abdominal fat areas (cnv*)+ 
Visceral 
Subcutaneous 
Total 
Energy expenditure 
RMR (kJ/min) 
RMR/FFM (kJ/min*kg) 
DIT (kJ/min) 
DIT/RMR (%) 
DTT/En-test (%) 
11.7 
7.2 
1.4 
10.3 
0.03 
35 
117 
152 
0.27 
0.003 
-0.01 
-1.0 
-0.1 
+ 
t 
± 
± 
± 
± 
+ 
+ 
+ 
± 
+ 
+ 
± 
3.8" 
3.0" 
1.3" 
3.6" 
0.03* 
2 5 " 
5 8 " 
6 4 " 
0.40* 
0.008 
0.17 
4.3 
2.0 
38 
12.6 ± 3.2** 
6.9 ± 2.7" 
2.9 ± 1.7"* 
9.8 ± 3 .1" 
0.07 ± 0.03"* 
61 ± 26"* 
113 ± 4 5 " 
174 ± 5 3 " 
0.50 ± 0.26"§ 
0.004 ± 0.004" 
0.07 ± 0.23 
0.2 ± 4.7 
0.8 ± 2.7 
Values are means ± SD; 
FFM=fat free mass, RMR=resting metabolic rate, DIT=diet induced thermogenesis, En-test=energy content of test meal; 
t Change in variable was assessed as value before minus after weight loss; 
+ 37 women, 35 men; 
* p<0.05, " p< 0.0001: before versus after weight loss; 
§ p<0.01, t p<0.0001: women versus men. 
RMR were significantly different between both sexes, and the difference in correlations 
with DIT was borderline significant (p = 0.10). Within each sex, DIT expressed as 
percentage increase over RMR as well as expressed as percentage of energy content of 
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test meal showed similar tendencies with body fat distribution variables as the absolute 
DIT did (data not shown). 
In Table 4, the effects of weight loss on body composition, fat distribution, and energy 
expenditure are presented for women and men. After weight loss all body composition 
variables and indicators of fat distribution decreased significantly in either sex. Loss of 
body weight and fat mass did not differ significantly between men and women. A 
relatively large proportion of the total body weight loss was fat mass, in women 88% and 
in men 78%. After weight loss in both sexes, the mean RMR was significantly reduced 
in absolute terms as well as expressed on the basis of FFM. No significant changes in 
DIT values were observed in women or men. 
Table 5 shows the correlations between changes in energy expenditure variables and 
changes in body fat distribution. Only in women was the change in DIT significantly 
related to the change in visceral fat and the change in V/S ratio. However, these 
significant positive correlations were mainly dependent on one woman, with the largest 
Table 5. Pearson correlation coefficients between changes in energy expenditure and changes 
in body fat distribution* 
Waist/hip ratio 
Visceral fat (cm2)+ 
V/S ratio+ 
RMR (kJ/min) 
Women 
-0.17 
0.24 
0.19 
Men 
-0.22 
-0.22 
-0.09 
DIT (kJ/min) 
Women Men 
0.12 0.07 
0.41' 0.19 
0.34* 0.17 
RMR=resting metabolic rate, DIT=diet induced thermogenesis, V/S ratio=visceral/subcutaneous fat ratio; 
t Change in variable was assessed as value before minus after weight loss; 
+ 37 women, 35 men; 
• p<0.05. 
decrease in visceral fat and DIT. Without this outlier the significant correlations 
disappeared (r=0.23, p=0.18; r=0.27, p=0.12, respectively). The observed significant 
correlations in women did not differ significantly from the correlations in men. 
The age and fat mass adjusted correlations between body fat distribution variables 
before weight loss with changes in body composition and the calculated total amount of 
body energy loss with weight reduction are given in Table 6. In both sexes, none of the 
correlations between initial waist/hip ratio and changes in body composition reached 
statistical significance. In men, the initial amount of visceral fat was significantly related 
to a reduced loss in body weight and fat mass. In women, no such significant associations 
were observed, although the observed significant correlations in men were not 
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significantly different from the correlations in women. Within each sex, the correlations 
between the various indicators of fat distribution with changes in body fat mass were 
comparable to those with the calculated amount of body energy losses due to the high 
relationship between loss of fat mass and the amount of body energy loss in both sexes 
(r=0.999, p< 0.0001). 
Table 6. Partial correlations between fat distribution variables before weight loss (adjusted 
for age and fat mass) with changes in body composition and calculated amount 
of body energy loss^ 
Initial parameters 
WOMEN 
Waist/hip ratio 
Visceral fat (cm2) 
V/S ratio 
MEN 
Waist/hip ratio 
Visceral fat (cm ) 
V/S ratio 
Body weight (kg) 
0.02 
-0.10 
-0.26 
0.05 
-0.34' 
-0.31 
Change in 
Fat mass (kg) 
-0.14 
-0.24 
-0.36* 
0.07 
-0.34* 
-0.28 
Body energy loss* (MJ) 
-0.13 
-022 
-0.35* 
0.06 
-0.34* 
-0.28 
V/S ratio=visceral/subcutaneous fat ratio; 
t Change in variable was assessed as value before minus after weight loss; 
t Body energy loss was calculated according to Grande (21); 
* p<0.05. 
Table 7 shows the partial correlations between fat distribution variables before weight 
loss (adjusted for age and fat mass) with changes in abdominal fat depots. In both sexes, 
the initial amount of visceral fat was not significantly related to an increased or reduced 
loss in the total abdominal fat depot. However, an initially large visceral fat depot and 
a high initial V/S ratio were significantly associated with a larger loss of visceral fat 
compared with a smaller loss of subcutaneous abdominal fat. In women, however, the 
inverse association between initial amount of visceral fat and change in subcutaneous fat 
did not reach statistical significance (p=0.14). Within both sexes, an initial abundance 
of visceral fat was not significantly related to neither changes in RMR nor changes in 
DIT (data not shown). 
The unadjusted relationships between initial visceral fat accumulation and loss of 
visceral fat are illustrated in Figure 1 for the whole study population. The regression 
lines of men and women did not differ significantly in slope and intercept. 
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Table 7. Partial correlations between fat distribution variables before weight loss (adjusted 
for age and fat mass) with changes in abdominal fat depots* 
Initial parameters Total 
Change in (cm2) 
Visceral Subcutaneous 
WOMEN (n=37) 
Waist/hip ratio 
Visceral fat (cm2) 
V/S ratio 
-0.05 
-0.02 
-0.26 
0.15 
0.59* 
0.60* 
-0.11 
-0.26 
-0.52* 
MEN(n = 35) 
Waist/hip ratio 
y 
Visceral fat (cm ) 
V/S ratio 
0.32 
-0.08 
-0.30 
0.31 
0.59* 
0.50*' 
0.21 
-0.43* 
-0.63* 
V/S ratio=visceral/subcutaneous fat ratio; 
t Change in variable was assessed as value before minus after weight loss; 
* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001. 
visceral fat loss (cm2) 
150 
3.8 V2 4.6 5.0 
men and women 
Y=52X-199 
r = 0.71, p-0.0001 
5.4 5.8 6.2 
log [visceral fat] (cm2) 
Figure 1. Relationship between initial amount of visceral fat before weight loss and changes 
in visceral fat with weight loss in the whole study population (37 women (o) and 
35 men (•)) 
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DISCUSSION 
The present study shows that, in healthy premenopausal obese women but not in obese 
men, visceral fat accumulation was positively correlated with higher levels of RMR and 
DIT. Furthermore, obese men with an initial abundance of visceral adipose tissue lost 
less body weight and fat mass than gluteal-femoral obese men. In both sexes, the 
mobilization of visceral fat seems to be increased at the expense of a reduced loss of 
subcutaneous abdominal fat in obese subjects with initially large amounts of visceral fat. 
It is well known that resting energy expenditure is dependent on several constitutional 
factors such as sex, age, and the amount of FFM (28-30). In this study, no significant 
associations were found between age and variables of energy expenditure in both sexes, 
probably due to the small age range of the study population. Body fat mass was 
significantly associated with RMR in women but not in men. This is in accordance with 
previous findings (13,28). Cunningham (28) demonstrated that fat mass may be a 
significant predictor of resting energy expenditure in obese women, although this may not 
be observed in the general population. This phenomenon together with the proposed 
higher proportion of metabolically less 'active' tissues in FFM in men compared with 
women (29) may partially explain the difference observed in RMR expressed per 
kilogram FFM between both sexes. Consistent with other studies (28,29), we observed 
positive correlations between RMR and FFM in both women and in men (r=0.47, 
/><0.01; r=0.62,p<0.0001, respectively). Previous studies demonstrated that it may not 
be correct to use the ratio of RMR to FFM neither in cross-sectional studies (31) nor 
in weight loss studies (32). 
Studies in obese women (9-11,13,14) in whom the relations between body fat 
distribution and energy expenditure were investigated have yielded contradictory findings. 
Some investigators did not observe an association between RMR and body fat 
distribution (10,13,14). In the study of den Besten et al. (9), a nonsignificant trend toward 
higher RMR values in abdominal obese women was found. Weststrate et al. (11) 
reported a significantly higher RMR in obese women with an abdominal type of fat 
distribution in comparison with obese women with a gluteal-femoral type of fat 
distribution. This is consistent with our findings. They speculated that among obese 
women the proportion of metabolically 'active' organs in the FFM may be higher in the 
abdominal obese than in the gluteal-femoral obese. Only in the study of Vansant et al. 
(10) was a significantly higher glucose-induced thermogenesis in abdominal obese women 
found. They suggested that elevated insulin levels in abdominal obese could activate the 
sympathetic nervous system, which may have a stimulating effect on the thermogenic 
response. In the present study, in obese women an accumulation of visceral fat was 
associated with a higher DIT in response to a mixed meal as well as with higher insulin 
levels (r=0.40,/?<0.05). Also in obese men, a significant positive correlation was found 
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between visceral fat and insulin levels (r=0.43, p< 0.05). However, no higher rate of 
energy expenditure could be demonstrated in men with initially large amounts of visceral 
fat, which is in agreement with findings of van Gaal (12). Recently, Wahren (33) 
reported that sympathetic nervous activity may not be required for meal-induced 
thermogenesis in humans. Possible reasons for the differences in the relation of visceral 
fat to energy expenditure between both sexes are still unclear. It is possible that 
differences in sex steroid concentrations between both sexes play a role. Vansant et al. 
(34) reported that estradiol could be important as a determinant of energy expenditure, 
whereas the role of androgens is limited. Astrup et al. (35) demonstrated that variations 
in plasma androstenedione contribute to the interindividual variance in energy 
expenditure of women. The complex associations between hormonal status, energy 
expenditure, and body fat distribution requires further investigation. 
In the majority of the above-mentioned studies, the waist/hip ratio was used as an 
indicator of body fat distribution. The present study showed that different conclusions 
about the relationship between fat distribution and energy expenditure are obtained 
when the different adipose tissue depots are quantified more precisely by the use of 
imaging techniques. In both sexes, waist/hip ratio was not significantly correlated with 
RMR, whereas visceral fat was positively correlated to RMR in women compared with 
a negative association with subcutaneous abdominal fat. 
Contradictory results have been obtained from studies in which the associations 
between body fat distribution and the prognosis of weight reduction were examined (3-9). 
This study does not support the findings of previous studies that abdominal obese do lose 
body weight and fat more easily than gluteal-femoral obese (3-5). In the present study, 
an initially large visceral fat deposition was in fact significantly associated with a reduced 
loss of weight and fat mass in men, whereas, in women, this trend was not significant. 
Wadden et al. (6) also found a smaller loss of total body fat in upper-obesity. Other 
investigators, however, did not observe associations between fat distribution and the 
ability to lose weight (7-9). Differences in the definition and measurement techniques of 
body fat distribution, characteristics of the study population, or experimental design may 
be responsible for differences observed between the results of the present study and 
others. In contrast to previous studies in which all subjects received the same amount of 
calories, in this study, each subject had equal energy deficits at the start of the weight 
reduction period. It may be that the larger weight losses in women with abdominal 
obesity in previous studies are due to the larger energy deficits in these women resulting 
from the same standardized caloric-restricted diet for the whole study population. 
In the present study, we were able to distinguish the reduction in visceral and 
subcutaneous abdominal fat. Although obese subjects with an initial abundance of 
visceral fat did not lose more body weight than subjects with smaller amounts of visceral 
fat, the reduction of the visceral fat was increased at the expense of a reduced loss of the 
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subcutaneous fat in these subjects. Changes in fat mass and changes in visceral fat were 
not significantly related in women (r=0.18, /?=0.28) and men (r=0.28, /?=0.11). The 
preferential reduction of visceral fat is consistent with the proposed findings that lipolysis 
in visceral fat cells is increased compared with subcutaneous fat cells (36). Visceral 
adipose tissue seems to be the fat depot that plays a critical role in the associations with 
an unfavorable lipid profile (37). Therefore, the preferential reduction of visceral fat may 
be expected to lead to favorable changes in serum lipoproteins and other risk factors for 
metabolic disorders. 
We conclude that there may be gender differences in the associations between visceral 
fat accumulation and components of energy expenditure in obese subjects. The reasons 
for these gender differences remain unclear, and further investigations are needed. In 
addition, obese subjects with visceral fat accumulation do not lose body weight more 
easily than subjects with less visceral fat. However, in obese men and women, an 
abundance of visceral fat, the most hazardous fat depot related to metabolic disorders, 
is associated with a larger reduction of visceral fat with weight loss. 
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VISCERAL FAT LOSS MEASURED BY MAGNETIC RESONANCE IMAGING IN 
RELATION TO CHANGES IN SERUM LIPID LEVELS OF OBESE MEN AND 
WOMEN* 
Rianne Leenen, Karin van der Kooy, Anneke Droop, Jaap C. Seidell, Paul Deurenberg, Jan 
A. Weststrate, Joseph GAJ. Hautvast 
ABSTRACT 
The effect of weight reduction on serum lipids in relation to visceral fat 
accumulation was studied in 78 healthy obese subjects (40 premenopausal women 
and 38 men) aged 27-51 years and with an initial body mass index of 30.7 ± 2.2 
kg/m2 (mean ± SD). The subjects received a 4.2 MJ/day energy-deficit diet for 
13 weeks. Magnetic resonance imaging was used to assess abdominal fat areas 
before and after weight loss. Weight reductions of 12.6 ± 3.2 kg in men and 11.7 
± 3.8 kg in women resulted in larger reductions in the fasting serum levels of total 
cholesterol (p<0.05), LDL cholesterol (p=0.06), and triglycerides (p<0.01) and 
a larger increase in the HDL cholesterol/LDL cholesterol ratio (p=0.05) in men 
compared with women. Men also lost more visceral fat (p< 0.0001), whereas the 
reductions in the total and subcutaneous abdominal fat depots were similar. In 
women, visceral fat loss was significantly related to an increase of the HDL 
cholesterol level, independent of the degree of total fat loss. In men, however, no 
significant correlations were observed between changes in visceral fat and any of 
the serum lipids. Comparisons of average changes in obese men and women 
suggest that visceral fat loss is associated with an improvement of the serum lipid 
profile. However, correlation analysis does not support a critical role of visceral 
fat in determining serum lipid concentrations on an individual level, except for an 
improvement of the HDL cholesterol level with visceral fat loss in obese women. 
INTRODUCTION 
Previous studies have clearly shown that the occurrence of several metabolic aberrations 
of obesity, such as diabetes mellitus and coronary heart disease, are related to body fat 
* Arteriosclerosis and Thrombosis 1993;13:487-494. 
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distribution (1,2). A relative predominance of visceral fat in the abdominal region seems 
to be a more important predictor for these metabolic disorders than is total body fatness. 
In numerous studies, the influence of weight reduction on changes in serum lipids in 
obesity has been examined. There have been only a few studies investigating the relations 
between changes in body fat distribution and changes in serum lipid levels in response 
to weight reduction (3-5). In two of these studies (3,4), changes in body fat distribution 
were measured by the waist/hip ratio, which is the commonly used anthropometric index 
for adipose tissue distribution. However, it has been previously demonstrated that 
changes in the waist/hip ratio seem to be inappropriate for the evaluation of changes in 
visceral fat (6,7). Only Fujioka et al. (5) have reported, in a study of obese Japanese 
women, relations between changes in visceral fat measured by computed tomography and 
changes in serum lipids. To our knowledge, no previous studies have investigated the 
associations between changes in serum lipid levels and changes in the visceral fat depot 
in obese men. Men have more visceral fat (8) and a serum lipid profile that indicates a 
higher risk for coronary heart disease compared with women (8,9). 
Visceral adipose tissue has been proposed to be the most important fat depot related 
to an unfavorable lipid profile (10). Recently, we have shown that there is a larger 
reduction in visceral fat with weight loss in obese subjects with an initial abundance of 
visceral fat than in obese subjects with smaller amounts of visceral fat (11). This 
preferential reduction in visceral fat, which may be due to the proposed elevated lipolytic 
capacity of the visceral adipocytes (12), is expected to be accompanied by favorable 
changes in the serum lipid profiles after a period of energy restriction, particularly in 
obese subjects with visceral fat accumulation. 
The purpose of this study was to investigate the effects of a controlled slimming diet 
during 13 weeks on serum lipids and on body fat distribution in obese men as well as in 
obese women. Particular attention was focused on whether reductions in the visceral fat 
depot, measured by magnetic resonance imaging, were correlated with favorable changes 
in the serum lipid profile in obese subjects. 
METHODS 
Subjects 
Participants were recruited by means of advertisements in local newspapers. Ninety-six 
obese subjects (48 women and 48 men) were selected on the basis of their body mass 
index (between 28 and 38 kg/m2), age (between 25 and 51 years), premenopausal state, 
smoking behavior (fewer than 5 cigarettes per day), and drinking behavior (fewer than 
2 alcoholic consumptions per day). All subjects were apparently healthy, as judged by 
their medical history and a physical examination. Subjects with glycosuria and proteinuria 
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were excluded. Throughout the study, none of the volunteers received medication known 
to affect the variables measured in this study, and the women did not use oral 
contraceptives before or during the study. None of the subjects had been on a slimming 
diet for several months before the study. Subjects with an abdominal and gluteal-femoral 
fat distribution, based on the waist/hip ratio (cutoff points, 0.85 in women and 1.00 in 
men), were matched for age and body mass index by sex. Fourteen subjects did not 
complete the dietary treatment successfully: 4 were excluded because of intercurrent 
illness, 6 were excluded for personal reasons, and 4 were excluded because of suspicion 
of poor dietary compliance. In addition, data were excluded for 2 subjects who were later 
diagnosed as having subclinical hypothyroidism and 2 who were later found to have 
severe fasting hyperinsulinemia (> 100 jiU/mL). Data for statistical analysis remained 
for 78 subjects (40 women and 38 men). All subjects gave their written informed consent 
to participate in this study, which was approved by the Medical Ethics Committee of the 
Department of Human Nutrition. The procedures had been fully explained to the 
volunteers. 
Experimental design and diet 
Subjects were divided into 4 groups; each group was given a different weight-maintaining 
diet before weight loss. The groups did not differ with respect to fat distribution (neither 
in the waist/hip ratio nor in abdominal fat depots). The diets were individually tailored 
to meet each person's energy requirement, which was estimated from resting metabolic 
rate and physical activity pattern as described previously (13). Body weights were 
recorded twice a week by the subjects, and energy intakes were adjusted to maintain 
individual weight stability. After this weight-stable period of 3-10 weeks, baseline 
measurements were performed to determine body composition, fat distribution, and 
serum lipids in the week preceding the weight-loss treatment. The weight-stable period 
was followed by a period of 13 weeks during which the subjects received a 4.2 MJ/day 
energy-deficit diet. Individual energy deficits were based on estimated daily energy intake 
at the end of the weight-stable period preceding the period of energy restriction. After 
the energy-deficit period, the subjects were given a diet for 3 weeks to maintain the new 
achieved body weight; this diet had the same nutrient composition as the weight-
reduction diet (post-slimming diet). At the end of this period, all measurements were 
repeated. 
The nutrient composition of the diets was calculated with the use of the Dutch 
computerized food-composition table (14). Ninety-five percent of the energy intake in 
each dietary period was supplied individually to the volunteers by the Department of 
Human Nutrition. In addition, the participants were allowed to choose a limited number 
of food items, free of fat and cholesterol, that provided a fixed amount of 5% of the total 
daily energy intake. Duplicate portions of each diet were collected, stored at -20 °C, 
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pooled per diet period, and analyzed after the study. These chemically determined values 
were combined with the values calculated (14) for the free-choice items (Table 1). 
The weight-stable diets consisted of conventional foods, whereas the energy-deficit diet 
was a combination of slimming products and conventional foods. The subjects were 
instructed to maintain their habitual physical activity pattern and smoking habits during 
the study period. They were asked to record any sign of illness, deviations from the diet, 
medication used, free-item choice, and changes in smoking and activity patterns in a 
diary. Compliance to the diet was checked by weight control and meetings with trained 
dietitians every 2 weeks. 
Table 1. Nutrient composition of the diets* 
Weight reduction 
23.3 
33.4 
9.9 
11.1 
11.1 
43.0 
0.4 
33.5 
3.6 
Type of diet 
Post-slimming 
21.7 
33.7 
11.2 
11.5 
10.1 
44.2 
0.6 
28.0 
2.9 
Protein (% of energy) 
Fat (% of energy) 
Saturated fatty acids 
Monounsaturated fatty acids 
Polyunsaturated fatty acids 
Carbohydrates (% of energy) 
Alcohol (% of energy) 
Cholesterol (mg/MJ)* 
Dietary fiber (g/MJ)* 
t Nutrient composition was based on chemical analysis of duplicate diets (95% of energy) and nutrient composition of the free-choice 
items (5% of energy); 
* To convert values for the intake of cholesterol to milligrams and dietary Tiber to grams per 1,000 kcal, multiply by 4.184. 
Blood sampling and analyses 
Venous blood was drawn twice in the morning after an overnight fast of 11-13 hours, 
with an interval of 2 days. The mean concentration of the 2 samples was used for 
statistical analysis. Serum was prepared by low-speed centrifugation within 1 hour after 
venipuncture and stored at -80 °C until analysis. Total serum cholesterol was determined 
by an enzymatic colorimetric method (15). Serum high density lipoprotein (HDL) 
cholesterol was measured by the same enzymatic method (15) after precipitation by 
dextran sulfate-Mg2* (16). Serum triglycerides were determined as previously described 
(17). The within-run coefficient of variation of control sera was 1.3% for total 
cholesterol, 1.6% for HDL cholesterol, and 1.6% for triglycerides. The between-run 
coefficient of variation of control sera was 0.7% for total cholesterol, 1.1% for HDL 
cholesterol, and 0.9% for triglycerides. Accuracy for total cholesterol and triglycerides 
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was checked by analysis of serum pools of known value provided by the US Centers for 
Disease Control (Atlanta,GA). Accuracy for HDL cholesterol was checked by serum 
pools of known value produced by Solomon Park Research Laboratories (Kirkland,WA). 
The mean bias with regard to target values of the Centers for Disease Control was +0.11 
mmol/L for total cholesterol and -0.02 mmol/L for triglycerides. The mean bias with 
regard to the Solomon Park target value for HDL cholesterol was +0.08 mmol/L. The 
low density lipoprotein (LDL) cholesterol concentration was calculated using the 
Friedewald equation (18). The ratio of HDL cholesterol to LDL cholesterol (HDL/LDL 
ratio) was calculated as an index of atherogenicity. 
Body composition 
All anthropometric measurements were made with the subjects wearing only swimming 
gear or underwear. Body weight was determined to the nearest 0.05 kg on a digital scale 
(model ED-60-T, Berkel, Rotterdam, The Netherlands), and body height was measured 
to the nearest 0.001 m using a wall-mounted stadiometer. Body mass index was 
calculated as weight (kg) divided by height squared (m2). Whole-body density was 
determined by underwater weighing (19). Residual lung volume was measured 
simultaneously by a helium dilution technique (20). Percent body fat was calculated from 
total body density by the equation of Siri (19). Percent body fat of 2 subjects was 
determined from weight and total body water as assessed by deuterium oxide dilution, 
assuming a hydration coefficient of the fat free mass of 0.73 (21). These subjects were 
afraid of complete immersion under water. 
Fat distribution 
Waist circumference was measured midway between the lower rib margin and the iliac 
crest at the end of a gentle expiration. The hip circumference was measured at the level 
of the widest circumference over the great trochanters. Both circumferences were 
measured to the nearest 0.001 m with the subjects in a standing position. Magnetic 
resonance imaging scans were made on a whole-body scanner (GYROSCAN S15, Philips 
Medical Systems, Best, The Netherlands) using a 1.5-T magnetic field (64 MHz) and a 
slice thickness of 10 mm. Transverse magnetic resonance imaging scans were taken 
midway between the lower rib margin and the iliac crest while subjects were lying supine. 
The scans were performed and interpreted as described previously (22). In this obese 
population, the reproducibility of the fat area determinations from the same scan, 
expressed as the coefficient of variation, before weight loss was 1.8%, 5.0%, and 2.2% 
for the estimation of total, visceral, and subcutaneous abdominal fat areas, respectively; 
after weight loss, the values were 2.3%, 5.7%, and 2.0%, respectively. In 6 subjects (3 
women and 3 men), only the measurements before weight loss could be used for 
statistical analysis because of incorrect measurements after weight loss. 
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Statistical methods 
Deviations from normality of the distributions of the variables were checked within each 
sex. The distributions of triglycerides, visceral fat, and the changes in visceral fat and 
triglycerides were slightly skewed. Natural logarithm-transformed values for triglycerides 
and visceral fat were performed in statistical analyses. No transformations for change in 
visceral fat and change in triglycerides were used because this resulted in findings 
principally identical to analyses based on normally distributed variables. Differences in 
variables before and after the weight loss treatment were tested by Student's paired t 
test. Pearson's product-moment correlations and partial correlation coefficients were 
computed within each sex by using univariate and multiple linear regression techniques 
with serum lipids as dependent variables and the covariates as independent variables. 
Differences between the regression lines for men and women were tested for differences 
in slopes and intercepts as described by Kleinbaum et al. (23). Regression analysis was 
also used to determine the effects of changes in visceral fat on the gender differences in 
changes in serum lipid levels. Two-sided probability values were considered statistically 
significant at/?<0.05. Results are expressed as means ± standard deviation (SD) unless 
otherwise indicated. 
RESULTS 
The characteristics of the study population before weight loss are summarized in Table 
2. The differences in variables between men and women were all statistically significant, 
except for age, body mass index, total abdominal fat area, and total and LDL cholesterol. 
Although men had, on average, a smaller fat mass compared with women, men had 
higher triglyceride concentrations and lower values for HDL cholesterol and the 
HDL/LDL ratio than women. Men had larger visceral fat areas and higher waist/hip 
ratios, whereas women had more subcutaneous abdominal adipose tissue. 
Table 3 shows the changes in body weight, body composition, and fat distribution after 
weight reduction for men and for women. Within each sex, all variables were significantly 
lower (p< 0.0001) after weight loss. Losses of body weight and fat mass induced by the 
energy-deficit diet did not differ significantly between men and women. Although men 
and women lost similar amounts of total and subcutaneous abdominal fat, men lost 
significantly more visceral fat than women, and the decrease in the waist/hip ratio was 
also significantly larger in men. In both sexes, the mean body weight remained stable 
from the end of the weight reduction period to the end of the post-slimming diet: +0.07 
± 0.87 kg (p=0.62) in women and -0.07 ± 1.22 kg (p=0.74) in men. 
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Table 2 Characteristics of the subjects before weight loss 
WOMEN MEN 
N 
Age(yr) 
Weight (kg) 
Body mass index (kg/m2) 
Body fat (%) 
Fat mass (kg) 
Waist/hip ratio 
Abdominal fat areas fcm'1 
Visceral 
Subcutaneous 
Total 
Serum lipids (mmol/L)' 
Total cholesterol 
LDL cholesterol 
HDL cholesterol 
HDL/LDL ratio 
Triglycerides 
40 
39 
85.0 
30.9 
43.0 
36.7 
0.87 
106 
390 
4% 
5.39 
3.63 
1.19 
0.34 
1.27 
± 
+ 
+ 
+ 
+ 
+ 
4; 
± 
+ 
+ 
± 
± 
+ 
+ 
6 
8.4 
2.2 
4.5 
6.2 
0.07 
44 
103 
109 
0.80 
0.67 
0.25 
0.08 
0.52 
38 
41 
96.5 
30.5 
32.5 
31.5 
0.98 
156 
314 
470 
5.63 
3.88 
0.91 
0.24 
1.87 
± 
+ 
± 
+ 
± 
-
+ 
± 
-
+ 
± 
+ 
+ 
+ 
6 
7.7" 
2.2 
4.1" 
5.1" 
0.05' 
39" 
67* 
77 
0.87 
0.78 
0.15* 
0.05* 
0.66* 
Values are means i SD; 
LDL=low density lipoprotein, HDL=high density lipoprotein, HDL/LDL ratio=hdl cholesterol/Idl cholesterol ratio; 
t To convert from mmol/L to mg/dL, multiply cholesterol values by 38.67 and triglyceride values by 8834; 
* p< 0.001, ** p< 0.0001: women versus men. 
Table 3. Changes in variables after weight reduction* 
WOMEN MEN 
N 
Weight (kg) 
Body mass index (kg/m ) 
Body fat (%) 
Fat mass (kg) 
Waist/hip ratio 
Abdominal fat areas (cm2)+ 
Visceral 
Subcutaneous 
Total 
40 
11.7 
4.3 
7.2 
10.3 
0.03 
35 
117 
152 
+ 
+ 
+ 
+ 
+ 
+ 
± 
+ 
3.8* 
1.4* 
3.0* 
3.6* 
0.03 
25* 
58* 
64* 
38 
12.6 
4.0 
6.9 
9.8 
0.07 
61 
113 
174 
± 
+ 
± 
+ 
+ 
± 
+ 
+ 
3.2* 
1.0* 
2.7* 
3.1* 
0.03** 
26** 
45* 
53* 
Values are means ± SD; 
t Change in variable was assessed as value before minus after weight loss; 
+ 37 women, 35 men; 
* p< 0.0001: before versus after weight loss; 
* p< 0.0001: women versus men. 
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Figure 1. Bar graph showing changes in serum lipids in 38 obese men (open bars) and 40 
obese women (hatched bars) with weight reduction (means ± SEM)* 
TC= total cholesterol, LDL=low density lipoprotein cholesterol, HDL=high density lipoprotein cholesterol, 
TG=triglycerides; 
f Change in variable was assessed as value before minus after weight loss; 
* p<0.05, ** p<0.01: women versus men. 
The effects of weight loss on the changes of the various serum lipid levels are 
illustrated in Figure 1. The changes of all serum lipids were highly significant (p < 0.0001), 
except for HDL cholesterol in women (p=0.15). The decreases in total cholesterol and 
triglycerides were significantly larger in men than in women. The differences in changes 
in LDL cholesterol and in the HDL/LDL ratio between both sexes were of borderline 
significance at p=0.06 and p=0.05, respectively. The HDL/LDL ratio rose, on average, 
in women by 0.05 ± 0.04 (p< 0.0001) and in men by 0.07 ± 0.05 (p< 0.0001). 
In Table 4, the correlations between changes in serum lipid levels and changes in body 
weight and fat mass are presented. In men, a reduction in body weight was significantly 
associated with an improvement of the serum lipid profile and a loss of fat mass with 
increases in HDL cholesterol and the HDL/LDL ratio as well as a decrease in 
triglycerides (p=0.05). In women, reductions in body weight and fat mass were positively 
related to decreases in total, LDL and HDL cholesterol concentrations, although the 
correlation between changes in body weight and HDL cholesterol did not reach statistical 
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significance (p=0.13). It has been demonstrated that the extent of changes in cholesterol 
levels that occur with weight loss is also partly dependent on the initial serum levels (24). 
There were some significant differences in initial serum lipid levels between the 4 groups 
that received different pre-slimming diets (data not shown). However, adjustment for the 
contribution of the initial serum lipid levels on changes in serum lipids did not 
appreciably affect the observed correlations in both sexes, except for higher significant 
correlations between changes in fat mass and changes in total cholesterol (r=0.38, 
/?<0.05), LDLcholesterol (r=0.31,p=0.07), and triglycerides (r=0.52,p<0.001) in men. 
Table 4. Pearson correlation coefficients between changes in serum lipids and decreases in 
body weight and fat mass after weight reduction* 
Change in (mmol/L) 
Total cholesterol 
LDL cholesterol 
HDL cholesterol 
HDL/LDL ratio 
Triglycerides 
Decrease in body 
Women (n=40) 
035*** 
0.48** 
0.24 
-0.14 
0.19 
weight (kg) 
Men (n = 
0.49** 
0.42** 
-0.44** 
-05V" 
0.49** 
38) 
Decrease in 
Women (n = 
0.55*** 
052'" 
0.35* 
-0.09 
0.02 
fat mass (kg) 
=40) Men (n=38) 
0.25 
0.23 
-0.43** 
-0.41** 
0.32 
LDL=low density lipoprotein, HDL=high density lipoprotein, HDL/LDL ratio=hdl cholesterol/ldl cholesterol ratio; 
t Change in variable was assessed as value before minus after weight loss; 
* p<0.05, ** p<0.01, *** p<0.001. 
The correlations between changes in serum lipid levels and decreases in fat distribution 
parameters due to weight loss are given in Table 5. In men and women, none of the 
correlations between changes in visceral fat or the waist/hip ratio and changes in serum 
lipids reached statistical significance. Reductions in the total and subcutaneous 
abdominal fat depots were significantly associated with improvement of the levels of total 
and LDL cholesterol in women, whereas in men these reductions were associated with 
improvement of HDL cholesterol and the HDL/LDL ratio. In both sexes, a decrease in 
total fat mass was strongly related to decreases in total (r=0.77 and/?< 0.0001 in women, 
r=0.64 and/7<0.0001 in men) and subcutaneous abdominal fat depots (r=0.78 and 
p< 0.0001 in women, r=0.58 and p< 0.001 in men). After adjustment for the degree of 
total fat loss, only the correlation between reduction in the visceral fat depot and 
improvement of the HDL cholesterol level in women reached statistical significance 
(r=-0.41, p< 0.05), and additional adjustment for the initial serum lipid level showed the 
same tendencies compared with analyses with adjustment for degree of total fat loss 
alone. 
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Table 5. Pearson correlation coefficients between changes in serum lipids and decreases in 
body fat distribution variables after weight reduction* 
Change in (mmol/L) 
WOMEN rn=37} 
Total cholesterol 
LDL cholesterol 
HDL cholesterol 
HDL/LDL ratio 
Triglycerides 
MEN(n=35) 
Total cholesterol 
LDL cholesterol 
HDL cholesterol 
HDL/LDL ratio 
Triglycerides 
Total 
fat 
0.34* 
0.33' 
0.11 
-0.10 
0.10 
0.13 
0.14 
-0.48** 
-0.41* 
0.20 
Decrease in 
Abdominal fat depots (cm ) 
Subcutaneous 
fat 
0.41* 
0.41* 
0.26 
-0.02 
0.01 
0.07 
0.0S 
-0.41* 
-0.35* 
0.22 
Visceral 
fat 
-0.08 
-0.09 
-0.31 
-0.19 
0.26 
0.13 
0.19 
-0.25 
-0.22 
0.02 
Waist/hip 
ratio 
0.03 
0.11 
-0.18 
-0.13 
-0.03 
0.26 
0.19 
-0.24 
-0.23 
033 
LDL=low density lipoprotein, HDL=high density lipoprotein, HDL/LDL ratio=hdl cholesterol/ldl cholesterol ratio; 
t Change in variable was assessed as value before minus after weight loss; 
* p<0.05, ** p<0.01. 
In Figure 2, the unadjusted relations for changes in visceral fat with changes in levels 
of total cholesterol (panel A) and HDL cholesterol (panel B) are presented for the 
whole study population. In both cases, the regression lines for men and women did not 
differ significantly with respect to the slopes. Only the regression lines between changes 
in total cholesterol and visceral fat differed significantly in the intercept (p<0.05). 
Gender differences in changes in total cholesterol and triglyceride levels could not be 
fully explained by adjustment for the change in visceral fat area. Such adjustment 
reduced the gender differences by approximately 6% for total cholesterol and 16% for 
triglycerides, but they remained statistically significant (p < 0.05 and/>=0.01, respectively). 
The borderline-significant differences between men and women for changes in LDL 
cholesterol and the HDL/LDL ratio were reduced by approximately 13% (p=0.15) and 
38% (p=0.20), respectively, after controlling for visceral fat loss. The gender difference 
in change in HDL cholesterol was already not significant (p=0.16), and adjustment for 
change in visceral fat area reduced this difference by approximately 66% (p=0.56). 
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Figure 2. Plots showing relations between changes in visceral fat with changes in total 
cholesterol levels (panel A) and changes in HDL cholesterol levels (panel B) with 
weight loss in 37 obese women (o) and 35 obese men (»)* 
t Change in variable was assessed as value before minus after weight loss. 
Table 6 shows the correlations between indicators of body fat distribution before weight 
loss and changes in serum lipids in response to weight reduction after controlling for age 
and initial total fat mass. Adjustment for these 2 parameters was necessary because age 
in both sexes and initial fat mass in men were significantly correlated with visceral fat 
accumulation: r=0.49 and p< 0.01 versus age and r=0M and p< 0.01 versus initial fat 
mass in men, and r=0.41 and p< 0.01 versus age in women. In both sexes, no significant 
correlations between the initial waist/hip ratio and changes in serum lipid profile could 
61 
Chapter 4 
be observed, although in women the correlation with HDL cholesterol was of borderline 
significance (p=0.05). In women, an initial abundance of visceral fat before weight loss 
was significantly associated with an improvement of HDL cholesterol and triglyceride 
levels after weight loss, whereas in men it was associated with a deterioration of the 
HDL cholesterol level. Additional adjustment for degree of total fat loss did not 
appreciably affect the observed correlations in women, although in men the significant 
relation disappeared. 
Table 6. Partial correlations (adjusted for age and initial fat mass) between body fat 
distribution variables before weight loss and changes in serum lipids after weight 
reduction* 
Change in (mmol/L) 
Total 
fat 
0.05 
-0.01 
-0.07 
0.01 
0.20 
0.12 
0.11 
-0.04 
-0.05 
0.08 
Initial 
Abdominal fat depots (cm ) 
Subcutaneous 
fat 
0.16 
0.14 
0.16 
0.06 
-0.03 
0.12 
0.08 
-0.28 
-0.23 
0.23 
parameters 
Visceral 
fat 
-0.27 
-0.30 
-0.48" 
-0.10 
0.36' 
-0.01 
0.02 
0.37* 
0.31 
-0.21 
Waist/hip 
ratio 
-0.09 
-0.08 
-0.32 
-0.12 
0.18 
0.08 
-0.02 
0.13 
0.12 
0.18 
WOMEN (n=40) 
Total cholesterol 
LDL cholesterol 
HDL cholesterol 
HDL/LDL ratio 
Triglycerides 
MEN(n = 38) 
Total cholesterol 
LDL cholesterol 
HDL cholesterol 
HDL/LDL ratio 
Triglycerides 
LDL=low density lipoprotein, HDL=high density lipoprotein, HDL/LDL ratio=hdl cholesterol/ldl cholesterol ratio; 
t Change in variable was assessed as value before minus after weight loss; 
* p<0.05, *• p<0.01. 
DISCUSSION 
This study in healthy, moderately obese subjects showed that, with similar reductions in 
body weight and fat mass, men had larger reductions in serum total cholesterol, LDL 
cholesterol, and triglyceride levels and a larger increase in the HDL/LDL ratio 
compared with women. Men also lost more visceral fat, whereas reductions in total and 
subcutaneous abdominal fat were similar. Although these results suggest that a larger 
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reduction in visceral fat is associated with a better improvement of the serum lipid 
profile, correlations between changes in the visceral fat depot and changes in serum 
lipids were not significant in either sex. Only the change in HDL cholesterol was 
inversely associated with a change in visceral fat in women. 
The average weight reduction of approximately 12 kg caused by caloric restriction 
resulted in changes to more favorable serum lipid levels in both sexes, except for HDL 
cholesterol in women. This weight loss was accompanied by substantial changes in body 
fat distribution in men as well as women. The larger loss in visceral fat in men compared 
with women is in accordance with our previous findings that larger baseline amounts of 
visceral fat are associated with larger reductions in the visceral fat depot with weight loss 
(11). 
Analysis of the data at baseline revealed that in the studied obese men the amount 
of visceral fat was not significantly related to serum lipid levels independent of age and 
percent body fat (8). In this context, it is not surprising that in these men the loss of 
visceral fat did not correlate with any of the changes in serum lipids levels. In contrast, 
the total amount of body fat lost was significantly related to improvement of all serum 
lipids in men. This suggests that total body fat loss seems to be more important in 
improving the serum lipid profile of obese men than loss of visceral fat. 
In women, initial visceral fat was found to be strongly inversely associated with HDL 
cholesterol and positively with triglyceride levels but not with levels of total and LDL 
cholesterol (8). Reductions in visceral fat in women did lead to improvement of levels 
of HDL cholesterol but not of triglycerides, independent of the degree of total fat loss. 
The lack of significant correlations between changes in visceral fat and triglyceride levels 
may be partly due to the relatively large within-person variations in both variables 
(22,25). 
The only other prospective study in which imaging techniques were used demonstrated 
a significant correlation between reduction of the visceral fat depot and improvement of 
triglyceride levels in obese Japanese women, whereas no significant relation was observed 
with improvement of total and HDL cholesterol (5). The different results in the Japanese 
study and the present study could perhaps be partly explained by the initial higher serum 
triglyceride levels of the Japanese women, the larger obtained reduction in triglycerides, 
and the fact that serum lipids were probably not measured at the end of a completely 
weight-stable period. It has been reported that it is important to measure concentrations 
of HDL cholesterol in a weight-maintenance state (26,27). 
The relatively large measurement error of visceral fat areas, as described previously 
by Seidell et al. (22), might cause attenuation of the correlations. Despite these 
limitations, the correlation between reduction of visceral fat and improvement of the 
HDL cholesterol level in women was obvious in the present study. Especially obese 
women with an initial abundance of visceral fat may benefit from weight reduction with 
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regard to their HDL cholesterol levels because they lose relatively more visceral fat than 
women with less visceral fat at baseline (11). The exact mechanism by which visceral fat 
influences HDL concentrations is not fully resolved. It has been proposed that the high 
hepatic triglyceride lipase activity in obese women with visceral fat accumulation could 
be responsible for the reduction in plasma HDL cholesterol levels, particularly HDLj 
cholesterol levels, whereas variations in sex steroid levels may play a potential role in the 
associations between visceral fat and hepatic triglyceride lipase activity (28). Therefore, 
gender differences in sex steroid concentrations may be partly responsible for the 
associations between improvement of HDL cholesterol and visceral fat reduction in 
women only. 
It has been suggested that body fat distribution may be responsible for the gender 
differences in serum lipid concentrations (29). This seems to be particularly true for 
HDL cholesterol and triglycerides. It is less clear for total and LDL cholesterol, as 
indicated in a previous study (8) and in others (29,30). In the present study, average 
initial levels of total and LDL cholesterol were similar in men and women. The changes 
in total and LDL cholesterol and visceral fat loss, however, were all larger in men than 
in women, despite the same degree of total fat loss. These latter findings suggest that 
visceral adipose tissue seems to play a role in determining serum cholesterol levels. The 
reason for this discrepancy is still unknown. 
In conclusion, the larger observed reduction in visceral fat and the better improvement 
of the serum lipid profile accompanying weight loss in healthy, moderately obese men 
compared with premenopausal, moderately obese women suggests a crucial role of the 
visceral fat depot in the improvement of the serum lipid levels of obese subjects. 
However, within each sex, no significant correlations between reductions of the visceral 
fat depot and improvement of the serum lipid profile could be found, with the exception 
of a significant association in women between visceral fat loss and an increase in HDL 
cholesterol. It may be that even with imaging techniques the changes in the visceral fat 
depots cannot be measured precisely enough because of the large within-subject 
variability in the estimate of visceral fat and that the present study population was too 
homogeneous with respect to ranges of body fatness and serum lipids. In addition, 
measurement of changes in total visceral fat does not allow separation of the effects of 
changes in the different intra-abdominal fat depots (retroperitoneal, mesenteric, and 
omental). Particularly, the mesenteric and omental fat depots ('portal tissues') are 
proposed to be associated with metabolic disorders (2). It may be that associations 
between these fat depots and serum lipids are diluted by looking at all intra-abdominal 
fat depots simultaneously. There are no techniques that make it possible to distinguish 
between these different intra-abdominal fat depots. With the use of the present 
techniques, the importance of visceral fat in prospective studies on changes in risk factors 
for coronary heart disease seems to be less clear than previously anticipated (1,2). 
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RELATIVE EFFECTS OF WEIGHT LOSS AND DIETARY FAT MODIFICATION ON 
SERUM LIPID LEVELS IN THE DIETARY TREATMENT OF OBESITY* 
Rianne Leenen, Karin van der Kooy, SasMa Meyboom, Jaap C. Seidell, Paul Deurenberg, 
Jan A. Weststrate 
ABSTRACT 
The independent effects of weight loss and dietary fat modification on serum 
lipids were investigated in two groups of healthy moderately obese men and 
women, who were first fed a weight-stable high-fat,high-saturated-fat diet for 3 
weeks. In one group ('sequential' group, n = 19), a weight-stable low-fat,low-
saturated-fat diet (Low-Sat) was given for 7 weeks, followed by a 4.2 MJ/day 
deficit Low-Sat diet and a weight stabilising Low-Sat diet for 3 weeks. Another 
group ('simultaneous group', n=22) was subjected to the same regime, but the 7 
weeks weight-stable Low-Sat diet was omitted. Both groups lost similar amounts 
of body weight of about 13 kg and had similar overall changes in total cholesterol, 
LDL cholesterol, HDL cholesterol, the HDL/LDL ratio, and triglycerides. 
Analysis of the separate effects of the Low-Sat diet without energy restriction and 
of weight loss in the 'sequential' group showed that weight loss per se was 
responsible for about 50% of the total reduction in total cholesterol, and for about 
60% and 70% of the fall in LDL cholesterol and triglycerides, respectively. Fat 
modification without weight loss reduced HDL cholesterol by 11.1% and the 
HDL/LDL ratio by 7.7%, while weight loss per se led to increases in HDL 
cholesterol of 12.5% and in the HDL/LDL ratio of 24.0%. We conclude that the 
effects of reduction in fat and saturated fat intake and weight loss are additive. 
The net favourable effect of weight loss seems to be greater than that of dietary 
fat modification in optimizing the serum lipid profile of obese subjects. 
INTRODUCTION 
One of the health hazards in affluent countries is obesity, which is associated with an 
increased risk of coronary heart disease (1,2). Obese subjects tend to have elevated 
* Submitted for publication. 
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serum levels of total cholesterol, low-density-lipoprotein (LDL) cholesterol, and 
triglycerides, whereas their levels of high-density-lipoprotein (HDL) cholesterol tend to 
be reduced. Elevated total cholesterol levels as well as reduced HDL cholesterol levels 
are both risk factors for coronary heart disease (3,4). 
Obese subjects, especially when they are hypercholesterolemic, are usually advised to 
lose weight in order to improve their serum lipid profile. The effects of weight loss on 
serum lipid levels in obese subjects have been investigated extensively. However, 
differences in experimental design, type of diet, heterogeneity of the subjects studied as 
well as lack of controlled dietary regimens in some studies, make comparison of these 
studies difficult. The most controversial issue in weight loss studies is whether or not 
there is a change in HDL cholesterol concentration after weight loss. Recently, a meta-
analysis of 70 weight loss studies has been published, which revealed beneficial effects 
of weight reduction on all serum lipid levels, including an increase in HDL cholesterol 
at a stabilised reduced weight (5). However, in this meta-analysis, it was not possible to 
distinguish between the independent effect of dietary alterations, usually accompanied 
by weight loss, and of weight reduction per se. It might be that the changes in lipid 
concentrations could, at least partly, be explained by changes in total fat intake and fatty 
acid composition of the diets. The current recommendations regarding the dietary 
management of hypercholesterolemia include a low-fat diet with a high ratio of 
polyunsaturated to saturated fat (P/S-ratio) (6,7). To our knowledge, no previous studies 
have examined the independent effects of losing body weight on the one hand and of 
lowering the total fat intake and increasing the P/S-ratio of the diet as indicated by 
dietary guidelines on the other hand, on altering the serum lipid profile in obese subjects. 
The purpose of the present study was to evaluate the effects of these factors separately 
by introducing a change in nutrient composition either simultaneously with or preceding 
a period of energy restriction. 
SUBJECTS AND METHODS 
Subjects 
This study was part of a project concerning the effects of weight loss on energy 
metabolism, serum lipids, body composition, and several hormones in relation to visceral 
fat accumulation (8,9). Participants were recruited by means of advertisements in local 
newspapers. Fifty obese subjects (26 women and 24 men) were selected on the basis of 
their body mass index (between 28 and 38 kg/m2), age (between 25 and 51 years), 
premenopausal state, smoking behaviour (less than 5 cigarettes per day) and drinking 
behaviour (less than 2 alcoholic consumptions per day). The subjects selected were 
apparently healthy, as evaluated by a medical history, a physical examination, an urine 
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test for glycosuria and proteinuria, and a blood screening for serum levels of total 
cholesterol, triglycerides and glucose. The levels of serum lipids of the subjects before 
the experiment ranged from 3.67 to 7.78 mmol/L (mean, 6.00 mmol/L) for total 
cholesterol and from 0.38 to 2.65 mmol/L (mean, 1.45 mmol/L) for triglycerides. Serum 
glucose levels ranged from 4.90 to 7.10 mmol/L (mean, 5.71 mmol/L) and systolic blood 
pressure from 110 to 180 mmHg (mean, 141 mmHg). Throughout the study, none of the 
volunteers received any medications known to affect serum lipids and the women did not 
use oral contraceptives. None of the subjects had been on a slimming diet for several 
months before the study. 
Seven subjects did not complete the dietary treatment successfully: 3 subjects due to 
intercurrent illness, 3 subjects for personal reasons and 1 subject was excluded from the 
analysis, because of suspicion of poor dietary compliance. The lipid levels of this latter 
subject was unknown at the time of exclusion. In addition, data of 1 woman who was 
later diagnosed as having subclinical hypothyroidism and of 1 woman who was later 
found to have severe fasting hyperinsulinemia (>100 jiU/mL), were also excluded. 
Results of 41 subjects (20 women and 21 men) remained for statistical analysis. 
The protocol for the study, which had been approved by the Medical Ethical 
Committee of the Department of Human Nutrition, was fully explained to the volunteers 
and all subjects gave their written informed consent. No monetary incentive was given 
except for the free food. 
Diets and design 
Figure 1 shows the experimental design of the study. Ten subjects per week entered the 
study over a period of 5 weeks. All subjects consumed a standardized affluent-type high-
fat,high-saturated-fat diet (High-Sat) for 3 weeks, during which their body weight was 
kept stable. At week 1 and 3 of this run-in period, body composition and serum lipid 
levels were determined. After this period, the subjects were divided into 2 groups 
matched for age and body mass index within each sex. 
One group ('sequential' group: 8 women, 11 men) was fed a weight-stable low-fat,low-
saturated-fat diet (Low-Sat) for 7 weeks. This diet consisted of a low percent of energy 
provided by total fat and a high P/S-ratio. At the end of week 7, all measurements were 
repeated. The subjects subsequently received a 4.2 MJ/day energy-deficit diet for 13 
weeks with the same nutrient composition as the Low-Sat diet. The individual amount 
of energy provided equalled daily energy intake at the end of the weight-stable Low-Sat 
diet minus 4.2 MJ/day. Measurements of body composition were repeated after 7 and 
13 weeks in this slimming period. After this period, the subjects were given a weight-
stabilising diet for 3 weeks with the same nutrient composition as the Low-Sat diet. At 
the end of this stabilisation period, all measurements were repeated. 
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'Sequential' group (/?=19) 
Weeks: h—3—+— 
Measurements: t t 
-13-
t 
J" 
—+—3—I 
'Simultaneous' group (n=22) 
Weeks: I—3—I— 
Measurements: t f 
-13-
_T 
-4—3-H 
High-tat, high-saturated-tat diet (High-Sat) 
I Low-fat, low-saturated-fat diet (Low-Sat), low level indicates energy restriction 
t Body weight + blood sampling 
t Body weight 
Figure 1. Experimental design of the study 
The other group ('simultaneous' group: 12 women, 10 men) received the energy-deficit 
Low-Sat diet immediately after the run-in period, followed by the 3 weeks stabilisation 
period comparable with the 'sequential' group. The 7-weeks period on a weight-stable 
Low-Sat diet was thus omitted in this group. 
For both groups, the weight-stable diets were individually tailored to meet each 
person's energy requirement, which was estimated from resting metabolic rate and 
physical activity pattern at the beginning of the weight-stable periods as described 
elsewhere (10). Body weights were recorded twice a week by the subjects and energy 
intakes were adjusted by us to maintain individual weight stability. 
The nutrient composition of the diets was calculated with the use of a Dutch 
computerized food-composition table (11). Ninety-five percent of the energy intake in 
each dietary period was supplied individually to the volunteers. In addition, the 
participants were allowed to choose a limited number of food items, free of fat and 
cholesterol, that provided 5% of the total daily energy intake in order to give subjects 
some possibility to vary their choice and, thereby, to improve their cooperation. The 
weight-stable diets consisted of conventional foods and the energy-deficit diet was a 
combination of slimming products and conventional foods. The subjects were instructed 
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to maintain their habitual pattern of physical activity and smoking habits during the 
study. They were asked to record any sign of illness, deviations from the diets, 
medications used, free-food choice and changes in smoking and activity patterns in a 
diary. Compliance with the diets was checked by trained dieticians by means of 
interviews, checking the diary and measuring body weight every 2 weeks. 
Duplicate portions of each diet were collected on alternate days for three imaginary 
participants with different daily energy intakes on every three days, stored at -20 °C, 
pooled per diet period, and analyzed after the study. These chemically determined values 
were combined with the values calculated (11) for the free-food-choice items (Table 1). 
Table 1. Mean daily intake of energy and nutrient composition of the diets* 
Energy (MJ/day) 
(kcal/day) 
Protein (% of energy) 
ftt (% of energy) 
Saturated fatty acids 
C12:0+C14:0+C16:0 
C18:0 
Monounsaturated fatty acids 
Polyunsaturated fatty acids 
Carbohydrates (% of energy) 
Alcohol (% of energy) 
Cholesterol (mg/MJ)* 
Dietary fibre (g/MJ)* 
High -fat, 
iiigu-oaiuiaicu-
fat 
10.3 
2458 
14.4 
40.2 
18.3 
12.1 
3.5 
15.2 
5.0 
44.7 
0.7 
27.8 
3.7 
± 1.7 
i 410 
Weight stable 
(7 weeks) 
10.8 
2572 
21.5 
33.2 
11.0 
6.5 
3.0 
11.5 
9.2 
44.9 
0.5 
24.2 
3.0 
± 2.1 
± 507 
Low-fat,low-saturated-fat 
Energy 
65 ± 
1561 ± 
23.3 
33.2 
9.6 
6.0 
2.5 
11.5 
10.8 
43.2 
0.3 
30.6 
3.8 
deficit 
1.7 
409 
Weight stable 
(3 weeks) 
9.5 ± IS 
2272 ± 370 
21.3 
34.2 
11.5 
6.8 
31 
11.7 
9.6 
44.0 
0.6 
25.1 
31 
Based on chemical analysis of duplicate diets (95% of energy) and calculated nutrient composition of the free-choice items (5% 
of energy); Analysis of ancillary duplicate diets providing 7.8,10.8 and 12.3 MJ per day in the weight-stable periods and 3.6, 6.6, 
and 81 MJ per day in the energy-deficit period, showed that the variation between subjects in the composition of the diets was 
negligible, therefore, no standard deviations are given for the nutrients; 
To convert values for the intake of cholesterol to milligrams and dietary fibre to grams per 1,000 kcal, multiply by 4.184. 
Blood sampling and analyses 
Venous blood was drawn in the morning after an overnight fast of 11-13 hours, twice 
with an interval of 2 days. The mean concentration of the 2 samples was used for 
statistical analysis. Serum was obtained by low-speed centrifugation within 1 hour after 
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venipuncture, stored at -80 °C, and analyzed enzymatically for total- and HDL cholesterol 
and triglycerides (12-14). The within-run coefficient of variation of control sera was 1.5% 
for total cholesterol, 1.8% for HDL cholesterol, and 1.2% for triglycerides. The 
coefficient of variation of control sera between runs was 0.7% for total cholesterol, 0.8% 
for HDL cholesterol, and 1.1% for triglycerides. The mean bias with regard to target 
values of serum pools provided by the U.S. Centers for Disease Control 
(Atlanta,GA,USA) was +0.11 mmol/L for total cholesterol and -0.07 mmol/L for 
triglycerides. The mean bias with regard to target values of serum pools obtained from 
the Solomon Park Research Laboratories (Kirkland,WA,USA) was +0.10 mmol/L for 
HDL cholesterol. The LDL cholesterol concentration was calculated using the 
Friedewald equation (15). The ratio of HDL cholesterol to LDL cholesterol (HDL/LDL 
ratio) was calculated as an index of atherogenicity. 
Body composition 
Body weight was determined to the nearest 0.05 kg using a digital scale (Berkel ED-60-T, 
Rotterdam, The Netherlands) with the subjects wearing only swimming gear or 
underwear. Body height was measured to the nearest 0.001 m using a wall-mounted 
stadiometer. Body mass index was calculated as weight (kg) divided by height squared 
(m2). Whole-body density was determined by underwater weighing (16) with simultaneous 
measurement of the residual lung volume by a helium dilution technique (17). 
Percentage body fat was calculated from total body density by the equation of Siri (16). 
One woman was afraid of complete immersion under water. Percentage body fat of this 
subject was determined from weight and total body water as assessed by the deuterium 
oxide dilution technique, assuming 73% of the fat free mass to be water (18). 
Statistical methods 
Deviations from normality of the distributions of the variables were checked. Only the 
distribution of HDL cholesterol at week 3 of the High-Sat period was slightly skewed and 
natural logarithm-transformed values for this variable were used in statistical analysis. 
Differences in variables at week 3 of the High-Sat period and differences in responses 
between the 'simultaneous' group and the 'sequential' group were performed using 
unpaired Student's Mests. Changes in variables due to the diets within each group were 
tested using Student's paired Mests. Pearson's product-moment correlation coefficients 
were computed between the changes in body weight and the responses in serum lipids 
for both sexes. Two-sided p-values were considered statistically significant at p< 0.05. 
Results are expressed as means ± standard deviation (SD) unless otherwise indicated. 
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RESULTS 
Table 2 presents the baseline characteristics of the 41 subjects who completed the study 
successfully. No significant differences in variables were found between the 
'simultaneous' group and the 'sequential' group. Comparison of the characteristics of 
women (n=20) with those of men («=21) demonstrated that men had significantly lower 
levels of percent body fat (p<0.0001), fat mass (p<0.01), HDL cholesterol (p<0.0001) 
and the HDL/LDL ratio (p < 0.0001), whereas the levels of body weight (p < 0.0001) and 
serum triglycerides (p< 0.001) were significantly higher in men than in women (data not 
shown). 
Table 2. Characteristics of the 'simultaneous' group and the 'sequential' group* 
N (females/males) 
Age(yr) 
Weight (kg) 
Body mass index (kg/m ) 
Body fat (%) 
Eat mass (kg) 
Serum lipids'1' 
Total cholesterol (mmol/L) 
LDL cholesterol (mmol/L) 
HDL cholesterol (mmol/L) 
HDL/LDL ratio 
Triglycerides (mmol/L) 
'Simultaneous' 
means ± SD 
22 (12/10) 
41 ± 
90.7 ± 
30.6 ± 
39.3 ± 
35.5 ± 
5.62 ± 
3.83 ± 
1.10 ± 
0.30 ± 
1.53 ± 
6 
8.5 
2.0 
6.2 
5.9 
0.71 
0.65 
0.22 
0.08 
0.59 
group 
range 
31-51 
70.7-103.9 
27.6-34.4 
30.1-51.4 
25.4-46.6 
4.34-7.08 
2.74-5.28 
0.69-1.69 
016-0.47 
0.45-2.75 
'Sequential' group 
means ± SD 
19 (8/11) 
40 ± 
89.7 ± 
30.5 ± 
39.0 ± 
34.7 ± 
5.57 ± 
3.85 ± 
0.99 ± 
0.26 ± 
1.63 ± 
5 
9.4 
2.3 
7.8 
63 
0.81 
0.73 
0.21 
0.07 
0.62 
range 
2848 
73.2-110.4 
27.1-363 
25.9-50.7 
24.1483 
4.00-717 
238-5.09 
0.72-131 
018-0.40 
038-2.83 
LDL=low density lipoprotein, HDL* high density lipoprotein, HDL/LDL ratio=hdl cholesterol/ldl cholesterol ratio; 
t Characteristics were taken at week 3 on a high-fat, high-saturated-fat diet; 
+ To convert from mmol/L to mg/dL, multiply cholesterol values by 38.67 and triglyceride values by 8834. 
Changes in body weight during the study are illustrated in Figure 2 for the 2 groups 
separately. During the High-Sat period, the mean body weight fell by 1.4 ± 1.0 kg 
{p< 0.0001) in the 'simultaneous' group and by 1.6 ± 0.9 kg (p< 0.0001) in the 
'sequential' group. During the 7 weeks on a Low-Sat diet, body weight was reduced 
further by 1.5 ± 1.4 kg (p< 0.001) in the 'sequential' group. No significant correlations 
were found between changes in body weight and changes in serum lipids in this period, 
calculated either for all subjects together or for men and women separately. Weight loss 
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due to energy restriction was not statistically different between the 'simultaneous' group 
and the "sequential' group (p=0.84), and body weights remained stable during the 
following weight stabilisation period. The total reductions in body weight and fat mass 
during the weight loss and final stabilisation period together were 13.5 ± 3.3 kg 
(p<0.0001) and 11.8 ± 3.4 kg (p<0.0001), respectively in the 'simultaneous' group versus 
KG 
100-
80-
60-
B0DY WEIGHT 
1 
HIGH-
SAT LOW-SAT 
weight stable | energy deficit • weight stable 
K 3 - H 7- -13- -3H wk 
— - • — - 'simultaneous' group 'sequential' group 
Figure 2 Body weight (means ± SEM) for the 'simultaneous' group (n=22) and the 
'sequential' group (n=19) during the study 
High-Sal=high fat, high saturated fat; Low-Sat=low fat, low saturated fat. 
13.2 kg ± 3.0 kg (p< 0.0001) and 10.9 kg ± 2.3 kg (p< 0.0001), respectively in the 
'sequential' group. 
Table 3 shows the separate effects of change in dietary fat without energy restriction 
and of pure weight loss on serum lipids in the 'sequential' group. As a result of the 
weight-stable Low-Sat diet as well as of weight loss, the levels of serum total cholesterol, 
LDL cholesterol and triglycerides reduced significantly: -7.2%, -5.2% and -12.9% after 
the Low-Sat diet, and -7.9%, -8.5% and -33.1% after weight loss, respectively. The levels 
of HDL cholesterol and HDL/LDL ratio decreased significantly after the Low-Sat diet: 
-11.1% and -7.7%, respectively, whereas after weight loss a significant increase in HDL 
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cholesterol and in HDL/LDL ratio could be observed, +12.5% and +24.0%, 
respectively. During the weight loss period, changes in body weight were positively 
associated with changes in serum total cholesterol (r=0.58, p< 0.01), LDL cholesterol 
(r=0.42, /?=0.08) and triglyceride levels (r=0.64, p<0.01). In contrast, no significant 
correlations could be observed with changes in levels of HDL cholesterol or the 
HDL/LDL ratio. 
Table 3. The separate effects of change in dietary fat and weight loss on serum lipids in the 
'sequential' group (n=19) 
Total cholesterol (mmol/L) 
before 
after 
change 
LDL cholesterol (mmol/L) 
before 
after 
change 
HDL cholesterol (mmol/L) 
before 
after 
change 
HDL/LDL ratio 
before 
after 
change 
Triglycerides (mmol/L) 
before 
after 
change 
Values are means ± SD; 
LDL=low density lipoprotein, HDL=high density lipoprotein, HDL/LDL ratio=hdl cholesterol/ldl cholesterol ratio; 
To convert from mmol/L to mg/dL, multiply cholesterol values by 38.67 and triglyceride values by 8834; 
* p<0.05, ** p<0.01, •** p<0.0001: before versus after diet or weight loss. 
The combined effects of change in dietary fat and weight loss for both groups as well 
as the separate effects for the 'sequential' group on serum lipid levels are illustrated in 
Figure 3. As a result of the combined effects of change in diet composition and weight 
loss, the serum levels of total cholesterol, LDL cholesterol and triglycerides fell to the 
same extent in both groups: -0.82 ± 0.50 mmol/L, -0.51 ± 0.35 mmol/L and -0.68 ± 0.52 
mmol/L, respectively in the 'sequential' group, and -0.81 ± 0.40 mmol/L, -0.59 ± 0.38 
mmol/L and -0.55 ± 0.44 mmol/L, respectively in the 'simultaneous' group. All these 
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5.57 i 0.81 
5.16 ± 0.87 
-0.40 ± 0.30"* 
3.85 ± 0.73 
3.65 S 0.81 
-0.20 ± 0.25" 
0.99 ± 0.21 
0.88 ± 016 
-0.11 ± 0.08*" 
0.26 ± 0.07 
0.25 ± 0.06 
-0.02 ± 0.03* 
1.63 ± 0.62 
1.42 ± 031 
-0.21 ± 0.33* 
Weight loss 
5.16 ± 0.87 
4.75 ± 0.71 
-0.41 i OSV 
3.65 ± 0.81 
3.34 ± 0.65 
-0.31 + 0.42' 
0.88 ± 0.16 
0.99 ± 0.19 
+011 ± 0.07* 
0.25 t 0.06 
0.31 ± 0.08 
+0.06 + 0.04< 
1.42 ± 031 
0.95 ± 0.30 
-0.47 ± 0.40' 
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reductions were statistically significant (p< 0.0001). In the 'sequential' group, the weight-
stable Low-Sat diet produced a fall in HDL cholesterol, while weight loss per se led to 
a comparable increase in HDL cholesterol, resulting in an overall unchanged HDL 
change in serum lipids (mmol/L) 
0.2-
-0.2 
-0.4 i 
-0.6 
-0.8 H 
TC LDL HDL 
m 
ssa 
TG 
Sq Sm Sq Sm Sq Sm Sq Sm 
Sq ='sequential ' group 
I J J M Low-fat, low-saturated- fa t diet 
I | Weight loss 
Sm ='simultaneous' group 
BSSSSi Low-fat, low-sa tura ted- fa t diet + weight loss 
Figure 3. Changes in serum lipid levels for the 'sequential' group (n=19) and the 
'simultaneous' group (n =22) during the study* 
TC=total cholesterol, LDL=low density lipoprotein cholesterol, HDL=high density lipoprotein cholesterol, 
TG=triglycerides; 
t Changes are expressed as after minus before diet and/or weight loss. 
cholesterol level (-0.002 ± 0.10 mmol/L). In the 'simultaneous' group, the HDL 
cholesterol level also did not change significantly (+0.03 ± 0.14 mmol/L). As a 
consequence, the HDL/LDL ratio increased significantly within each group: +0.04 ± 
0.05 in the 'sequential' group (p<0.01) and +0.06 ± 0.05 in the 'simultaneous' group 
(p< 0.0001). The differences in the overall responses between both groups were not 
statistically significant for any of the serum lipids. 
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DISCUSSION 
The main findings of this strictly controlled study in moderately obese subjects are that 
the nett favourable effect of body weight loss on serum lipids as a result of energy 
restriction seems to be greater than that of reduction in fat intake and increase in P/S-
ratio of the diet. Furthermore, the separate effects of weight loss and dietary fat 
modification appear to be additive. The HDL cholesterol-lowering effect of a low-fat diet 
with a high P/S-ratio was effectively counteracted by the effect of losing body weight. 
The design of the present study makes it possible to distinguish the effects of weight 
loss per se from the effects of dietary fat modification. Switching from an affluent-type 
diet to a diet with a decreased percent of energy provided by total fat and an increased 
P/S-ratio without energy restriction by obese subjects, resulted in reductions of all serum 
lipid levels, including HDL cholesterol. Dietary guidelines recommend a decrease in 
intake of total fat from the current average of 40 percent of energy in most affluent 
societies down to about 30 percent. In particular, the intake of saturated fatty acids 
should be reduced (6,7). However, it has been suggested that a reduction in total fat 
intake may lower HDL cholesterol levels (19-21). In the present study, HDL cholesterol 
was significantly reduced on a weight-stable low-fat,low-saturated-fat diet both in males 
and in females. The reduction in women was significantly greater (p<0.05) than that in 
men (-0.16 ± 0.08 mmol/L (14.5%) and -0.07 ± 0.05 mmol/L (7.8%), respectively). 
Whether or not this is a real gender difference in response to a low-fat,low-saturated-fat 
diet remains to be established. 
The change in serum total cholesterol as a result of the change to the low-fat diet with 
a high P/S-ratio in this study was less than the 0.58 mmol/L predicted from the Keys' 
equation (22). Cole et al. (23) also demonstrated smaller decreases than predicted by 
Keys' equation in obese subjects. They speculated that obesity may diminish the 
responsiveness to dietary change. This is in accordance with the observations of Goff and 
colleagues, which indicated that fatter men apparently do not benefit from a diet lower 
in cholesterol (24). In the present study, the subjects were highly motivated and the 
average weight loss was of a magnitude expected from a 4.2 MJ/day deficit diet. 
Distortion of the results due to lack of dietary compliance is, therefore, thought to be 
minimal. 
It should be noted that isocaloric replacement of dietary fat by carbohydrates as 
advocated by the dietary guidelines instead of by protein in this study, might produce a 
less favourable serum lipid profile than observed in the present study. In a study with 
moderately hypercholesterolemic subjects, it has been demonstrated that isocaloric 
substitution of dietary protein for carbohydrate lowers total-, LDL cholesterol, and 
triglycerides and increases HDL cholesterol (25), while the findings of Lithell et al. (26) 
indicated that carbohydrates increase the VLDL level and slightly decrease HDL 
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cholesterol compared with dietary protein. 
Pure weight loss of approximately 13 kg of which 83% was fat, had beneficial effects 
on all serum lipid levels. During this weight loss period, changes in body weight were 
positively associated with changes in serum total cholesterol, LDL cholesterol and 
triglyceride levels, whereas no significant correlations were observed with changes in 
HDL cholesterol or the HDL/LDL ratio. This latter result could possibly be explained 
by the relatively small variation in the responses of HDL cholesterol in this study. 
Another explanation could be that the amount of weight loss per se might not entirely 
be responsible for changes in HDL cholesterol concentrations. Previous studies have 
reported that significant increases of serum HDL cholesterol may occur in obese subjects 
in response to weight loss after their body weight has been stable for some time (5,27). 
In agreement with these findings, Schwartz and Brunzell (28) found an enhanced activity 
of adipose tissue lipoprotein-lipase after weight stabilisation at a reduced body weight, 
resulting in increased HDL cholesterol levels, whereas during active weight loss a 
decreased lipoprotein-lipase activity has been observed (29). 
In the present study, the average weight losses per se in men and women were similar, 
12.8 ± 3.0 kg and 13.8 ± 3.1 kg, respectively. Comparing the responses of serum lipids 
to the weight losses of obese men with those of women clearly demonstrated no sex-
specific pattern: decreases in serum levels of total cholesterol, LDL cholesterol and 
triglycerides were -9.2%, -9.8%, and -33.5% in men and -6.3%, -6.6%, and -33.3% in 
women, respectively. There were considerable increases in average HDL cholesterol and 
the HDL/LDL ratio in men (+13.3%, +25.0%, respectively) as well as in women 
(+11.7%, +19.2%, respectively). 
The present study shows that the effects of weight loss and that of change to a low-fat 
diet with a high P/S-ratio were additive: the total effect of slimming on reducing serum 
levels of total-, LDL cholesterol and triglycerides could be ascribed for 50%, 61%, and 
69%, respectively, to weight loss per se. The unfavourable reductions in HDL cholesterol 
and the HDL/LDL ratio in response to the recommended dietary fat modification 
without energy restriction, were compensated by weight loss. In conclusion, our findings 
support beneficial effects of a diet low in total fat and a high P/S-ratio on some serum 
lipid levels in obese subjects. The considerable additive effects of weight loss per se 
underscores the importance of establishing successful dietary treatment and weight 
maintenance programmes for obesity. 
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CHAPTER 6 
VISCERAL FAT ACCUMULATION IN RELATION TO SEX HORMONES IN OBESE 
MEN AND WOMEN UNDERGOING WEIGHT LOSS THERAPY* 
Rianne Leenen, Karin van der Kooy, Jaap C. Seidell, Paul Deurenberg, Hans P.F. 
Koppeschaar 
ABSTRACT 
In 70 healthy obese subjects (37 men and 33 premenopausal women: age 27-51 yr, 
body mass index 28-38 kg/m2), associations between initial body fat distribution 
and sex hormone levels were studied as well as between changes that occurred in 
response to a 4.2 MJ/day deficit diet for 13 weeks. Visceral and subcutaneous 
abdominal fat areas were determined by magnetic resonance imaging. In women, 
visceral fat accumulation was significantly related to diminished levels of sex-
hormone-binding-globulin (SHBG) and the ratio of free 176-estradiol (ly/free 
testosterone (T) and to elevated levels of free T, after adjustment for age and 
total fat mass. In men, total body fatness and subcutaneous abdominal fat, but not 
visceral fat, were significantly inversely associated with total T and free T levels. 
The mean total fat loss was 11.3 ± 3.3 (SD) kg as a result of the energy-deficit 
diet. In women, loss of visceral fat was significantly related to rises in SHBG level 
and the free E^/free T ratio independent of total body fat loss, whereas in men, 
only the correlation between visceral fat loss and increase in estrone level reached 
statistical significance. In conclusion, in obese premenopausal women, visceral fat 
predominance seems to be associated with a relatively increased androgenicity. In 
obese men, sex steroid levels appear to depend mainly on the degree of obesity. 
In obese women but not in obese men, visceral fat loss seems to be accompanied 
by a relative reduction in androgenicity regardless of total body fat loss. 
INTRODUCTION 
Several studies have shown that obesity (1-8) and, particularly, the distribution of body 
fat (9-19) are associated with various abnormalities of sex hormone metabolism. 
* Submitted for publication. 
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Abdominal fat distribution has been found to be an independent risk factor for metabolic 
disorders such as coronary heart disease and diabetes mellitus (20-21). It has been 
suggested that sex steroids may play an important role in the regulation of regional fat 
accumulation and mobilization (22,23), and they may be determinants of coronary heart 
disease as well (24,25). 
Numerous studies have investigated the relationship between abdominal fat 
distribution and sex steroids in peripheral blood (7-19,26). The majority of these studies 
demonstrated that an abdominal type of fat distribution is accompanied by diminished 
levels of sex-hormone-binding-globulin (SHBG). Furthermore, it has been reported that 
predominance of fat in the abdomen is associated with low androgen levels in men (10), 
whereas in women, with increased androgenicity as reflected by elevated levels of total 
testosterone (T) (13,16,19), free T (16,17,19) or percentages of free T (11,12). However, 
not all studies could confirm these findings. The discrepancies may be explained by 
differences in study population and in methods used for the assessment of hormone 
levels and body fat distribution. In virtually all studies, the waist/hip ratio (WHR) was 
used as a measure of fat distribution. Imaging techniques such as computed tomography 
and magnetic resonance imaging, however, give more accurate information about the 
separate adipose tissue depots (visceral and subcutaneous) than the WHR. Only in the 
study of Seidell et al. (10) were fat areas included, which were determined by computed 
tomography. 
In general, weight loss has been reported to reverse abnormal levels of sex steroids 
in obese subjects, suggesting that these endocrine abnormalities are a result rather than 
a cause of obesity (3-7,27). To our knowledge, only Pasquali et al. (27) have investigated 
whether changes in fat distribution due to weight reduction were associated with changes 
in sex steroid levels in obese hyperandrogenic amenorrheic women. However, they have 
measured changes in body fat distribution by the WHR, which is reported to be an 
inappropriate indicator for the evaluation of changes in visceral fat (28). To our 
knowledge, no studies have reported on the effects of reduction of the visceral fat depot 
on sex steroids in obese subjects. 
In the present prospective study, the relationships between visceral adipose tissue, 
measured by magnetic resonance imaging, and sex steroids were examined in moderately 
obese men and premenopausal women undergoing weight loss therapy. 
SUBJECTS AND METHODS 
Subjects 
Participants were recruited by means of advertisements in local newspapers. Ninety-six 
obese subjects (48 women and 48 men) were selected on the basis of their age (between 
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25 and 51 yr), body mass index (between 28 and 38 kg/m2), smoking behavior (less than 
5 cigarettes per day) and drinking behavior (less than 2 alcoholic consumptions per day). 
All subjects were apparently healthy, as evaluated by a medical history and physical 
examination. Throughout the study, none of the volunteers received any medication 
known to affect any of the variables studied. The women selected did not use oral 
contraceptives and reported normal menstrual cycles. They were screened for hirsutism 
at the physical examination. None of the subjects had been on a slimming diet for several 
months before the study. Within each sex, abdominal and gluteal-femoral obese subjects, 
based on the waist/hip ratio, were matched for age and body mass index. 
Fourteen subjects did not complete the dietary treatment successfully: 4 due to 
intercurrent illness, 6 for personal reasons and 4 were excluded because of suspicion of 
poor dietary compliance. The serum lipid and hormone levels of these latter 4 subjects 
were unknown at the time of exclusion. Data of 2 subjects who were later diagnosed as 
having subclinical hypothyroidism, and of 2 subjects who were later found to have severe 
fasting hyperinsulinemia (> 100 jiU/mL), were also excluded. Furthermore, in 4 subjects 
not enough blood for determining hormone levels could be taken before or after weight 
loss. Data of 4 women were additionally excluded, because they were not in the early 
follicular phase of the menstrual cycle at the time of blood sampling before or after 
weight loss. Women were considered to be in the early follicular phase, when their blood 
samples were taken within the first 10 days of the menstrual cycle. The complete results 
of 70 subjects (33 women and 37 men) remained for statistical analysis. 
The study was approved by the Medical Ethical Committee of the Department of 
Human Nutrition. All subjects gave their written informed consent after the procedures 
had been fully explained to the volunteers. 
Experimental design and diet 
After 3 weeks on a standardized affluent-type weight-stable diet, baseline measurements 
were performed to determine body composition, body fat distribution, and blood 
parameters. This diet consisted of 12 energy percent (en%) protein, 40 en% fat, and 48 
en% carbohydrates. The diet was individually tailored to meet each person's energy 
requirement, which was estimated from resting metabolic rate and physical activity 
pattern as described elsewhere (29). Body weights were recorded twice a week by the 
subjects themselves, and energy intakes were adjusted to maintain individual weight 
stability if necessary. Some of the subjects remained on a weight-stable diet up until 7 
weeks before the weight loss treatment started. The weight-stable period was followed 
by a weight reduction period of 13 weeks during which the subjects received a 4.2 
MJ/day deficit diet. This energy-deficit diet consisted of 25 en% protein, 33 en% fat, and 
42 en% carbohydrates. The individual amount of energy provided equalled the daily 
energy intake at the end of the weight-stable period minus 4.2 MJ/day. After the energy-
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deficit period, the subjects were given a weight-stabilising diet for 3 weeks; this diet had 
the same nutrient composition as the weight-reduction diet. At the end of this weight-
stable period, all measurements were repeated. 
The subjects were instructed to maintain their habitual physical activity pattern and 
smoking habits during the study. They were asked to record any sign of illness, deviations 
from the diets, the first day of menstruation, medications used, and changes in both 
smoking and activity patterns in a diary for the entire study period. More information 
about the diets and dietary compliance has been reported in detail elsewhere (30). 
Hormonal analyses 
Venous blood samples were taken in the morning after an overnight fast of 11-13 hours. 
Serum was obtained by centrifugation within 1 hour after venipuncture, distributed in 
aliquots in small plastic cups, and stored at -80 °C until analysis. Levels of sex-hormone-
binding-globulin (SHBG) were determined using the immunoradiometric assay of Farmos 
Diagnostica (Oulunsalo, Finland) with interassay variations of 4.9% at the level of 25 
nmol/L, and 4.4% at levels of 54 nmol/L and 106 nmol/L (all levels: n = 18). Total 
testosterone (T) was measured by radio-immuno-assay (RIA) after extraction with 
diethylether as described previously (31). The interassay variations were 8.7%, 10.9%, 
and 12.7% at levels of 0.53 nmol/L, 2.9 nmol/L, and 7.4 nmol/L, respectively (all levels: 
n=24). Androstenedione (A) was also determined by RIA (31) after extraction with a 
hexane-toluene mixture (80:20, v/v) with an interassay variation of 9.1% at 2.3 nmol/L 
(n=28), 7.4% at 7.1 nmol/L («=25), and 11.0% at 12.6 nmol/L (n=25). Determinations 
of dehydroepiandrostenedione-sulphate (DHEAS) were done by RIA (31) directly in 
serum using the commercially available reagents from DPC (Los Angeles, USA, 'Coat-a-
count'). The interassay variations were 9.4%, 9.7%, and 9.1% at 1.3 nmol/L, 5.4 jimol/L, 
and 9.7 jimol/L, respectively (all levels: «=30). Estrone (Ej) and total 176-estradiol (E2) 
were extracted with diethylether, purified and separated by chromatography on Sephadex 
LH-20 columns using toluene:methanol (92:8, v/v) as eluent and quantitated by RIA 
(31). Interassay variations for E, were 19.0%, 9.6%, and 7.2% at 148 pmol/L, 457 
pmol/L, and 1160 pmol/L, respectively (all levels: n=25), and for E^ 23.6% and 10.0% 
at levels of 88 pmol/L and 411 pmol/L, respectively (all levels: n=25). The percentages 
free T and free Ej were calculated indirectly by the use of the equations as described by 
Nanjee and Wheeler (32), and Moore et al. (33), respectively, and were used to estimate 
the concentrations of free T and free Ej, respectively. 
Body composition 
All anthropometric measurements were made with the subjects wearing only swimming 
gear or underwear. Body weight was determined to the nearest 0.05 kg on a digital scale 
(Berkel ED-60-T, Rotterdam, The Netherlands), and body height was measured to the 
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nearest 0.001 m using a wall-mounted stadiometer. Body mass index was calculated as 
weight (kg) divided by height squared (m2). Whole-body density was determined by 
underwater weighing (34). Residual lung volume was measured simultaneously by a 
helium dilution technique (35). Percent body fat was calculated from total body density 
according to Siri's formula (34). One woman was afraid of complete immersion under 
water. Percent body fat of this woman was determined from weight and total body water, 
assessed by deuterium oxide dilution assuming a hydration coefficient of the fat free mass 
of 0.73 (36). 
Fat distribution 
Body fat distribution was assessed by circumference measures and by magnetic resonance 
imaging (MRI). Waist circumference was measured midway between the lower rib 
margin and the iliac crest at the end of a gentle expiration. Hip circumference was 
measured at the level of the widest circumference over the great trochanters. The 
circumferences were measured to the nearest 0.001 m with the subjects standing upright. 
MRI was performed with a whole-body scanner (GYROSCAN S15, Philips Medical 
Systems, Best, The Netherlands) using a 1.5-T magnetic field (64 MHz) and a slice 
thickness of 10 mm. Transverse MRI-scans were taken midway between the lower rib 
margin and the iliac crest while subjects were lying supine. Imaging analysis to determine 
the visceral and subcutaneous fat areas, was carried out as described previously (37). In 
this obese population, the reproducibility of calculating fat areas from the same scan 
expressed as the coefficient of variation, was better than 6% for visceral fat, and better 
than 2.5% for subcutaneous abdominal fat. In 6 subjects (3 women, 3 men), only the 
measurements before weight loss were used for statistical analysis due to practical 
problems with the measurements after weight loss. 
Statistical methods 
The distributions of DHEAS, free T, and the free Ej/free T ratio before weight loss 
were slightly skewed. Natural logarithm-transformed values for these variables were used 
in statistical analyses. The distributions of the changes in SHBG, DHEAS and the free 
E^free T ratio in response to weight loss were also lightly skewed. However, no 
transformations for the changes in those variables were used because this resulted in 
findings principally identical to analyses based on normally distributed variables. 
Differences in baseline characteristics as well as the differences in responses due to 
weight loss between the sexes were tested by the Student's unpaired Mest. The effect of 
weight loss on variables within each sex was tested with the Student's paired /-test. 
Pearson's product-moment correlations and partial correlation coefficients were 
computed within each sex by using univariate and multiple linear regression techniques. 
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Two-sided/7-values less than 0.05 were considered to be statistically significant. Results 
are expressed as means ± standard deviation (SD). 
RESULTS 
Data concerning some specific characteristics of the subjects are presented in Table 1. 
There were no significant differences between both sexes in age, body mass index, and 
DHEAS level. As could be expected, men had, on average, a lower body fat percentage 
and total fat mass than women, although they had a larger amount of visceral abdominal 
fat and a higher waist/hip ratio. The concentrations of total T and free T were 
significantly higher in men compared with women, whereas the levels of SHBG, 
estrogens, the free I^/free T ratio, and A were significantly lower in men than in women. 
Table 1. Characteristics of the subjects 
WOMEN MEN 
N 
Age(yr) 
Weight (kg) 
Body mass index (kg/m ) 
Body fat (%) 
Fat mass (kg) 
Waist/hip ratio 
Abdominal fat areas (car) 
Visceral 
Subcutaneous 
Hormones 
SHBG (nmol/L) 
Ej (pmol/L) 
Total Ej (pmol/L) 
Free E2 (pmol/L) 
Total T (nmol/L) 
Free T (nmol/L) 
FreeEj/FreeT 
DHEAS (umol/L) 
A (nmol/L) 
Values are means ± SD; 
SHBG=sex hormone binding globulin, Ej=estrone, Ej^lTB-cstradiol, T=testosterone, DHEAS=dehydroepiandrosteron sulphate, 
A=androstenedione; 
* p<0.01, " p<0.001, **• p<0.0001: women versus men. 
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33 
39 
86.9 
31.3 
44.2 
38.6 
0.87 
103 
39S 
30 
216 
254 
4.98 
1.2 
0.03 
168 
5.30 
5.21 
+ 
+ 
+ 
± 
± 
± 
+ 
+ 
± 
+ 
+ 
+ 
+ 
+ 
+ 
± 
± 
5 
7.6 
2.2 
4.7 
6.3 
0.07 
35 
111 
14 
66 
143 
2.63 
0.3 
0.01 
104 
2.41 
1.28 
37 
40 
97.4 
30.7 
33.5 
32.7 
0.99 
155 
314 
17 
143 
102 
232 
12.7 
0.41 
S3 
6.22 
439 
+ 
± 
+ 
+ 
+ 
+ 
± 
+ 
+ 
± 
+ 
+ 
+ 
± 
± 
+ 
+ 
6 
8.0**« 
2.2 
3.9*** 
5.1*" 
0.05** 
38*** 
68" 
6"* 
4 8 " ' 
2 9 * " 
0.59" 
3.2*" 
0.08** 
1.6*** 
2.85 
1.19* 
Visceral fat, sex hormones and weight loss 
Table 2. Pearson correlation coefficients between age, fat mass and body fat distribution 
variables with sex hormone levels in obese women (n =33) 
SHBG (nmol/L) 
Ej (pmol/L) 
Total E2 (pmol/L) 
Free E2 (pmol/L) 
Total T (nmol/L) 
Free T (nmol/L) 
Free E2/Free T 
DHEAS (|imol/L) 
A (nmol/L) 
Age 
(yr) 
-0.04 
0.24 
0.05 
0.07 
-0.26 
-0.26 
0.10 
-0.30 
-0.11 
Fat mass 
(kg) 
-0.06 
-0.03 
-0.16 
-0.20 
0.09 
0.11 
-0.26 
-0.30 
-0.02 
Abdominal fat 
Subcutaneous 
0.18 
-0.02 
-0.08 
-0.18 
0.04 
-0.11 
-0.13 
-0.13 
-0.11 
areas (cm2) 
Visceral 
-0.48" 
-0.03 
-0.26 
-0.17 
-0.11 
0.21 
-0.28 
-0.15 
0.13 
Waist/hip 
ratio 
-0.38* 
-0.17 
-0.38' 
-0.32 
-0.19 
0.05 
-0.31 
-0.23 
0.01 
SHBG=sex hormone binding globulin, Ej=estrone, E2=17B-estradiol, T=testosterone, DHEAS=dehydroepiandrosteron sulphate, 
A=androstenedione; 
• p<0.05, " p<0.01. 
Table 2 shows the correlations between age, fat mass, and body fat distribution 
variables with sex hormone levels in women. None of the correlations between age, fat 
mass or subcutaneous abdominal fat area with sex hormone levels reached statistical 
significance. Visceral fat area and the WHR were negatively associated with the SHBG 
Table 3. Pearson correlation coefficients between age, fat mass and body fat distribution 
variables with sex hormone levels in obese men (n =37) 
SHBG (nmol/L) 
Ej (pmol/L) 
Total Ej (pmol/L) 
Free Ej (pmol/L) 
Total T (nmol/L) 
Free T (nmol/L) 
FreeEj/FreeT 
DHEAS (umol/L) 
A (nmol/L) 
Age 
(yr) 
0.30 
0.07 
-0.01 
-0.06 
-0.06 
-0.29 
0.12 
-0.24 
-0.01 
Fat mass 
(kg) 
-0.16 
-0.06 
-0.25 
-0.26 
-0.42" 
-0.42" 
-0.01 
-0.11 
-0.23 
Abdominal fat 
Subcutaneous 
-0.06 
-0.14 
-0.22 
-0.23 
-0.33* 
-0.38* 
-0.02 
-0.24 
-0.33* 
areas (cm ) 
Visceral 
0.02 
-0.17 
-0.07 
-0.09 
-0.10 
-0.11 
-0.03 
-0.04 
-0.13 
Waist/hip 
ratio 
-0.07 
-0.26 
•0.17 
-0.18 
-0.30 
-0.37* 
0.05 
0.14 
-0.22 
SHBG=sex hormone binding globulin, E j=estrone, E2=178-estradiol, T=testosterone, DHEAS=dehydroepiandrosteron sulphate, 
A=androstenedione; 
* p<0.05, " p<0.01. 
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level and (not shown) positively with the percentages of free E^ and free T. In the 
present study, the SHBG level was highly inversely correlated with the calculated free 
percentages of free T and free E2 in both sexes (r>0.97). The WHR was also 
significantly inversely related to the total Ej level in women, whereas for visceral fat an 
inverse trend was observed (p=0.08). 
In Table 3, the correlations between age, fat mass, abdominal fat areas, and the WHR 
with sex hormone levels in men are given. The fat mass and the subcutaneous abdominal 
fat area as well as the WHR were inversely related to levels of total T and free T. 
Subcutaneous abdominal fat area was also negatively associated with the A level, 
whereas visceral fat area was not significantly related to any of the sex hormone levels. 
Table 4. Pearson correlation coefficients (adjusted for age and fat mass) between body fat 
distribution variables and sex hormone levels in obese women (n=33) and men 
(n=37) 
SHBG (nmol/L) 
Ej (pmol/L) 
Total Ej (pmol/L) 
Free 63 (pmol/L) 
Total T (nmol/L) 
Free T (nmol/L) 
Free Ej/free T 
DHEAS (nmol/L) 
A (nmol/L) 
WOMEN 
Visceral fat 
(em2) 
-0.51** 
-0.14 
-0.31 
-0.21 
-0.01 
0.35* 
-0.36* 
-0.01 
0.19 
Waist/hip 
ratio 
-039* 
-0.27 
-0.42* 
-0.37* 
-0.12 
0.14 
-0.37* 
-0.14 
0.05 
MEN 
Visceral fat 
(cm2) 
-0.02 
-0.21 
0.04 
0.05 
0.13 
0.23 
-0.08 
0.11 
-0.04 
Waist/hip 
ratio 
-0.10 
-0.29 
-0.0S 
-0.07 
-0.14 
-0.17 
0.03 
0.30 
-0.14 
SHBG=sex hormone binding globulin, E,= estrone, E2=17B-estradiol, T=testosterone, DHEAS=dehydroepiandrosteron sulphate, 
A=androstenedione; 
* p<0.05, ** p<0.01. 
In Table 4, the age and fat mass adjusted correlations are shown between the amount 
of visceral fat and the WHR with sex hormone levels, separately for women and men. 
Adjustment for the potential confounding effects of age and fat mass was necessary, 
because age in both sexes and fat mass in men were positively associated with visceral 
adipose tissue, r=0.42, p<0.05 in women and r=0.47, p<0.01; r=0.46,/?< 0.01 in men, 
respectively. In women, the amount of visceral fat as well as the WHR remained 
negatively associated with the SHBG level. After adjustment, the visceral fat area in 
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women was positively related to free T concentrations and negatively to the free E2/free 
T ratio, and a tendency towards decreasing Ej levels with visceral fat accumulation could 
be observed. In men, the inverse association between WHR and free T disappeared after 
adjustment for age and fat mass. 
The effects of weight reduction on the variables measured are given in Table 5. Within 
each sex, all the body composition and fat distribution variables decreased significantly 
after weight reduction. The reductions in WHR and visceral fat area were significantly 
larger in men than in women. The levels of SHBG and DHEAS increased significantly 
in both sexes, and Ej increased only significantly in men. The levels of total E2, free Ej, 
and A decreased significantly within each sex, while the total T and free T levels 
decreased only significantly in women. Only the changes in Ej levels were significantly 
different in men and women. 
Table 5. Changes in variables with weight reduction^ 
WOMEN MEN 
N 
Weight (kg) 
Body mass index (kg/m ) 
Body fat (%) 
Fat mass (kg) 
Waist/hip ratio 
Abdominal fat areas (cm2)+ 
Visceral 
Subcutaneous 
Hormones 
SHBG (nmol/L) 
Ej (pmol/L) 
Total E2 (pmol/L) 
Free E2 (pmol/L) 
Total T (nmol/L) 
Free T (nmol/L) 
Free E ^ r e e T 
DHEAS (umol/L) 
A (nmol/L) 
33 
-12.4 
•AS 
-8.2 
-113 
-0.04 
-33 
-117 
7 
-1 
-51 
-1.18 
-0.17 
-0.01 
6.0 
1.93 
-1.38 
+ 
+ 
+ 
± 
± 
+ 
± 
± 
* 
± 
± 
± 
± 
± 
± 
* 
4 . 3 " " 
1 .6"" 
2.8**" 
3.7**** 
0.03**** 
21**** 
58**** 
12** 
56 
141* 
2.40** 
0.20**** 
0.01**** 
108 
3.26** 
1.10**** 
37 
-133 
•A3 
-7.9 
-11.0 
-0.07 
-61 
-114 
4 
28 
-16 
-0.38 
0.64 
-0.01 
-OS 
1.95 
-0.90 
+ 
+ 
± 
+ 
± 
± 
+ 
+ 
+ 
± 
+ 
± 
+ 
+ 
+ 
+ 
33**** 
1.1**** 
2.6**** 
3.0**** 
0.03**** t 
26**** t 
46**** 
5**** 
4 9 " § 
3 0 " 
0.67** 
3.33 
0.10 
3.1 
2.40**** 
1.05"" 
Values are means ± SD; 
SHBG=sex hormone binding globulin, Ej = estrone, B^=17B-estradiol, T=testosterone, DHEAS=dehydroepiandrosteron sulphate, 
A=androstenedione; 
t Changes in variables are expressed as after minus before weight loss; 
+ 30 women, 34 men; 
* p<0.05, " p<0.01, *•* p<0.001, *"* p<0.0001: after versus before weight loss; 
$ p<0.05, t p<0.0001: women versus men. 
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The correlations between visceral fat and SHBG level before weight loss are illustrated 
in Figure 1A for each sex separately. In Figure IB, the relationship between changes in 
the visceral fat depot and changes in the SHBG levels due to weight loss are shown. 
SHBG(nmol/L) 
60-
45 
3<H 
15 
0 
SHBG (nmol/L) 
women 
r=-0A8,p<0.01 
60 
45 
.30-
lb 
0 
men 
r=0.02 p=0.69 
• 
t *** • 
• 
0 40 80 120 160 200 240 280 0 40 80 120 160 200 240 280 
visceral fa t lcm 2 ) visceral fat (cm2) 
change in SHBG (nmol/L) 
60 H 
40 
20 
0 -\ 
-20 
women 
r=-0A1,p<0.05 
-120 -100 -80 -60 -40 -20 0 
change in visceral fa t lcm 2 ) 
change in SHBG (nmol/L) 
60 i 
40 
20 
0 • 
-20{ 
U 
men 
r=0l)1 p=0.96 
120 -100 -80 -60 -40 -20 0 
change in visceral fa t lcm 2 ) 
Figure 1. Relationship between visceral fat and SHBG level before weight loss (A) and in 
response to weight loss (B) in women (o) and men (0)* 
SHBG=sex hormone binding globulin; 
t Changes are expressed as after minus before weight loss. 
Table 6 shows the correlations between changes in fat mass and abdominal fat areas 
with changes in sex hormone levels. In women, the reduction in the visceral fat depot was 
significantly related to increases in the SHBG level and the free E^free T ratio, whereas 
subcutaneous abdominal fat loss was also associated with a rise in SHBG. In men, none 
of the correlations between changes in fat mass and both abdominal fat areas with 
changes in sex hormone levels were statistically significant, except for an inverse relation 
between visceral fat and Ev Neither in women nor in men were the reductions in WHR 
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Table 6. Pearson correlation coefficients between changes in fat mass and body fat 
distribution with changes in sex hormone levels in obese women (n -30) and men 
(n=34) 
SHBG (nmol/L) 
Ej (pmol/L) 
Total E2 (pmol/L) 
Free E2 (pmol/L) 
Total T (nmol/L) 
Free T (nmol/L) 
F r e e E ^ r e e T 
DHEAS (pmol/L) 
A(nmol/L) 
Fat mass (kg) 
-0.33 
0.13 
-0.07 
-0.09 
-0.09 
0.06 
-0.11 
0.18 
-0.05 
WOMEN 
Abdominal fat 
Subcutaneous 
-0.37' 
0.25 
-O.01 
-0.01 
-0.11 
-0.02 
-0.03 
0.31 
-0.03 
areas (cm ) 
Visceral 
-0.41* 
-0.14 
-0.27 
-0.26 
0.02 
0.24 
-0.40* 
0.27 
-0.01 
Fat mass (kg) 
-0.10 
-0.09 
-0.09 
-0.08 
-0.04 
-0.01 
0.04 
-0.08 
0.20 
MEN 
Abdominal fat 
Subcutaneous 
-0.27 
-0.05 
-0.13 
-0.10 
-0.02 
0.06 
-0.01 
-0.07 
0.23 
areas (cm ) 
Visceral 
0.01 
-0.38* 
-0.07 
-0.07 
0.07 
0.05 
-0.08 
0.05 
-0.20 
SHBG=sex hormone binding globulin, Ej =estrone, E2=17B-estradiol, T=testosterone, DHEAS=dehydroepiandrosteron sulphate, 
A=androstenedione; 
* p<0.05. 
significantly related to any of the changes in the sex hormone levels (data not shown). 
In addition, after adjustment for the reduction in fat mass, because of the high 
interrelationship between loss of total fat mass and subcutaneous abdominal fat loss 
(r=0.81,/?<0.0001 in women, and r=0.69,p<0.0001 in men), the significant correlation 
between the loss of subcutaneous abdominal fat and change in SHBG level in women 
disappeared, whereas this adjustment did not appreciably affect the other observed 
correlations in women and men (data not shown). 
DISCUSSION 
The present study demonstrated that in healthy obese premenopausal women, an 
abundance of visceral fat seems to be related to a relatively increased androgenicity. In 
obese men, an association between visceral fat accumulation and sex hormone levels 
could not be confirmed. Weight loss was beneficial in normalizing most of the sex steroid 
levels in both sexes. In women but not in men, a reduction in the visceral fat depot 
seems to be accompanied by a relative reduction in androgenicity independent of the 
degree of total fat loss. 
It is well documented that obesity in men and women can be associated with several 
abberations in sex hormone regulation. In the present study, the amount of total body 
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fat mass was only in men significantly related to some sex hormones. An inverse 
relationship was found between total body fatness and levels of total T and free T. These 
latter observations are similar to what has been reported previously in men (1,4,5,8-
10,19). The fact that the basal hormonal concentrations in the present study were not 
consistently related to the degree of overweight, may be due to the relatively narrow 
range of body fatness of the study population. It should be noted that this study was 
particularly designed to study the contribution of body fat distribution rather than the 
degree of obesity on sex steroid levels. 
Comparison of the average SHBG levels of the obese men and women studied, 
supports the hypothesis that body fat distribution is inversely related to SHBG binding 
capacity as described by previous studies (9-12,14-16,18,19). Instead of expected lower 
SHBG levels in women than in men as a result of the larger adiposity in women, obese 
women had, on average, higher SHBG levels compared with obese men as well as 
smaller amounts of visceral fat. This is in accordance with the observed inverse 
relationship between visceral fat predominance and SHBG level within the female obese 
population studied, regardless of the degree of obesity. This first study in women capable 
to distinguish the associations between the separate abdominal fat depots and sex steroid 
levels, clearly demonstrates that the relationship between an abdominal fat distribution 
and SHBG is primary attributable to the amount of visceral fat and not to subcutaneous 
fat. In women, SHBG levels are mainly determined by the ratio of circulating androgens 
to estrogens, hence, SHBG may be a sensitive indicator for androgenicity in women (38). 
A decline in SHBG would cause a greater change in free T than in free E2, since the 
affinity of SHBG for T is considerably higher than that for E2 (38) and this might result 
in a relative increase in androgenic activity. 
The studies in women in which the relationships between regional fat distribution and 
androgen levels were investigated, yielded, however, contradictory results (7,11-
13,16,17,19,26). In the present study, no significant associations between visceral fat 
accumulation and total androgen levels could be found in women. This is in agreement 
with some previous studies (7,11,12), although other studies in women were able to find 
a positive relationship between WHR and total T levels (13,16,19). Evans et al. (11) 
suggested that a decrease in SHBG might result in a relative increase in androgenic 
activity which may be too small to be reflected in changes in androgen levels. However, 
in this study as well as in others (16,17,19), abdominal fat distribution was positively 
related to the biologically active free T concentrations. In two other studies (11,12), 
positive associations were observed between the WHR and percentage free T, consistent 
with our findings. We did not focus on free percentages, because in the present study as 
well as in others (12), SHBG levels were extremely highly inversely correlated with the 
calculated free percentages of T as well as of E2. It will be clear that the different indices 
of androgenicity and the differences in populations studied, make it difficult to compare 
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the results of the above-mentioned studies. 
At present, the evidence for a relationship between abdominal fat distribution and 
estrogen levels in women, is also far from clear-cut (7,11,12,16,19). Positive correlations 
between WHR and levels of total Ej and free Ej were reported by Kirschner et al. 
(16,19) in women, although other investigators failed to find such associations (7,11,12). 
The present study shows a tendency towards a negative correlation between ^ levels and 
visceral fat predominance in women, whereas the ratio of free Ej/free T was significantly 
inversely related to visceral fat accumulation. Overall, declining levels of SHBG and a 
diminished free Ej/free T ratio accompanied by increasing free T levels, as observed in 
this study, strongly suggests a relatively increased androgenicity in women with an 
abundance of visceral fat, although this was not reflected by changes in total androgen 
and estrogen levels. 
The few studies in men in which the contribution of body fat distribution on sex 
hormones was examined, reveal also discrepancies (8-10). Similar to the findings of 
Pasquali et al. (8), no association could be demonstrated between SHBG level and 
abdominal fat distribution in our study, although in the remaining studies (9,10) inverse 
relationships were observed. Seidell et al. (10) were the only investigators who found a 
negative relation between total and free T concentrations and the amount of visceral fat, 
measured by CT, in a male population covering a wide range of fatness and fat 
distribution. This is in accordance with the results of Marin et al. (39). They found that 
administration of moderate doses of transdermal preparations of T in middle-aged men 
with abdominal obesity, resulted in a reduction of the visceral adipose tissue mass. In the 
present study, however, none of the sex steroids were associated with visceral fat 
accumulation. We previously reported that the amount of visceral fat was also not 
independently related to serum lipid levels in the obese men studied (40). Significant 
negative associations between T levels (total as well as free) and the amounts of total 
fat mass and subcutaneous abdominal fat were found in the present study. This is in 
agreement with the findings of Pasquali et al. (8) indicating that the degree of obesity 
rather than adipose tissue distribution may be involved in determining abnormalities of 
sex hormone metabolism in moderately obese men. 
The weight reduction of approximately 13 kg resulted in favourable changes in most 
of the sex steroid levels and all body fat distribution variables. Levels of SHBG increase 
in both men and women after weight loss. Zumoff (5) and O'Dea et al. (3) also found 
a rise in SHBG in response to weight loss. On the contrary, other previous studies in 
women (6,7) and men (4) did not find a change in SHBG after weight loss. However, 
comparison of these results should be done with caution because of the differences in 
experimental design (e.g., duration of therapy and amount of weight loss) and in 
heterogeneity of the subjects studied (e.g., pre- or postmenopausal women, differences 
in degree of body fatness). 
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The fact that the changes in sex hormones seen in the subjects studied were not 
significantly correlated with the reduction in body fat mass within each sex, does not 
necessarily mean that losses of weight and fat do not play a role in changing sex steroid 
levels. Correlations of changes should be interpreted with caution. There is a relatively 
large between- and within-subject variability in sex steroid levels, particularly with regard 
to estrogen levels in women. These substantial variations might have caused attenuation 
of correlations. Additionally, the measurement error of visceral fat areas is relatively 
large as described previously (37). Despite these limitations, the observed relations 
between changes in sex steroids and changes in the visceral fat depot do support the 
results obtained from the cross-sectional correlations. Within women, SHBG levels and 
the free Ej/free T ratio are associated with the amount of visceral fat before as well as 
accompanying weight loss. It is interesting to note that a significant relation could be 
observed between visceral fat loss and increase of the Ej level in men, suggesting a role 
of the visceral fat depot in determining Ej levels. Moreover, before weight loss, a 
negative tendency between the amount of visceral fat and Ej was shown in men. This 
might be an explanation for the observed difference in increase of the average Ej level 
between men and women in response to weight loss. However, the physiological meaning 
of this phenomenon is unknown and whether this is real or remained by chance needs 
further investigation. 
In conclusion, these findings in healthy moderately obese men and women suggest that 
in women, visceral fat accumulation is related to a relatively increased androgenicity. In 
men, the degree of obesity rather than the type of regional fat distribution seems to be 
important in sex hormone regulation. In women but not in men, visceral fat loss seems 
to be accompanied by a relative reduction in androgenicity regardless of the degree of 
total fat loss. Thus, there seems to exist a gender difference in the relationship between 
sex hormone regulation and visceral fat predominance. 
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GENERAL DISCUSSION 
In the past decades, difference in the anatomical distribution of body fat has been an 
intensive field of interest in obesity research. It has been suggested that an abdominal 
fat predominance, which reflects an excess of visceral adipose tissue, should be 
considered as an important clinical entity. There appears to be increasing support that 
this form of obesity should therefore be treated preferentially. The research described 
in this thesis focused on the relationships between visceral fat accumulation and serum 
lipids, energy expenditure, and sex hormone levels in healthy obese men and 
premenopausal women undergoing a strictly controlled weight loss therapy. 
Magnetic resonance imaging 
Magnetic resonance imaging (MRI)-scans were used for the quantification of the various 
fat depots in the present study. The study population was too small to separate subgroups 
with extreme high and low levels of visceral fat, hence, linear associations between 
visceral fat accumulation and the variables measured were examined. 
MRI and the other available techniques suitable for human intervention studies do, 
however, not distinguish between the different visceral fat depots (1,2). There appears 
to be increasing evidence that in particular the visceral 'portal' adipose tissues (omental 
and mesenteric fat) which deliver free fatty acids (FFA) into the portal vein, and not 
retroperitoneal fat, are responsible for the metabolic disorders (3). In men, 
approximately 20% of the total visceral fat mass consists of retroperitoneal fat (4). It may 
be that associations between the visceral fat depot and the variables measured are 
attenuated by the use of the total amount of visceral fat depot instead of omental, 
mesenteric and retroperitoneal fat separately. 
It should be noted that in the present study, fat areas of different fat depots were 
calculated from one MRI-scan, and were assumed to represent the total amount of fat 
in a specific depot. Due to logistic reasons only a single scan was performed during the 
MRI-measurements, but previous studies have shown that the visceral fat area assessed 
from a single scan taken at L4-L5 level was highly correlated to the volume of visceral 
fat estimated from multiple scans (5,6). 
Although the commonly used waist/hip ratio is an useful tool in cross-sectional 
studies, it seems not to be appropriate for assessing the changes in the visceral fat depot 
(7). Correlations reported in this thesis between visceral fat loss and changes in the 
several variables measured should, however, also be interpreted with caution, because 
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of the possible error in the estimation of visceral fat (1) which reduce the precision of 
the estimate changes. 
Body fat distribution and serum lipids 
Cross-sectional 
Visceral adipose tissue has been proposed to be the most important fat depot related to 
an unfavourable serum lipid profile (8). Comparison of the average serum lipid values 
and the amounts of visceral fat in obese men and women as described in Chapter 2, 
indeed suggests a crucial role of the visceral fat depot in determining the serum lipid 
profile. Although men had, on average, lower body fat percentages than women, men had 
larger amounts of visceral fat, higher serum triglyceride levels, lower levels of HDL 
cholesterol and a lower HDL cholesterol/LDL cholesterol ratio compared with women. 
However, within each sex, the importance of the visceral fat depot in the associations 
with a less favourable serum lipid profile could only be confirmed in the females studied 
(Chapter 2). 
Terry et al. (9) suggested that an increased deposition of subcutaneous fat in the 
gluteal or femoral region, measured by dual-photon absorptiometry, may actually be 
associated with a favourable serum lipid profile. It remains to be determined whether 
this is a real biological phenomenon, because an obese person with excess body fat 
predominantly stored in the subcutaneous regions may have less fat in the abdominal fat 
depots compared with equally obese subjects with less subcutaneous fat. The present 
study could not confirm the proposed favourable protective role of the subcutaneous fat 
layer. The subcutaneous adipose tissues at abdominal and hip level were not related to 
any of the serum lipids in either sex. 
Age and the extent of obesity are, in addition to gender, the most important variables 
that affect body fat distribution (10,11). Despite the attempt in the present study to 
match both men and women with high and low waist/hip ratios properly for age and 
body mass index, age in both sexes and body fat percentage or fat mass in men were 
positively associated with the amount of visceral fat. It is well known that the body mass 
index is a relatively good, but not perfect indicator of the degree of adiposity. Body fat 
percentage as measured by hydrostatic weighing seems to be a better indicator (12). 
After adjustment for age and body fatness in the men studied, the significant positive 
relations between an abundance of visceral fat and total-, LDL cholesterol and 
triglycerides as well as the inverse association with the HDL cholesterol/LDL cholesterol 
ratio disappeared. From a review of the literature, Seidell (13) suggested that three 
behavioral characteristics (physical activity pattern, smoking and alcohol consumption) 
may also play a role in the relationships between body fat distribution and metabolic and 
clinical abnormalities. In the present study, these possible confounding factors were 
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absent or minimal and the variability in physical activity pattern in our, in general, 
sedentary individuals was low. 
As proposed in the introduction, portal levels of FFAs derived from visceral adipose 
tissue may be a direct causative link between visceral fat accumulation and the 
generation of risk factors for metabolic disorders related to abdominal obesity. In the 
present study, however, in both sexes no relationship between FFA concentrations in 
peripheral blood and visceral fat predominance was observed (unpublished results). 
Explanations for this failure might be the determinations of FFAs in peripheral blood 
instead of portal blood and/or the large within-subject variability of FFA concentrations. 
It has previously been proposed that exposure of the liver to high portal FFAs may lead 
to increased levels of insulin by interfering with the hepatic clearance of insulin (3). 
Indeed, in both sexes, visceral fat accumulation was related to increased levels of insulin 
and to an elevated insulin/glucose ratio, even after adjustment for age and body fatness 
(Chapter 3). Recently, investigators suggested that a family history of diabetes may play 
a potential role in the relationship between body fat distribution and insulin levels (14). 
Unfortunately, adequate information concerning a family history of diabetes were not 
available in the present study. It has been proposed that hyperinsulinaemia may lead to 
elevated triglyceride concentrations and decreased HDL cholesterol concentrations (15), 
and consequently, elevated insulin levels may be partially responsible for the associations 
between visceral fat accumulation and an unfavourable serum lipid profile. It is clear that 
further research is required to reveal the complex associations between visceral fat 
accumulation and the risk factors for metabolic disorders associated with obesity. 
Response to weight loss treatment 
Obese subjects with an initial abundance of visceral fat lose more visceral fat on a strictly 
controlled energy-deficit diet than obese subjects with smaller amounts of visceral fat 
(Chapter 3), which may be expected to lead to beneficial changes in the serum lipid 
profile particularly in obese subjects with visceral fat predominance. In obese women but 
not in men, visceral fat accumulation before weight loss was associated with improvement 
of HDL cholesterol and triglyceride levels after weight loss (Chapter 4). 
Comparison of the observed larger reduction in visceral fat and the more marked 
improvement of the serum lipid profile in men than in women in response to the weight 
loss treatment, suggests a potential role of visceral fat loss in improving the serum lipid 
levels of obese subjects. While in women a loss of visceral fat was associated with an 
increased HDL cholesterol, a more general beneficial effect of visceral fat loss was not 
seen using correlation analyses within each sex (Chapter 4). 
Only very few studies have investigated the relationships between changes in body fat 
distribution and changes in serum lipid profile in obese women undergoing weight loss 
treatment (16-18) and, to our knowledge, this is the first study carried out in obese men. 
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These intervention studies revealed, however, equivocal results. Fujioka et al. (16) found 
that in severely obese Japanese women, visceral fat loss, measured by CT, was associated 
with improvement of triglyceride levels but not with total- and HDL cholesterol. From 
the description of their study design, it is not clear whether they measured serum lipid 
levels in a real weight-maintenance state, which is particularly important with regard to 
HDL cholesterol levels (19). The other two studies in women (17,18) used changes in 
waist/hip ratio as an indicator of changes in body fat distribution. Changes in waist/hip 
ratio, however, do not seem to reflect changes in the visceral fat depot adequately (7). 
Effects of factors known to affect body fat distribution as well as serum lipid levels 
such as smoking, physical activity pattern and alcohol consumption, were kept to a 
minimum by selection of the subjects and by instructions not to change any of these 
behaviours during the course of the study. It should be noted that in addition to changes 
in body weight and the various fat depots in response to the energy-deficit diet, the 
nutrient composition of this diet per se might be, at least partly, attributable to the 
observed changes in serum lipid levels. On the basis of the analyses described in Chapter 
4, it is impossible to distinguish completely the specific contributions of visceral fat loss, 
loss of body weight and changes in diet on improving the serum lipid profile of obese 
subjects. This phenomenon is inherent to dietary weight loss programs. The independent 
effects of weight loss and dietary fat modification on serum lipids are reported in 
Chapter 5. 
Weight loss, dietary fat modification and serum lipids 
Weight loss per se without changes in the composition of the diet, had beneficial effects 
on all serum lipid levels. Dietary fat modification according to dietary recommendations 
(reductions in intake of total fat and saturated fatty acids (20,21)) without energy 
restriction, also had favourable effects on total-, LDL cholesterol, and triglycerides, but 
it led to unfavourable reductions in HDL cholesterol and HDL cholesterol/LDL 
cholesterol ratios. The effects of weight loss per se and dietary fat modification seem to 
be additive. The resultant effect of weight loss and fat modification combined on HDL 
cholesterol was practically nihil (Chapter 5). 
In the present study, the diets were as well controlled as is possible in an outpatient 
setting. As mentioned before, confounding factors known to affect serum lipids were 
absent or were kept constant during the study. It is therefore likely that the effects 
observed can be attributed to the imposed dietary changes and changes in body 
composition. 
Despite the great effort to maintain the body weights of the subjects stable preceding 
the weight loss period by adjustments of individual energy intakes, a small average weight 
loss was observed. This phenomenon has also previously been reported by other 
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investigators (22). Taking into account this small weight loss as well as the fact that 
dietary fat was isocaloric replaced by carbohydrates, as actually advocated by dietary 
guidelines, instead of by protein (23,24), the favourable contribution of the dietary fat 
modification without energy restriction on the serum lipid profile may expected to be 
slightly less than observed in this study. Recently, some studies suggested that obesity 
may diminish the responsiveness to certain dietary changes (25,26). Thus, in the dietary 
treatment of obesity, weight loss seems to be important in optimizing the serum lipid 
profile of obese subjects and seems to be even greater than that of dietary fat 
modification, although these latter differences were not statistically tested. 
Unfortunately, the groups of men and women which remained for these analyses, 
were too small to derive definite conclusions with respect to gender differences. 
Particulary, differences in body fat deposition could be an important aspect to take into 
consideration. 
Body fat distribution and energy expenditure 
The impact of body fat distribution on energy expenditure has been investigated by 
several research groups. Research on human energy expenditure has mainly focused on 
studying the resting metabolic rate (RMR) and diet-induced thermogenesis (DIT), 
because these two components of daily energy expenditure are quantitatively important 
for overall energy expenditure and can be assessed relatively easy with the use of indirect 
calorimetry. The results in Chapter 3 showed that, in obese women but not in obese men, 
a relative predominance of visceral fat was positively related to RMR and DIT. The 
reasons for these observed gender differences are unknown, but it should be noted that 
relationships between visceral fat and other variables were generally stronger in the 
women than in the men of this study population. The proposed explanations in the 
literature for the increased RMR and DIT in abdominal obese in comparison to gluteal-
femoral obese as described in Chapter 3, are in fact applicable to both men and women. 
Differences in sex hormone concentrations between both sexes might be a possible 
explanation, although at the moment there is only little evidence to support this 
possibility. 
The question how to interpret the relatively higher RMR and DIT among obese 
females with larger amounts of visceral fat is intriguing. Obesity is clearly associated with 
a high absolute RMR, although the variation in the relative RMR at any given body size 
can be substantial (27). Controversy exists whether or not the obese are characterized 
by a defective DIT (27,28). In the present study, no comparison could be made with 
results in lean subjects. Among the studies in which the relationships between body fat 
distribution and energy expenditure were investigated, only Weststrate et al. (29) 
included an age-matched non-obese control group of women in their study. They found 
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that the gluteal-femoral obese can be characterized by relatively reduced RMRs in 
comparison with either abdominally obese women or lean women. This might implicate 
that a gluteal-femoral type of obesity seems to be more closely associated with decreased 
energy expenditure rather than abdominal obesity with increased energy expenditure. It 
is obvious, however, that more research is necessary to investigate this issue more 
properly. 
The relatively higher observed RMR and DIT in women with abdominal obesity 
might be an explanation why previous studies have found larger weight losses in response 
to a dietary weight loss treatment in these women compared with obese women with a 
gluteal-femoral fat distribution. If the same standardized energy restricted diet was given 
to obese subjects with different types of body fat distribution, which was the case in 
previous studies, women with abdominal obesity might have larger energy deficits which 
might have led to larger losses of body weight. In the present study, all obese individuals 
were subjected to the same 4.2 MJ/day energy-deficit diet, which theoretically would lead 
to similar amounts of weight loss in all subjects. Obese subjects with an initial abundance 
of visceral fat did not lose more body weight and body fat, but they lost more visceral 
than subjects with less visceral fat (Chapter 3). 
Body fat distribution and sex hormones 
In the obese men studied, no relationship could be found between visceral fat 
accumulation and any of the sex hormone levels. On the contrary, in the premenopausal 
obese women, an abundance of visceral fat appeared to be associated with a relatively 
increased androgenicity, which was reflected by reduced levels of sex-hormone-binding 
globulin (SHBG), a diminished free 176-oestradiol/free testosterone ratio as well as by 
elevated levels of free testosterone, but not by differences in total androgen and 
oestrogen levels (Chapter 6). Diminished SHBG levels may result in increased metabolic 
clearance rates of testosterone and other androgens for which it has a high binding 
affinity, and it may lead to enhanced turnover and tissue exposure to androgens despite 
normal plasma levels (30). Thus, metabolic clearance and production rates reveal more 
about sex hormone status than peripheral concentrations of sex hormones, and therefore, 
more sophisticated studies are necessary in which these complicated variables can 
accurately be measured. 
The weight loss intervention was beneficial in normalizing most of the sex hormone 
levels in both sexes. In women but not in men, a reduction in the visceral fat depot 
seems to be accompanied by a relative reduction in androgenicity regardless of the 
degree of total fat loss (Chapter 6). It should be noted, however, that these observed 
changes in sex hormone concentrations are not only attributable to changes in body 
composition per se but might also be the result of changes in the nutrient composition 
102 
General discussion 
of the diets. It has been reported that dietary lipids may alter some sex hormone levels 
(31,32), although an other study could not support these findings (33). 
Comparison of the present results with previous published studies, in which the 
contribution of the body fat distribution pattern on sex hormones was investigated, is 
rather difficult due to the different indices of androgenicity and the heterogeneity of the 
subjects studied. In this study, only healthy obese men and premenopausal obese women 
with regular menstrual cycles were included. At the selection, the women were screened 
for hirsutism in order to prevent inclusion of females with a poly cystic ovary (PCO) 
syndrome, who have increased levels of androgens. In this study, serum testosterone 
levels were all in the normal range, therefore, the possibility of having included women 
with PCO syndrome was unlikely. An underlying problem with interpreting the results 
of sex hormone measurements in women is the length of the menstrual cycle. An 
epidemiological study in 32,856 women, demonstrated that the prevalence of relatively 
long menstrual cycles is higher in women with a larger waist/hip ratio (34). This suggests 
that at the time of blood sampling, the women with an abdominal fat distribution might 
have been in an earlier stage of the menstrual cycle than the women with a gluteal-
femoral type of fat distribution. It is noteworthy, however, that despite this confounding 
aspect, which potentially could mask an association, cross-sectionally as well as 
prospectively the same relationships between body fat distribution and sex hormone 
levels were obtained. 
Sex hormones may play a major role in determining the risk of coronary heart disease 
(35,36). Several hypothetical mechanisms were proposed to explain the relationship 
between sex hormones and serum lipid metabolism, but any discussion of the nature of 
this relationship must include other metabolic variables such as hyperinsulinaemia and 
body fat distribution, as previously reviewed by Wild (37). Preliminary data from the 
present study in half of the study population indeed suggested an association between sex 
hormone concentrations and serum lipid levels in obese men and women (38). However, 
in women only, the relationship between sex hormones and serum lipids appeared to be 
mediated by differences in body fat distribution (38). In addition, some investigators 
proposed that hyperandrogenism may be, at least partly, responsible for 
hyperinsulinaemia and insulin resistance in abdominally obese women (39,40). Vice 
versa, it has been suggested that insulin may be a factor amplifying LH-dependent 
ovarian androgen synthesis (41). Nestler et al. (42) found it unlikely that 
hyperandrogenism causes insulin resistance, because normal men do not have insulin 
resistance despite they have high androgen levels. In previous studies in men, the 
associations between androgens, insulin metabolism and abdominal fat distribution as 
observed in women, could not be confirmed (43,44). Pasquali et al. (44) suggested that 
hyperinsulinaemia may be involved in the regulation of sex hormone metabolism in 
obese men by mechanisms that probably differ from those involved in the development 
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of hyperandrogenism in obese women. The underlying mechanisms have, however, not 
yet been clarified. Further research is required to reveal the complex inter-relationships 
between sex hormones, serum lipids, insulin levels and body fat distribution. 
Study population and gender differences 
It is noteworthy that healthy moderately obese men and premenopausal women were 
included in the present study in order to preclude the effects of metabolic disturbances 
on the observations. This selection of the participants may have some disadvantages with 
respect to the applicability of the results to a general obese population (e.g., including 
postmenopausal women, hyperlipidaemic subjects, adolescents, diabetics or morbidly 
obese subjects). These limitations should be kept in mind when extrapolating the results. 
As a consequence of the selection criteria used, the present study population was rather 
homogeneous with respect to the degree of body fatness and serum lipids, whereas the 
ranges in body fat distribution were considerable in men as well as in women. 
The present findings suggests that there may be gender differences in the 
relationships between visceral fat accumulation and serum lipids, energy expenditure, and 
sex hormones (Chapter 2,3,4,6). It is surprising to note that in women, the visceral fat 
depot plays an important role in all these three aspects, whereas in men, the visceral fat 
depot seems not to be important. In both sexes, the variability in waist/hip ratio, body 
fatness, age and in the amounts of the different fat depots were similar. Most previous 
studies, in which the importance of the visceral fat depot has been established, have been 
carried out in obese women. It might be that the few studies performed in men did not 
correct for the possible confounders of age and the degree of adiposity. One should keep 
in mind that in samples of subjects showing large variations in levels of total body fat, 
any indicator of total body fatness may be related to the amount of visceral fat. Whether 
or not these gender differences are real or due to this specific population studied should 
be confirmed in future studies. In addition, the precise underlying mechanisms potentially 
responsible for these gender differences should be further investigated as well, because 
they could not be derived from the present study. 
Conclusions 
Health authorities recommend obese subjects to lose body weight in order to reduce the 
risk for metabolic complications associated with obesity. It has been suggested that 
weight loss strategies should be aimed primarily to those individuals with abdominal 
obesity, due to their elevated risk for such health hazards. However, clear scientific 
evidence for these propositions is still scarce. 
The present findings suggest that there seem to be gender differences in the 
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associations between visceral fat accumulation and the serum lipid profile, components 
of energy expenditure (RMR and DIT), and sex hormone levels in healthy moderately 
obese subjects. In women but not in men, visceral fat predominance was related to a less 
favourable serum lipid levels, higher levels of RMR and DIT, as well as to a relatively 
increased androgenicity. In obese men, the critical role of the visceral fat depot could not 
be confirmed. The reasons for these gender differences remain to be elucidated. 
The impact of weight loss per se appears to be substantial in optimizing the serum 
lipid profile of obese subjects in weight loss programmes. Dietary fat modification as 
advocated by dietary guidelines (reducing the intake of total fat and saturated fatty acids 
(20,21)) also had beneficial effects on some serum lipid levels. The considerable additive 
effects of weight loss per se underscores the importance of establishing successful dietary 
weight loss treatment for obesity. It is, however, notoriously difficult for post-obese 
subjects to maintain the reduced body weight (45) and, therefore, more emphasis should 
be paid to the improvement of the long-term prognosis of the treatment of obesity and 
most of all to the prevention of obesity. 
In addition, it is concluded that particularly healthy moderately obese women with 
a visceral fat predominance benefit from a dietary weight loss treatment with respect to 
their serum lipid profile and sex hormone levels, whereas in healthy moderately obese 
men, a distinction with respect to the amount of visceral fat seems not to be relevant. 
Extrapolation from this selected group of obese subjects to a general obese population 
should be done with caution. It should be kept in mind that the present findings do not 
reveal whether weight loss treatment will indeed reduce the number of subjects with 
coronary heart disease. Therefore, in future, long-term follow-up studies are needed to 
evaluate the efficacy of weight loss treatment for the prevention of this hazardous 
disease. 
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SUMMARY 
Obesity is a major public health problem in affluent societies, which is associated with 
a large number of metabolic complications. Health authorities recommend obese subjects 
to lose body weight in order to reduce the increased health risks associated with obesity. 
However, it has been suggested that particularly the distribution of body fat rather than 
overall body fatness may be responsible for specific health hazards of obesity. In 
particular, the adipose tissue stored in the abdominal cavity i.e. the visceral fat depot, 
seems to play an important role. At present, there appears to be increasing support that 
weight loss strategies should be aimed primarily to those obese individuals with visceral 
fat predominance. However, clear scientific evidence for these propositions is still scarce. 
The purpose of the research described in this thesis was to investigate the 
relationships between visceral fat accumulation and serum lipids, energy expenditure, and 
sex hormone levels in healthy obese men and premenopausal women undergoing weight 
loss therapy. The subjects, aged 27-51 years, with an initial body mass index of 28-38 
kg/m2, received a strictly controlled diet for 13 weeks providing a 4.2 MJ/day energy 
deficit. Magnetic resonance imaging was used to quantify fat depots. 
In women but not in men, visceral fat accumulation was associated with a less 
favourable serum lipid profile independent of age and body fat percentage: higher 
triglyceride levels, lower levels of high-density-lipoprotein (HDL) cholesterol and a 
reduced HDL cholesterol/low-density-lipoprotein (LDL) cholesterol ratio. Within each 
sex, subcutaneous fat neither at abdominal level nor at hip level was related to serum 
lipid levels (Chapter 2). In addition, in women only, visceral fat predominance was 
positively related to resting metabolic rate (RMR) and diet-induced thermogenesis (DIT) 
(Chapter 3). Furthermore, in women, an abundance of visceral fat was associated with 
a relatively increased androgenicity as reflected by diminished levels of sex-hormone-
binding-globulin (SHBG) and the ratio of free 176-oestradiol (ly/free testosterone (T), 
and elevated levels free T. In men, a relationship between visceral fat accumulation and 
sex hormone levels could not be confirmed (Chapter 6). 
Obese women and men with an initial abundance of visceral fat did not lose body 
weight more easily than obese subjects with less visceral fat, but they lost larger amounts 
of visceral fat (Chapter 3). As a consequence of the initially larger visceral fat depot in 
men than in women, men had a larger reduction in visceral fat compared with women. 
The mean weight reduction of 12.2 ± 3.5 (SD) kg due to the energy-deficit diet, resulted 
also in larger reductions in serum levels of total cholesterol, LDL cholesterol, and 
triglycerides and a larger increase in the HDL cholesterol/LDL cholesterol ratio in men 
than in women. Comparison of these average changes between both sexes suggests a 
potential role of visceral fat loss in improving the serum lipid profile of obese subjects. 
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However, within each sex, no significant associations between visceral fat loss and 
changes in serum lipids could be found, except for a significant relationship in women 
between visceral fat loss and improvement of the HDL cholesterol level. In obese women 
but not in men, visceral fat accumulation before weight loss was associated with 
improvement of HDL cholesterol and triglyceride levels after weight loss (Chapter 4). 
In addition, in women only, a reduction in the visceral fat depot was accompanied by 
rises in SHBG levels and the free E2/free T ratio, and thus, by a relative reduction in 
androgenicity regardless of total body fat loss (Chapter 6). 
In this study, the independent effect of weight loss on serum lipids could be 
separated from the effect of dietary fat modification usually accompanying a dietary 
weight loss treatment. Weight loss per se had a beneficial effect on all serum lipid levels. 
Dietary fat modification as advocated by dietary guidelines (reducing the intake of total 
fat and saturated fatty acids) without energy restriction, also had a favourable effect on 
total-, LDL cholesterol, and triglycerides, but it led to unfavourable reductions in HDL 
cholesterol and HDL cholesterol/LDL cholesterol ratios. The effects of weight loss per 
se and dietary fat modification seems to be additive (Chapter 5). 
The considerable additive effects of weight loss per se in optimizing the serum lipid 
profile of obese subjects underscores the importance of establishing successful dietary 
weight loss treatment for obesity. It is, however, notoriously difficult for post-obese 
subjects to maintain the reduced body weight and, therefore, more emphasis should be 
paid to the improvement of the long-term prognosis of the treatment of obesity and most 
of all to the prevention of obesity. Furthermore, the present findings suggest that there 
seems to be gender differences in the associations between visceral fat accumulation and 
serum lipids, energy expenditure (RMR and DIT), and sex hormone levels in healthy 
moderately obese subjects. The reasons for these gender differences remain to be 
elucidated. It is concluded that particularly healthy moderately obese women with a 
visceral fat predominance benefit from a dietary weight loss treatment with respect to 
their serum lipid profile and sex hormone levels, whereas in healthy moderately obese 
men, a distinction with respect to the amount of visceral fat seems not to be relevant. 
Extrapolation from this selected group of obese subjects to a general obese population 
should be done with caution. It should be kept in mind that the present findings do not 
reveal whether weight loss treatment will indeed reduce the number of subjects with 
coronary heart disease. Therefore, in future, long-term follow-up studies are needed to 
evaluate the efficacy of weight loss treatment for the prevention of this hazardous 
disease. 
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Obesitas (vetzucht) is een groot probleem voor de volksgezondheid in welvarende 
landen. Gezondheidsorganisaties adviseren dikke mensen af te slanken om zo de 
verhoogde gezondheidsrisico's die samengaan met obesitas, zoals coronaire hartziekten 
en niet-insuline afhankelijke diabetes, te reduceren. In diverse studies wordt echter 
beweerd dat vooral de vetverdeling en niet zozeer de mate van overgewicht de specifieke 
metabole complicaties van obesitas veroorzaakt. Met name het vet dat opgeslagen is in 
de buikholte (het zogenaamd visceraal vet) schijnt hierbij een belangrijke rol te spelen. 
Momenteel wordt in toenemende mate gesuggereerd dat vooral dikke mensen met een 
overmaat aan visceraal vet geadviseerd zou moeten worden om af te slanken. Duidelijke 
wetenschappelijke bewijzen voor deze beweringen zijn nog niet geleverd. 
Dit onderzoek had als doel de relaties te bestuderen tussen de hoeveelheid visceraal 
vet enerzijds en de serum lipiden, het energieverbruik en de geslachtshormonen 
anderzijds bij gezonde, obese mannen en premenopausale vrouwen die een afslankdieet 
volgden. De proefpersonen varierend in leeftijd van 27 tot 51 jaar en met een 
queteletindex van 28 tot 38 kg/m2, ontvingen gedurende 13 weken een gecontroleerd 
dieet dat 4,2 MJ (1000 kcal) lager was dan hun normale energiebehoefte. De 
verschillende vetdepots werden gekwantificeerd met behulp van een beeldvormende 
techniek gebaseerd op magnetische resonantie. 
In tegenstelling tot bij mannen, werd bij vrouwen geconstateerd dat een overmaat 
aan visceraal vet, onafhankelijk van leeftijd en vetpercentage, gerelateerd was aan een 
minder gunstig serum-lipidenprofiel: hogere triglyceriden spiegels, lagere concentraties 
hoog-densiteit-lipoproteine (HDL)-cholesterol en een lagere verhouding tussen HDLr 
cholesterol en laag-densiteit-lipoproteine (LDL)-cholesterol. Voor beide sexen bleek er 
geen relatie te bestaan tussen de hoeveelheid onderhuidsvet ter hoogte van de buik en 
de heupen, en het gehalte aan serum lipiden (Hoofdstuk 2). Bovendien werd alleen bij 
vrouwen een positief verband gevonden tussen de hoeveelheid visceraal vet enerzijds en 
de ruststofwisseling en de door voeding gei'nduceerde thermogenese anderzijds 
(Hoofdstuk 3). Vrouwen met een overmaat aan visceraal vet bleken tevens een relatief 
verhoogde androgeniteit te hebben, hetgeen tot uitdrukking kwam in een lagere 
geslachtshormoon-gebonden-globuline (SHBG) spiegel, een verhoogde vrije testosteron 
(T) spiegel en een lagere verhouding vrij 178-oestradiol (Ey/vrij T. Bij mannen kon 
echter geen relatie worden aangetoond tussen de hoeveelheid visceraal vet en 
geslachtshormonen concentraties (Hoofdstuk 6). 
Obese vrouwen en mannen met relatief veel visceraal vet bleken niet gemakkelijker 
hun lichaamsgewicht te verminderen dan obese mensen met minder visceraal vet. 
Daarentegen verloren zij wel grotere hoeveelheden visceraal vet (Hoofdstuk 3). 
115 
Samenvatting 
Aangezien mannen meer visceraal vet hebben dan vrouwen, verloren obese mannen dus 
ook meer visceraal vet. Het gemiddelde gewichtsverlies van 12,2 ± 3,5 (SD) kg als gevolg 
van het energiebeperkt dieet, resulteerde bij mannen in een grotere afname in het totaal 
cholesterol-, LDL-cholesterol- en triglyceridengehalte, en in een grotere toename van de 
HDL-cholesterol/LDL-cholesterol verhouding dan bij vrouwen. Vergelijking van deze 
gemiddelde veranderingen tussen beide sexen suggereert dat een reductie van de 
hoeveelheid visceraal vet van belang is bij het verbeteren van het serum-lipidenprofiel 
van obese mensen. Binnen beide sexen konden echter geen significante relaties worden 
aangetoond tussen de hoeveelheid visceraal vetverlies en veranderingen in de serum 
lipiden spiegels, met uitzondering van een significant verband bij vrouwen tussen een 
reductie van visceraal vet en een verhoging van het HDL-cholesterolgehalte. Alleen bij 
obese vrouwen bleek een overmaat aan visceraal vet voor afslanken gerelateerd te zijn 
aan een verbetering van zowel de HDL-cholesterol- als de triglyceriden spiegel na 
afslanken (Hoofdstuk 4). Bovendien werd bij vrouwen een verband gevonden tussen de 
hoeveelheid visceraal vetverlies enerzijds en een verhoging in de SHBG Spiegel en de 
verhouding vrij Ej/vrij T, en dus een relatieve reductie in androgeniteit, anderzijds 
(Hoofdstuk 6). 
In deze afslankstudie was het mogelijk om het effect van het gewichtsverlies op het 
serum-lipidenprofiel afzonderlijk te bestuderen van het effect van veranderingen in de 
voedingssamenstelling. Het gewichtsverlies had een gunstig effect op alle serum lipiden 
spiegels. Een verandering in voedingsvet volgens de voedingsrichtlijnen (vermindering 
van totale vet- en verzadigde vetzurenconsumptie) zonder een beperking in de energie-
inname bleek ook een gunstig effect te hebben op het totaal cholesterol-, LDL-
cholesterol- en triglyceridengehalte. Het leidde echter ook tot een afname van het HDL-
cholesterolgehalte en de HDL-cholesterol/LDL-cholesterol verhouding. De effecten van 
gewichtsverlies en de veranderingen in de voeding bleken cumulatief te zijn (Hoofdstuk 
5). 
De aanzienlijke bijdrage van het gewichtsverlies aan de verbetering van het serum-
lipidenprofiel van obese mensen bij een energiebeperkt dieet benadrukt het belang van 
afslanken. Voor afgeslankte mensen is het echter moeilijk om hun gereduceerde 
lichaamsgewicht te behouden. Daarom zou meer aandacht moeten worden besteed aan 
het handhaven van een succesvolle gewichtsafname en vooral aan de preventie van 
obesitas. De resultaten van dit onderzoek suggereren dat er bij gezonde, matige obese 
mensen verschillen bestaan tussen mannen en vrouwen voor wat betreft de relaties 
tussen een overmaat aan visceraal vet enerzijds en de serum lipiden, het energieverbruik 
(de ruststofwisseling en de door voeding geinduceerde thermogenese) en de 
geslachtshormonen anderzijds. Een verklaring voor dit verschil tussen de sexen moet nog 
worden onderzocht. Concluderend kan gesteld worden dat met name gezonde, matige 
obese, premenopausale vrouwen met een overmaat aan visceraal vet baat hebben bij een 
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afslankdieet vanwege een verbetering van het serum-lipidenprofiel en de 
geslachtshormoonspiegels. Bij gezonde, matige obese mannen daarentegen, lijkt een 
onderscheid ten aanzien van de hoeveelheid visceraal vet niet relevant te zijn. 
Extrapolatie van de resultaten uit dit onderzoek, uitgevoerd bij een geselecteerde groep 
obese mensen, naar een algemene obese populatie zou met voorzichtigheid betracht 
moeten worden. Verder moet men zich realiseren dat de huidige resultaten niet 
aangeven of afslanken inderdaad leidt tot minder gevallen met coronaire hartziekten. In 
de toekomst zijn daarom lange termijn follow-up studies nodig die het effect van 
afslanken op de preventie van deze ziekten evalueren. 
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